
<html lang="en"     class="pb-page"  data-request-id="33ce1423-e61b-4556-8b1c-0883d64d5211"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-22;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b01228"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells" /></meta><meta name="dc.Creator" content="Andrew J.  Robles" /></meta><meta name="dc.Creator" content="Shelby  McCowen" /></meta><meta name="dc.Creator" content="Shengxin  Cai" /></meta><meta name="dc.Creator" content="Michaels  Glassman" /></meta><meta name="dc.Creator" content="Francisco  Ruiz, II" /></meta><meta name="dc.Creator" content="Robert H.  Cichewicz" /></meta><meta name="dc.Creator" content="Stanton F.  McHardy" /></meta><meta name="dc.Creator" content="Susan L.  Mooberry" /></meta><meta name="dc.Description" content="Targeted therapies for ER+/PR+ and HER2-amplified breast cancers have improved patient survival, but there are no therapies for triple negative breast cancers (TNBC) that lack expression of estroge..." /></meta><meta name="Description" content="Targeted therapies for ER+/PR+ and HER2-amplified breast cancers have improved patient survival, but there are no therapies for triple negative breast cancers (TNBC) that lack expression of estroge..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 3, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01228" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01228" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01228" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01228" /></link>
        
    
    

<title>Structure–Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01228" /></meta><meta property="og:title" content="Structure–Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0009.jpeg" /></meta><meta property="og:description" content="Targeted therapies for ER+/PR+ and HER2-amplified breast cancers have improved patient survival, but there are no therapies for triple negative breast cancers (TNBC) that lack expression of estrogen and progesterone receptors (ER/PR), or amplification or overexpression of HER2. Gene expression profiling of TNBC has identified molecular subtypes and representative cell lines. An extract of the Texas native plant Amyris texana was found to have selective activity against MDA-MB-453 cells, a model of the luminal androgen receptor (LAR) subtype of TNBC. Bioassay-guided fractionation identified two oxazole natural products with selective activity against this cell line. Conducted analog synthesis and structure–activity relationship studies provided analogs with more potent and selective activity against two LAR subtype cell line models, culminating in the discovery of compound 30 (CIDD-0067106). Lead compounds discovered have potent and selective antiproliferative activities, and mechanisms of action studies show they inhibit the activity of the mTORC1 pathway." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01228"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01228">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01228&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01228&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01228&amp;href=/doi/10.1021/acs.jmedchem.7b01228" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9275-9289</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01209" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01280" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Robles">Andrew J. Robles</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3447-0169" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shelby++McCowen">Shelby McCowen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shengxin++Cai">Shengxin Cai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michaels++Glassman">Michaels Glassman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco++Ruiz%2C++II">Francisco Ruiz, II</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+H.++Cichewicz">Robert H. Cichewicz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0744-4117" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stanton+F.++McHardy">Stanton F. McHardy</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0070-4924" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+L.++Mooberry">Susan L. Mooberry</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Pharmacology and <sup>‡</sup>UT Health San Antonio Cancer Center, UT Health San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Center for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span></div><div class="aff-info" id="aff3"><span class="aff-text"><sup>∥</sup>Natural Product Discovery Group, Institute for Natural Products Applications and Research Technologies, and <sup>⊥</sup>Department of Chemistry & Biochemistry, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: +1 (210) 458-8676. Fax: +1 (210) 458-7428. E-mail: <a href="/cdn-cgi/l/email-protection#720106131c061d1c5c1f111a1300160b32070601135c171607"><span class="__cf_email__" data-cfemail="106364717e647f7e3e7d73787162746950656463713e757465">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Tel: +1 (210) 567-4788. Fax: +1 (210) 567-4300. E-mail: <a href="/cdn-cgi/l/email-protection#fb969494999e898982bb8e8f938898889ad59e9f8e"><span class="__cf_email__" data-cfemail="adc0c2c2cfc8dfdfd4edd8d9c5decedecc83c8c9d8">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01228&amp;href=/doi/10.1021%2Facs.jmedchem.7b01228" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9275–9289</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 20, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 August 2017</li><li><span class="item_label"><b>Published</b> online</span>3 November 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 November 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01228" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01228</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9275%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAndrew%2BJ.%2BRobles%252C%2BShelby%2BMcCowen%252C%2BShengxin%2BCai%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D22%26contentID%3Dacs.jmedchem.7b01228%26title%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BNew%2BNatural%2BProduct-Based%2BDiaryloxazoles%2Bwith%2BSelective%2BActivity%2Bagainst%2BAndrogen%2BReceptor-Positive%2BBreast%2BCancer%2BCells%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9289%26publicationDate%3DNovember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01228"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2026</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01228" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Robles&quot;},{&quot;first_name&quot;:&quot;Shelby&quot;,&quot;last_name&quot;:&quot;McCowen&quot;},{&quot;first_name&quot;:&quot;Shengxin&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Michaels&quot;,&quot;last_name&quot;:&quot;Glassman&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Ruiz&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;H. Cichewicz&quot;},{&quot;first_name&quot;:&quot;Stanton&quot;,&quot;last_name&quot;:&quot;F. McHardy&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;L. Mooberry&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;9275-9289&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01228&quot;},&quot;abstract&quot;:&quot;Targeted therapies for ER+/PR+ and HER2-amplified breast cancers have improved patient survival, but there are no therapies for triple negative breast cancers (TNBC) that lack expression of estrogen and progesterone receptors (ER/PR), or amplification or overexpression of HER2. Gene expression profiling of TNBC has identified molecular subtypes and representative cell lines. An extract of the Texas native plant Amyris texana was found to have selective activity against MDA-MB-453 cells, a model of the luminal androgen receptor (LAR) subtype of TNBC. Bioassay-guided fractionation identified two oxazole natural products with selective activity against this cell line. Conducted analog synthesis and structure–activity relationship studies provided analogs with more potent and selective activity against two LAR subtype cell line models, culminating in the discovery of compound 30 (CIDD-0067106). Lead compounds discovered have potent and selective antiproliferative activities, and mechanisms of action studies show &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01228&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01228" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01228&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01228" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01228&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01228" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01228&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01228&amp;href=/doi/10.1021/acs.jmedchem.7b01228" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01228" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01228" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01228%26sid%3Dliteratum%253Aachs%26pmid%3D29053266%26genre%3Darticle%26aulast%3DRobles%26date%3D2017%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BNew%2BNatural%2BProduct-Based%2BDiaryloxazoles%2Bwith%2BSelective%2BActivity%2Bagainst%2BAndrogen%2BReceptor-Positive%2BBreast%2BCancer%2BCells%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D22%26spage%3D9275%26epage%3D9289%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/jmcmar.2017.60.issue-22/20171122/jmcmar.2017.60.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Targeted therapies for ER+/PR+ and HER2-amplified breast cancers have improved patient survival, but there are no therapies for triple negative breast cancers (TNBC) that lack expression of estrogen and progesterone receptors (ER/PR), or amplification or overexpression of HER2. Gene expression profiling of TNBC has identified molecular subtypes and representative cell lines. An extract of the Texas native plant <i>Amyris texana</i> was found to have selective activity against MDA-MB-453 cells, a model of the luminal androgen receptor (LAR) subtype of TNBC. Bioassay-guided fractionation identified two oxazole natural products with selective activity against this cell line. Conducted analog synthesis and structure–activity relationship studies provided analogs with more potent and selective activity against two LAR subtype cell line models, culminating in the discovery of compound <b>30</b> (CIDD-0067106). Lead compounds discovered have potent and selective antiproliferative activities, and mechanisms of action studies show they inhibit the activity of the mTORC1 pathway.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65781" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65781" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Triple-negative breast cancers (TNBC) represent approximately 15% of breast cancers and are defined by the lack of expression of estrogen/progesterone receptors (ER/PR) and human epidermal growth factor receptor 2 (HER2).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> However, the classification of these cancers as triple-negative only provides information as to what these cancers are not, rather than what they are. Patients with TNBC typically have poorer prognoses than patients with ER+/PR+ and HER2-amplified tumors; the median survival is a mere 13 months for patients with metastatic TNBC.<a onclick="showRef(event, 'ref1 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref3 ref4">(1, 3, 4)</a> There are no targeted therapies or validated pharmacological targets for TNBC. Therefore, patients receive chemotherapy with cytotoxic and genotoxic agents, which include taxanes, eribulin, anthracyclines, carboplatin, gemcitabine, and/or cyclophosphamide.<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1, 3)</a> However, drug-resistance invariably develops leaving few effective treatment options. Patients with ER+/PR+ and/or HER2-amplified breast cancers are now surviving longer as a direct result of the development of targeted therapies that inhibit the molecular drivers of these cancers. However, the highly heterogeneous nature of TNBC, which encompasses diverse cancers with different molecular and phenotypic characteristics, has thus far precluded targeted therapies for these patients.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a></div><div class="NLM_p last">In 2011, Lehmann and Bauer et al. conducted a large meta-analysis of gene expression profiles for TNBC patient tumor samples and identified six distinct molecular subtypes of TNBC, each with defined molecular alterations and phenotypic characteristics.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> More recently, Lehmann et al. refined these subtypes based on new analyses, identifying four molecular subtypes of TNBC.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These include two basal-like (BL1 and BL2), a mesenchymal-like (M), and a luminal androgen receptor (LAR) subtype. They also identified cell lines representing these subtypes, thus allowing us to initiate a screening program to identify natural product extracts with selective activities against cell lines representing the different TNBC subtypes. In this study, a crude extract of the Texas native plant <i>Amyris texana</i> was found to have selective activity against MDA-MB-453 cells, a model of the LAR subtype of TNBC. The LAR subtype accounts for approximately 16% of all TNBCs, or roughly 3% of all breast cancers.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These tumors express high levels of androgen receptors (AR), making it the TNBC subtype with the clearest biomarker. Bioassay-guided fractionation identified one new and one known oxazole with selective activity in this cell line. Based on these data, 32 analogs of the natural products were synthesized, and structure–activity relationship studies were performed to identify a lead candidate for <i>in vivo</i> efficacy experiments and investigations into the mechanisms of action for this class of compounds against LAR cells.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Isolation and Identification of Novel Cytotoxic Oxazoles from <i>Amyris texana</i></h3><div class="NLM_p">We initiated a screening program to identify crude extracts of plants and fungal cultures with selective activity against cell lines modeling five molecular subtypes of TNBC. It was hypothesized that based on the different molecular characteristics and drivers of each subtype, extracts with selective activity against particular cell lines could be identified from novel natural product libraries. The plant and fungal extract libraries screened for this project were generated by the Mooberry and Cichewicz laboratories and previously yielded both new and known compounds with selective <i>in vitro</i> activities against different TNBC molecular subtypes <i>in vitro</i>.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> The crude supercritical CO<sub>2</sub> extract of the leaves and branches of <i>Amyris texana</i>, commonly known as the Texas torchwood, displayed modest selective antiproliferative activity against MDA-MB-453 cells, a model of the LAR subtype, relative to cells representing other molecular subtypes of TNBC. A second sample of the plant material was collected, extracted, and also found to have selective antiproliferative activity against this cell line (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). The crude plant extract was subjected to bioassay-guided fractionation over silica gel VLC and HP20ss columns, followed by C<sub>18</sub> preparative HPLC and C<sub>18</sub> semipreparative HPLC. Fractions F2 and F3 showed selective antiproliferative activity against MDA-MB-453 cells relative to HCC70 cells, which model the BL2 subtype (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B,C), and were selected for further purifications to identify the active constituents. From these fractions, one new diaryloxazole (<b>1</b>), which we named texazole A, and one known diaryloxazole (<b>2</b>) were purified (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Isolation of <b>2</b> from <i>Amyris plumieri</i> was first reported by Philip, Burke, and Jacobs in 1984, but its cytotoxic activity against cancer cell lines was not investigated.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The chemical structures of both <b>1</b> and <b>2</b> were established unequivocally through analysis of the spectroscopic data of both the naturally sourced material (see <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figures S1, S2, and S3–S8">Supplementary Figures S1, S2, and S3–S8</a>) as well as the spectroscopic data for both <b>1</b> and <b>2</b> from materials produced through two different and independent synthesis routes.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <i>Amyris texana</i> extract and isolated compounds selectively inhibit growth of LAR cells. SRB assay concentration–response curves for a crude supercritical CO<sub>2</sub> extract of <i>Amyris texana</i> (A); fractions F2 (B) and F3 (C); and isolated pure compounds <b>1</b> (D) and <b>2</b> (E) against TNBC cell lines representing different molecular subtypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of isolated natural products <b>1</b> and <b>2</b> and similar diaryloxazoles reported from other plant species.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The structure of compounds <b>1</b> and <b>2</b> were of interest to us not only because of their selectivity for cells representing the LAR subtype but also the opportunity they represent as structural leads for further medicinal chemistry investigation based on multiple structural moieties for SAR studies and favorable drug-like physicochemical properties.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Compounds <b>1</b> and <b>2</b> both comprise an oxazole ring core substituted at the 2- and 5-positions. The phenyl substituent at the 5-position either bears a 4-substituted <i>O</i>-prenyl group (compound <b>1</b>) or a 4-substituted <i>O</i>-geranyl group (compound <b>2</b>). The aryl substituent at the 2-position is either phenyl (compound <b>1</b>) or 3-pyridyl (compound <b>2</b>). Compounds <b>1</b> and <b>2</b> are also similar to the diaryloxazoles texalin (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), previously isolated from <i>Amyris elemifera</i>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and balsoxin (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), isolated from <i>Amyris balsamifera</i>.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Additionally, Cheplogoi and colleagues reported the isolation of uguenenazole (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) from <i>Vepris uguenensis</i>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> suggesting similar compounds may be present in multiple plant genera. Although other diaryloxazoles with algicidal and fungicidal activities have been isolated from <i>A. texana</i>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> to our knowledge there are no reports of these compounds having cytotoxic activity against cancer cells.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Evaluation of <i>in Vitro</i> Antiproliferative and Cytotoxic Activities of Isolated Natural Products</h3><div class="NLM_p">The <i>in vitro</i> antiproliferative and cytotoxic activities of the natural products <b>1</b> and <b>2</b> were evaluated using a sulforhodamine B (SRB) assay.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Both compounds displayed modest selective antiproliferative and cytotoxic activity against MDA-MB-453 cells, a model of the LAR subtype, compared to other TNBC cell lines (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D,E). Since our goal is to identify targeted therapies for the subtypes of TNBC, we sought to identify compounds that have potent activities in a cell line representing one TNBC subtype, as compared to cells representing the other subtypes. The discovery of such natural products is predicated on the hypothesis that these compounds are likely to specifically target a molecular driver of the sensitive cells. The results with <b>1</b> and <b>2</b> showed that both of these compounds had relatively low cytotoxic potency. The concentration of <b>1</b> that inhibited growth by 50% (GI<sub>50</sub>) was approximately 40 μM in MDA-MB-453 cells, but greater than 200 μM in HCC70 and MDA-MB-231 cells (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The GI<sub>50</sub> of <b>2</b> was approximately 17 μM in MDA-MB-453 cells but ranged from 77–100 μM in HCC70, HCC1937, and MDA-MB-231 cells. These results demonstrate that <b>1</b> and <b>2</b> have at least 5- and 4.5-fold selectivity for MDA-MB-453 cells. However, we expected that more potent analogs would be optimal for <i>in vivo</i> efficacy studies. Additionally, both compounds, but particularly <b>1</b>, have low aqueous solubility and analogs with improved physicochemical properties will be needed for consideration of this class of compounds for more advanced <i>in vivo</i> profiling.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antiproliferative Potency of Natural Products and First Generation Analogs in TNBC Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">GI<sub>50</sub> ± SD (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">MDA-MB-453</th><th class="colsep0 rowsep0" align="center">MDA-MB-231</th><th class="colsep0 rowsep0" align="center">HCC1937</th><th class="colsep0 rowsep0" align="center">HCC70</th><th class="colsep0 rowsep0" align="center">BT-549</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">natural <b>1</b></td><td class="colsep0 rowsep0" align="left">40 ± 30</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">synthetic <b>1</b></td><td class="colsep0 rowsep0" align="left">60 ± 40</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">natural <b>2</b></td><td class="colsep0 rowsep0" align="left">17 ± 4</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">100 ± 50</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">synthetic <b>2</b></td><td class="colsep0 rowsep0" align="left">11 ± 7</td><td class="colsep0 rowsep0" align="left">29 ± 4</td><td class="colsep0 rowsep0" align="left">13.7</td><td class="colsep0 rowsep0" align="left">16.8</td><td class="colsep0 rowsep0" align="left">27 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">13 ± 2</td><td class="colsep0 rowsep0" align="left">19 ± 6</td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">20 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">29 ± 9</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">10 ± 3</td><td class="colsep0 rowsep0" align="left">13 ± 1</td><td class="colsep0 rowsep0" align="left">16 ± 4</td><td class="colsep0 rowsep0" align="left">19 ± 5</td><td class="colsep0 rowsep0" align="left">20 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">8 ± 2</td><td class="colsep0 rowsep0" align="left">30 ± 4</td><td class="colsep0 rowsep0" align="left">35.0 ± 0.4</td><td class="colsep0 rowsep0" align="left">40 ± 10</td><td class="colsep0 rowsep0" align="left">25.3 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">12 ± 4</td><td class="colsep0 rowsep0" align="left">15 ± 1</td><td class="colsep0 rowsep0" align="left">17 ± 2</td><td class="colsep0 rowsep0" align="left">20 ± 10</td><td class="colsep0 rowsep0" align="left">30 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">17 ± 4</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">152</td><td class="colsep0 rowsep0" align="left">50 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">35 ± 6</td><td class="colsep0 rowsep0" align="left">50 ± 20</td><td class="colsep0 rowsep0" align="left">40 ± 10</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">40 ± 10</td><td class="colsep0 rowsep0" align="left">53 ± 8</td><td class="colsep0 rowsep0" align="left">41 ± 8</td><td class="colsep0 rowsep0" align="left">42 ± 8</td><td class="colsep0 rowsep0" align="left">43 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">2 ± 1</td><td class="colsep0 rowsep0" align="left">9.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">6 ± 2</td><td class="colsep0 rowsep0" align="left">8 ± 2</td><td class="colsep0 rowsep0" align="left">9 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">12 ± 6</td><td class="colsep0 rowsep0" align="left">21 ± 3</td><td class="colsep0 rowsep0" align="left">21 ± 3</td><td class="colsep0 rowsep0" align="left">24 ± 2</td><td class="colsep0 rowsep0" align="left">25 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">31 ± 6</td><td class="colsep0 rowsep0" align="left">50 ± 30</td><td class="colsep0 rowsep0" align="left">51.2</td><td class="colsep0 rowsep0" align="left">70 ± 30</td><td class="colsep0 rowsep0" align="left">80 ± 50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis of Natural Products <b>1</b> and <b>2</b> and Structural Analogs</h3><div class="NLM_p">Having isolated, characterized, and screened natural products <b>1</b> and <b>2</b>, we aimed to prepare the two compounds via independent synthesis to confirm structure, purity, and the antiproliferative and cytotoxic activities with synthesized samples. To this end, we utilized two different synthesis strategies to prepare <b>1</b> and <b>2</b>, such that the regiochemistry of the diaryloxazole substitution could be established, and two different synthesis routes would be available to prepare analogs for SAR studies. Within our synthesis strategy, we focused on developing a synthesis route that would allow us to easily incorporate structural changes at the 2-position of the oxazole core as well as the 4-phenolic ether side chain moieties to support preliminary SAR studies. In the first route to obtain <b>1</b> and <b>2</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), <i>para</i>-anisaldehyde was subjected to Van Leusen oxazole forming conditions to provide the desired oxazole intermediate <b>5</b> in excellent yield. With this common intermediate in hand, two different synthesis methods were employed to access the desired natural products <b>1</b> and <b>2</b>. First, functionalization of the 2-position of the oxazole was carried out using a palladium-mediated cross coupling reaction with an aryl bromide in the presence of CuI and K<sub>2</sub>CO<sub>3</sub> under microwave conditions to provide the desired coupled product <b>6</b> in low to moderate yields, depending on the aryl bromide substrate employed.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Multiple coupling conditions were screened for this transformation, and we ultimately settled on a palladium-free, copper-mediated cross coupling reaction reported by the Miura group, which proved to be more synthetically useful and reproducible.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Under these conditions (CuI, PPh<sub>3</sub>, Na<sub>2</sub>CO<sub>3</sub>, DMF), compound <b>6</b> could be produced in moderate yield with a wide range of aryl and heteroaryl bromide coupling partners. Thus, the forward synthesis involved treatment of compound <b>5</b> with excess BBr<sub>3</sub>, which cleanly produced the corresponding phenol (not depicted) and was alkylated under standard conditions to produce the geranyl or prenyl derivatives represented by compound <b>7</b>. Compound <b>7</b> was subjected to the CuI/PPh<sub>3</sub> coupling conditions with either bromobenzene or 3-bromopyridine to provide compounds <b>1</b> and <b>2</b>. Alternatively, compound <b>6</b> could undergo the BBr<sub>3</sub> demethylation/alkylation procedure to provide the final compounds <b>1</b> and <b>2</b> directly. In addition to the two natural products <b>1</b> and <b>2</b> prepared using these routes, the corresponding structural congeners <b>3</b> and <b>4</b> were also prepared. Analytical characterization and spectral data of the synthetically derived samples of compounds <b>1</b> and <b>2</b> supported the desired structures and were spectroscopically identical to those samples isolated from the natural source (see <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figures S1–S14">Supplementary Figures S1–S14</a>). To further confirm the regiochemistry of the oxazole substitution in <b>6</b> and develop an alternative route to analogs, we employed a similar route to that described by Copp and co-workers during their reported synthesis of the oxazole texalin (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Thus, <i>p</i>-methoxyacetophenone was carried through a three-step sequence involving bromination, azide formation, and reduction to form the desired amine <b>8</b>. Coupling of <b>8</b> and benzoic acid under HATU/DIPEA conditions afforded the desired benzamide <b>9</b>, which was subjected to Ac<sub>2</sub>O/H<sub>2</sub>SO<sub>4</sub> cyclization conditions to afford oxazole <b>6</b>. The <sup>1</sup>H and <sup>13</sup>C NMR as well as the HPLC/MS data for both samples of <b>6</b> from the two different synthetic routes were found to be identical, thus confirming the regiochemistry of oxazole <b>6</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figures S15 and S16">Supplementary Figures S15 and S16</a>). Utilizing the synthesis methods described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, compounds <b>1</b>–<b>4</b> and additional structural analogs <b>10</b>–<b>20</b>, highlighted in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>, were also prepared for SAR studies.</div><figure id="cht1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of First Generation Analogues <b>10</b>–<b>20</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Natural Products <b>1</b> and <b>2</b> and Analogs <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) <i>p</i>-toluenesulfonylmethylisocyanide (1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.7 equiv), MeOH (0.2 M), reflux, 97%; (b) Pd(OAc)<sub>2</sub> (0.2 equiv), CuI (1 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), Ar–Br (1.2 equiv), DMF (0.85M), mW, 150 °C, 41–55%; (c) Ar–Br (1.2 equiv), CuI (1 equiv, PPh<sub>3</sub> (1 equiv), Na<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF (1.0 M), 30–65% yield; (d) BBr<sub>3</sub> (6 equiv), DCM (0.2 M), −78 °C to r.t., 96% yield; (e) NaH (1.1 equiv), R-Br (1.1 equiv), THF/DMF (0.1M), 0 °C to r.t., 28–63%; (f) benzoic acid, HATU, DIPEA, DMF, 57% yield; (g) conc. H<sub>2</sub>SO<sub>4</sub>, Ac<sub>2</sub>O, 90 °C, 85% yield.</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vitro</i> Evaluation and SAR</h3><div class="NLM_p">The antiproliferative and cytotoxic activities of compounds <b>1</b>–<b>4</b> were evaluated in a panel of TNBC cells lines with the SRB assay. All four compounds inhibited growth and were cytotoxic to MDA-MB-453 cells. The GI<sub>50</sub> values of synthetically derived <b>1</b> and <b>2</b> were 60 and 11 μM, respectively (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These potencies were comparable to the natural products, further confirming the determined structures. Compounds <b>1</b> and <b>4</b>, which have a phenyl group at the 2-position of the oxazole, were less potent than compounds <b>2</b> and <b>3</b>, which have a 3-pyridine at the 2-position of the oxazole (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This suggested that a 3-pyridine group at the 2-position of the oxazole is advantageous for potency in this cell line and also offers physicochemical property advantages over the corresponding phenyl derivatives by providing lower lipophilicity and higher topological polar surface area. Interestingly, while <b>2</b> retained the selectivity observed with the natural product, compound <b>3</b> did not have the same selectivity for MDA-MB-453 cells as compared to cells representing other TNBC molecular subtypes. This suggested that the longer geranyl side chain and the 3-pyridine moiety are important for LAR subtype specificity; however, further SAR studies were required.</div><div class="NLM_p">Based on the preliminary data obtained from evaluation of the first four oxazoles, SAR studies focused on changing both the heteroaryl group at the 2-position of the oxazole, as well as the structure and electronic nature of the phenol side chain, as represented by analogs <b>10</b>–<b>20</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). The antiproliferative activities of each compound were evaluated, and nine of these compounds showed antiproliferative and/or cytotoxic activities at concentrations below 100 μM (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Compounds <b>15</b> and <b>20</b> did not have any activity at 100 μM, so their biological effects were not evaluated further. The GI<sub>50</sub> values for the other nine compounds ranged from 2–40 μM in MDA-MB-453 cells (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). First, modification of the phenolic side chain to <i>n</i>-propyl (compound <b>10</b>) produced an analog with similar potency to the natural product <b>2</b>. Replacement of the 3-pyridine moiety with other six-membered heteraromatics such as pyrimidine provided potent activity as well, assuming the prenyl phenolic side chain was present (compounds <b>13</b> and <b>18</b>). Five-membered heterocyclic analogs such as 1<i>H</i>-pyrrazole showed a marked decrease in potency (compound <b>16</b>). A phenolic ester functionality such as acetate also decreased potency as represented by compound <b>14</b>. Installation of a 4-pyrrolidine moiety (compound <b>11</b>) produced potency in the MDA-MB-453 cell line virtually equivalent to natural product <b>2</b>; even though compound <b>11</b> possesses the methyl group at the R<sub>1</sub> position. This result suggests that some structural modifications at both positions are tolerated and can produce analogs with good potency. Further investigation into pyridine substitution patterns and the substituent effects lead to the discovery of compound <b>17</b>, which was the most potent analog identified during initial SAR studies. Compound <b>17</b> showed selectivity for MDA-MB-453 cells, consistent with the activities of the natural products (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The activity of this compound also indicated that the relative position of the pyridine nitrogen could be changed while still maintaining the potency and selectivity for MDA-MB-453 cells observed with the natural products. The GI<sub>50</sub> for <b>17</b> was found to be 2 μM in MDA-MB-453 cells, but ranged from 6–9 μM in the other TNBC cells, indicating 3- to 4.5-fold selectivity for MDA-MB-453 cells compared to other TNBC cell lines (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The structural nature and physicochemical properties of compound <b>17</b> were also greatly improved relative to the natural products by lowering LogD, increasing tPSA, and providing a tertiary amine handle for salt formation, all of which likely contributed to the improved aqueous solubility observed for <b>17</b> in comparison to earlier compounds. These results indicated that analogs with improved pharmacokinetic properties could be synthesized without compromising potency for MDA-MB-453 cells, prompting further efforts into the synthesis of LAR subtype-selective oxazoles with improved pharmaceutical properties. Based on the outcomes of the brief SAR study described in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and the identification of lead compound <b>17</b>, we focused our medicinal chemistry efforts to study the impact other structural modifications to the (pyridin-3-yl)methanamine moiety would have on potency, selectivity, and physicochemical properties. To this end, we designed a synthesis and SAR study holding the prenyl-phenolic side chain constant, while modifying the pyridyl-methanamine moiety. These analogs were prepared as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> starting from 4-hydroxybenzaldehyde. Treatment of 4-hydroxybenzaldehyde with NaH/prenyl bromide in CH<sub>3</sub>CN provided prenyl ether <b>21</b>, which was reacted under the standard Van Leusen conditions to form oxazole <b>22</b> in near quantitative yield. Coupling of <b>22</b> with 2- or 3-bromonicotinaldehyde under the CuI/PPh<sub>3</sub> conditions described previously produced the desired intermediate represented by <b>23</b>. Reductive amination<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> with an amine (HNR<sub>1</sub>R<sub>2</sub>) and NaHB(OAc)<sub>3</sub>, followed by HCl salt formation afforded the desired analogs <b>24</b>–<b>34</b>. The analogs <b>24</b>–<b>34</b> prepared in this study highlighted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> are a small group of acyclic and cyclic aliphatic amine derivatives that offer changes in tPSA, LogD, and hydrogen bond donors (HBD) and acceptors (HBA) while maintaining MW < 500. As before, these compounds were evaluated with the SRB assay against the panel of TNBC cell lines representing different molecular subtypes, and all 11 displayed antiproliferative activity and were selective for MDA-MB-453 cells (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These analogs were substantially more potent overall than our previous compounds, with GI<sub>50</sub> values ranging from approximately 0.2 to 2 μM in MDA-MB-453 cells. A direct comparison of the 3-pyridine analog <b>24</b> and the 2-pyridine analog <b>26</b> bearing the piperidine amine suggested that the position of the pyridine-nitrogen atom was not a major factor for potency or selectivity, thus the 2-pyridine template was used for the remaining analogs. Both secondary and tertiary amine derivatives showed potent activity as represented by compounds <b>25</b>, <b>27</b>, <b>31</b>, and <b>32</b>. Amine groups bearing an additional heteroatom or polar functional groups such as <b>28</b>, <b>29</b>, <b>30</b>, <b>33</b>, and <b>34</b> offered compounds with further improvements in potency and selectivity. While 1,2-diamine type analogs such as <b>28</b> and <b>33</b> show good potency, compounds bearing an additional carbonyl group such as compound <b>30</b> offer improved potency and selectively for MDA-MB-453 cells as compared to the other TNBC cells. Thus, compound <b>30</b> showed the greatest combination of potency and selectivity for MDA-MB-453 cells (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The GI<sub>50</sub> of <b>30</b> was 0.8 μM in MDA-MB-453 cells and 30–50 μM in the TNBC cell lines representing four different molecular subtypes. This indicated that <b>30</b> has approximately 37.5- to 62.5-fold antiproliferative selectivity for MDA-MB-453 cells (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). As outlined in our medicinal chemistry strategy, SAR studies leading to the identification of compound <b>30</b> provided simultaneous improvements in both potency against MDA-MB-453 cells and physicochemical properties. Interestingly, compounds <b>26</b>, <b>27</b>, <b>28</b>, and <b>30</b> had biphasic concentration–response curves in MDA-MB-453 cells but not in other TNBC cell lines (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), suggesting these compounds may have multiple mechanisms of action. These differences might explain the improved selectivity for MDA-MB-453 cells.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis and structures of analogs <b>24–34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) NaH (1.1 equiv), prenylbromide (1 equiv), ACN (1.0M), 0 °C, 61% yield; (b) <i>p</i>-toluenesulfonylmethylisocyanide (1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.7 equiv), MeOH (0.2M), reflux, 98%; (c) 2-bromonicotinaldehyde or 3- bromonicotinaldehyde, CuI (1 equiv), PPh<sub>3</sub> (1 equiv), Na<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF (1.0 M), 160 °C, 47% yield; (d) HNR<sub>1</sub>R<sub>2</sub> (1.1 equiv), NaHB(OAc)<sub>3</sub>, DCE, r.t., 21–71% yield; (e) HCl (1.0 equiv), ether (1.0 M), r.t.</p></p></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>17</b> more potently inhibits growth of MDA-MB-453 cells than natural product hits. SRB assay concentration–response curves for <b>17</b> (A) and potency measurements (B) in five TNBC cell lines representing different molecular subtypes. Results represent mean ± SE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Second generation analogs selectively inhibit growth of LAR cell lines MDA-MB-453 and SUM-185PE. SRB assay concentration–response curves for <b>24</b> (A), <b>26</b> (B), <b>27</b> (C), <b>28</b> (D), <b>30</b> (E), and <b>31</b> (F) in six TNBC cell lines representing five different molecular subtypes. Results represent mean ± SE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiproliferative Potency of Second Generation Analogs in TNBC Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">GI<sub>50</sub> ± SD (μM)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">MDA-MB-453</th><th class="colsep0 rowsep0" align="center">SUM-185PE</th><th class="colsep0 rowsep0" align="center">MDA-MB-231</th><th class="colsep0 rowsep0" align="center">HCC1937</th><th class="colsep0 rowsep0" align="center">HCC1806</th><th class="colsep0 rowsep0" align="center">BT-549</th><th class="colsep0 rowsep0" align="center">A10</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">2 ± 2</td><td class="colsep0 rowsep0" align="left">3 ± 2</td><td class="colsep0 rowsep0" align="left">18 ± 3</td><td class="colsep0 rowsep0" align="left">7 ± 1</td><td class="colsep0 rowsep0" align="left">16 ± 7</td><td class="colsep0 rowsep0" align="left">20 ± 10</td><td class="colsep0 rowsep0" align="left">10 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">n.d</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">2 ± 1</td><td class="colsep0 rowsep0" align="left">2.6 ± 0.5</td><td class="colsep0 rowsep0" align="left">16 ± 3</td><td class="colsep0 rowsep0" align="left">10 ± 1</td><td class="colsep0 rowsep0" align="left">17 ± 5</td><td class="colsep0 rowsep0" align="left">20 ± 10</td><td class="colsep0 rowsep0" align="left">8.5 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">0.8 ± 0.3</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.9</td><td class="colsep0 rowsep0" align="left">27 ± 5</td><td class="colsep0 rowsep0" align="left">11 ± 2</td><td class="colsep0 rowsep0" align="left">22 ± 9</td><td class="colsep0 rowsep0" align="left">23 ± 8</td><td class="colsep0 rowsep0" align="left">19 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">0.2 ± 0.3</td><td class="colsep0 rowsep0" align="left">1 ± 1</td><td class="colsep0 rowsep0" align="left">6 ± 3</td><td class="colsep0 rowsep0" align="left">3.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">5 ± 2</td><td class="colsep0 rowsep0" align="left">6 ± 4</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">n.d</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">0.8 ± 0.7</td><td class="colsep0 rowsep0" align="left">1.6 ± 0.4</td><td class="colsep0 rowsep0" align="left">50 ± 9</td><td class="colsep0 rowsep0" align="left">35 ± 1</td><td class="colsep0 rowsep0" align="left">30 ± 20</td><td class="colsep0 rowsep0" align="left">40 ± 30</td><td class="colsep0 rowsep0" align="left">35 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">1.4 ± 0.9</td><td class="colsep0 rowsep0" align="left">2.8 ± 0.8</td><td class="colsep0 rowsep0" align="left">12 ± 1</td><td class="colsep0 rowsep0" align="left">10 ± 1</td><td class="colsep0 rowsep0" align="left">20 ± 20</td><td class="colsep0 rowsep0" align="left">14 ± 7</td><td class="colsep0 rowsep0" align="left">10.5 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">n.d</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">n.d</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">0.90</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">n.d</td></tr></tbody></table></div></div><div class="NLM_p">To further evaluate the selectivity of this second series of compounds for LAR models, the six compounds with the greatest selectivity for MDA-MB-453 cells were evaluated against a second LAR cell line, SUM-185PE. Compounds <b>24</b>, <b>26</b>, <b>27</b>, <b>28</b>, <b>30</b>, and <b>31</b> potently inhibited growth of this cell line as well, with compound <b>30</b> again demonstrating the best combination of potency and selective activity in this cell line compared to cells modeling other TNBC molecular subtypes (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The GI<sub>50</sub> of <b>30</b> was 1.6 μM in SUM-185PE cells, indicating this compound has 18.8- to 31.3-fold selectivity against these cells as compared to cells representing other TNBC subtypes (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The other five compounds had GI<sub>50</sub> values ranging from 1 to 3 μM in SUM-185PE cells. However, these compounds did not show the same degree of selectivity for both LAR cell lines as compound <b>30</b>. Compounds <b>24</b>, <b>26</b>, <b>27</b>, <b>28</b>, <b>30</b>, and <b>31</b> were also tested against the A-10 rat smooth muscle cell line to measure their selectivity compared to noncancerous cells. The GI<sub>50</sub> values in A-10 cells were comparable to those calculated for non-LAR cells, further demonstrating their selectivity.</div><div class="NLM_p"><a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> captures the key physicochemical property data on lead compounds <b>17</b> and <b>30</b> in comparison to the original natural products <b>1</b> and <b>2</b>. Decreases in lipophilicity (LogD) and increases to tPSA were realized by the introduction of more polar functional groups, structural modifications that simultaneously improved MDA-MB-453 cell potency >100-fold compared to our starting natural products, and generation of increased selectivity for LAR cells over other TNBC cells. These results, taken together, suggested that <b>30</b> is a suitable candidate for future <i>in vivo</i> efficacy studies against LAR xenograft models and investigations into this class of compounds’ mechanisms of action.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Calculated Physicochemical Properties of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">LogP</th><th class="colsep0 rowsep0" align="center">LogD</th><th class="colsep0 rowsep0" align="center">tPSA</th><th class="colsep0 rowsep0" align="center">HBD</th><th class="colsep0 rowsep0" align="center">HBA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">305.4</td><td class="colsep0 rowsep0" align="left">4.71</td><td class="colsep0 rowsep0" align="left">4.71</td><td class="colsep0 rowsep0" align="left">35.3</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">374.5</td><td class="colsep0 rowsep0" align="left">5.15</td><td class="colsep0 rowsep0" align="left">5.15</td><td class="colsep0 rowsep0" align="left">48.15</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">389.5</td><td class="colsep0 rowsep0" align="left">4.23</td><td class="colsep0 rowsep0" align="left">3.02</td><td class="colsep0 rowsep0" align="left">51.39</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">447.5</td><td class="colsep0 rowsep0" align="left">4.06</td><td class="colsep0 rowsep0" align="left">4.03</td><td class="colsep0 rowsep0" align="left">77.69</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">5</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Mechanism of Action Studies</h3><div class="NLM_p">Prior to evaluation of our lead molecule against an <i>in vivo</i> LAR model, we sought to gain insight into the potential mechanisms of action of these compounds and why they have selectivity for LAR cells and potentially identify a molecular target, which might have therapeutic value for the LAR subtype of TNBC. Cell cycle analyses were performed to determine if these compounds produced changes in cell cycle distribution characteristic of other anticancer agents and to give an initial indication of their mechanism of action. Compounds <b>1</b>, <b>2</b>, <b>17</b>, <b>27</b>, and <b>30</b>, representing various potencies and selectivity for MDA-MB-453 cells, were evaluated for their effects on cell cycle distribution of MDA-MB-453 cells after 18 h of treatment. A range of concentrations spanning the GI<sub>50</sub> to LC<sub>50</sub> values for each compound were tested, but no significant changes in cell cycle distribution were observed for any of the compounds (data not shown). Accumulation of a sub-G<sub>1</sub> cell population was observed with compounds <b>17</b>, <b>27</b>, and <b>30</b>, consistent with the cytotoxicity of these compounds. Next the effects of compound <b>17</b> were evaluated using a fluorescence-based intracellular signaling array (data not shown). These data suggested that <b>17</b> affected PI3K/Akt/mTORC1 signaling in MDA-MB-453 cells, so further studies were conducted to evaluate the effects of the compounds on this signaling pathway.</div><div class="NLM_p">The mechanisms of action of <b>30</b> were investigated because it shows the highest degree of selectivity for MDA-MB-453 cells. Interestingly, Lehmann and Bauer et al. initially demonstrated that LAR cells are not only sensitive to antiandrogens but are also more sensitive to PI3K inhibitors than cells representing other TNBC subtypes <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Additionally, we previously reported that LAR cells are particularly sensitive to inhibition of mTORC1 signaling.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Based on this knowledge and our preliminary mechanistic data, we hypothesized that the highly selective activity of <b>30</b> against LAR cells results from inhibition of mTORC1 signaling. An immunoblotting time-course experiment was conducted to measure the activation of Akt, an upstream mediator of mTORC1 signaling, after treatment with <b>30</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Akt is phosphorylated at T308 by PDK1, which is phosphorylated by PI3Ks. Akt is also phosphorylated at S473 by mTORC2. Treatment of MDA-MB-453 cells with <b>30</b> resulted in a nearly two-fold increase in phosphorylation of Akt at T308, which was noticeable 1–6 h after treatment. No significant differences in Akt phosphorylation at S473 were observed relative to vehicle-treated cells over the same time-course. These data suggest that <b>30</b> caused an increase in upstream signaling from PI3K/PDK1 to Akt. Signaling downstream of Akt was then evaluated to investigate the effects of <b>30</b> on the entire PI3K/PDK1/Akt/mTORC1 signaling pathway in MDA-MB-453 cells. At 1 h post-treatment, we observed an approximate 49% decrease in the relative phosphorylation of mTOR at S2448 in compound <b>30</b>-treated cells compared to vehicle-treated controls. This effect was transient and phosphorylation at S2448 increased over the next 5 h, and by 6 h post-treatment, the relative phosphorylation at S2448 was approximately 60% higher than in vehicle-treated controls. mTOR is phosphorylated at S2448 via PI3K/Akt signaling, so these data suggest that <b>30</b> causes an initial inhibition of mTORC1 activation. We then investigated the activity of signaling proteins downstream of mTORC1. Interestingly, treatment with <b>30</b> resulted in complete loss of S6 kinase (S6K) phosphorylation at T389, as well as loss of S6 phosphorylation at S235/236. Collectively, these results suggested that <b>30</b> inhibits downstream signaling through mTORC1. Although the precise point of inhibition could not be established from these results, it is likely the observed increase in phosphorylation of Akt at T308 is a result of compensatory upstream activation of PI3K-mediated signaling, which can occur as a result of mTORC1 inhibition.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>30</b> rapidly decreases abundance of activated mTORC1 signaling proteins in LAR cells. Immunoblotting of compound <b>30</b>-treated MDA-MB-453 whole-cell lysates for phosphorylated and total PI3K/Akt/mTORC1 signaling proteins. Cells were treated with vehicle (DMSO) or 1 μM <b>30</b> for 1–6 h, as indicated. Quantification of phosphorylated protein relative to total protein is indicated below each band.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Evidence suggests that the molecular characteristics of the LAR subtype are significantly different than those of other TNBC subtypes, and these tumors respond poorly to current chemotherapeutic agents. Masuda et al. found that patients with the LAR subtype had one of the poorest rates of pathological complete response (10%) to neoadjuvant chemotherapy with taxanes and anthracyclines, suggesting that this subtype may be inherently resistant to these agents.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> These findings highlight the need for the development of better, more rationally targeted therapies for AR-expressing breast cancers.</div><div class="NLM_p last">Our results, obtained by initially evaluating extracts of Texas-native plants for selective activity against TNBC molecular subtypes, identified a new class of synthetically tractable, potent molecules with selective effects against cells modeling the LAR subtype of TNBC. Although the natural products that we initially procured had low potency and only moderate selectivity, SAR studies and medicinal chemistry efforts led to the identification of substantially more potent and selective analogs with improved physicochemical properties. Many of the compounds described herein are new chemical structures that may be useful scaffolds for developing additional compounds with efficacy against AR-expressing breast cancer cells, or form the basis for the development of new chemical tools to be used for mechanism of action studies. Additionally, these studies identified lead molecules such as compound <b>30</b> with more favorable drug-like physicochemical properties, which can be used to evaluate the potential <i>in vivo</i> antitumor efficacy of this class of molecules in AR-expressing TNBC models.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Materials and Instrumentation</h3><div class="NLM_p last">All compounds for cell treatments were dissolved in DMSO (Sigma-Aldrich) and stored at −20 °C. Absorbance (<i>A</i><sub>560</sub>) of SRB solutions was measured with a Spectramax 384 Plus spectrophotometer (Molecular Devices). NMR spectra were collected on a Varian 400 MHz NMR spectrometer. LCESIMS data were obtained on a Shimadzu LC–MS 2020 system (ESI quadrupole) coupled to a photodiode array detector, with a Phenomenex Kintex column (2.6 μm C<sub>18</sub> column, 100 Å, 75 × 3.0 mm). The preparative HPLC system utilized SCL-10A VP pumps and system controller with Luna 5 μm C<sub>18</sub> columns (110 Å, 250 × 21.2 mm, 10 mL/min). The analytical and semipreparative HPLC system utilized 1525 binary pumps (Waters) with 2998 photodiode array detectors (Waters) and Luna 5 μm C<sub>18</sub> columns (110 Å, 250 × 4.6 mm, 1 mL/min and 110 Å, 250 × 10 mm, 4 mL/min). All solvents were of ACS grade or better.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Compound Isolation</h3><div class="NLM_p">A supercritical CO<sub>2</sub> extract (5.0 g) was obtained from approximately 106 g of lyophilized <i>Amyris texana</i> (collected at San Antonio Botanical Gardens). A 5 mg sample of HP20ss and C18 processed crude extract was applied to a HPLC-based microtiter plate fractionation process, as previously described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Fractions F2 and F3 were identified as having selective activity and became our target fractions. To generate greater quantities of the compounds found in these fractions, the remaining crude extract was fractionated over silica gel and eluted with hexane–CH<sub>2</sub>Cl<sub>2</sub>–MeOH (hexane, hexane–CH<sub>2</sub>Cl<sub>2</sub> 50:50, CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>–MeOH 90:10, MeOH). Fractions F2 and F3 contained the targeted chemical signatures (mass spectrometric and UV profiles from LC–MS), and these fractions were combined and applied to an HP20ss column and eluted with MeOH–H<sub>2</sub>O. The fifth subfraction (100% MeOH) was further separated over C<sub>18</sub> preparative HPLC (gradient elution with MeOH–H<sub>2</sub>O from 30:70 to 100% organic phase in 30 min), followed by C<sub>18</sub> semipreparative HPLC (MeOH–H<sub>2</sub>O 90:10) to obtain <b>1</b> (4.0 mg) and <b>2</b> (10.0 mg), which corresponded to the target peaks from fraction F2. Balsoxin,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a><i>O</i>-isopentenyl-halfordinol,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Texamine,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Uguenenazole,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and 3-[5-(3,4-dimethoxyphenyl)-2-oxazolyl]-pyridine,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> which displayed similar UV profiles, were purified from the fourth subfraction (eluted with MeOH–H<sub>2</sub>O 90:10) of HP20ss column via C<sub>18</sub> preparative HPLC (gradient elution with MeOH–H<sub>2</sub>O from 30:70 to 100% organic phase in 30 min) followed by C<sub>18</sub> semipreparative HPLC (MeCN–H<sub>2</sub>O 75:25). These compounds were obtained from fractions that did not demonstrate selective activity against MDA-MB-453 cells, and their cytotoxic activities were not determined.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 5-(4-((3-Methylbut-2-en-1-yl)oxy)phenyl)-2-phenyloxazole (<b>1</b>)</h4><div class="NLM_p last">White amorphous powder; UV (from HPLC PDA detector) λ<sub>max</sub> 200, 314 nm. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): 8.02 (2H, dd, 7.9, 1.7), 7.64 (2H, brd, 8.7), 7.48 (3H, m), 7.32 (1H, s), 6.98 (2H, brd, 8.7), 5.51 (1H, t, 6.7), 4.56 (2H, d, 6.7), 1.81 (3H, s), 1.77 (3H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 160.9, 159.1, 151.4, 138.6, 130.1, 128.8 (×2), 127.6, 126.1 (×2), 125.7 (×2), 121.9, 120.8, 119.3, 115.1 (×2), 64.9, 25.8, 18.2. ESIMS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 306.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry Experiments</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedures</h4><div class="NLM_p last">Unless otherwise indicated, all reactions were conducted in standard commercially available glassware using standard synthetic chemistry methods and setup. All air- and moisture-sensitive reactions were performed under nitrogen atmosphere with dried solvents and glassware under anhydrous conditions. Starting materials and reagents were commercial compounds of the highest purity available and were used without purification. Solvents used for reactions were indicated as of commercial dry or extra-dry or analytical grade. Analytical thin layer chromatography was performed on aluminum plates coated with Merck Kieselgel 60F254 and visualized by UV irradiation (254 nm) or by staining with a solution of potassium permanganate. Flash column chromatography was performed on Biotage Isolera One 2.2 using commercial columns that were prepacked with Merck Kieselgel 60 (230–400 mesh) silica gel. Final compounds for biological testing are all ≥96% purity as determined by HPLC–MS and <sup>1</sup>H NMR. <sup>1</sup>H NMR experiments were recorded on Agilent DD2 400 MHz spectrometers at ambient temperature. Samples were dissolved and prepared in deuterated solvents (CDCl<sub>3</sub>, CD<sub>3</sub>OD, and DMSOd<sub>6</sub>) with TMS used as the internal standard in all cases. All deuterated solvent peaks were corrected to the standard chemical shifts (CDCl<sub>3</sub>, <i>d</i><sub>H</sub> = 7.26 ppm; CD<sub>3</sub>OD, <i>d</i><sub>H</sub> = 3.31 ppm; DMSO-<i>d</i><sub>6</sub>, <i>d</i><sub>H</sub> = 2.50 ppm). Spectra were all manually integrated after automatic baseline correction. Chemical shifts (<i>d</i>) are given in parts per million (ppm), and coupling constants (<i>J</i>) are given in Hertz (Hz). The proton spectra are reported as follows: d (multiplicity, coupling constant <i>J</i>, number of protons). The following abbreviations were used to explain the multiplicities: app = apparent, b = broad, d = doublet, dd = doublet of doublets, ddd = doublet of doublet of doublets, dddd = doublet of doublet of doublet of doublets, m = multiplet, s = singlet, t = triplet. All samples were analyzed on Agilent 1290 series HPLC system comprising binary pumps, degasser, and UV detector, equipped with an autosampler that is coupled with Agilent 6150 mass spectrometer. Purity was determined via UV detection with a bandwidth of 170 nm in the range from 230 to 400 nm. The general LC parameters were as follows: column, Zorbax Eclipse Plus C18, size 2.1 × 50 mm; solvent A, 0.10% formic acid in water, Solvent B, 0.00% formic acid in CH<sub>3</sub>CN; flow rate, −0.7 mL/min; gradient, 5% B to 95% B in 5 min and hold at 95% B for 2 min; UV detector, channel 1 = 254 nm, channel 2 = 254 nm; mass detector, Agilent Jet Stream–Electron Ionization (AJS-ES).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure for Pd/Cu Mediated Cross Coupling</h4><div class="NLM_p last">In a dried microwave vial equipped with a stir bar, oxazole (5.70 mmol), aryl bromide (11.25 mmol), anhydrous potassium carbonate (1.58 g, 11.4 mmol), copper(I) iodide (1.08 g, 5.70 mmol), and palladium(II) acetate (65 mg, 0.29 mmol) were dissolved in DMF (7 mL). The vial was purged with N<sub>2</sub> and the vial heated to 150 °C for 13 min under microwave irradiation. The crude reaction was then filtered over a pad of celete, pushing with DCM and concentrated under reduced pressure. The crude oil was then diluted with EtOAc (100 mL) and extracted with water (70 mL × 2) and brine (70 mL × 3). The organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude mixtures were then purified on a silica gel column, eluting with EtOAc–hexanes.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Phenol Alkylation Procedure</h4><div class="NLM_p">In a dried round-bottom flask equipped with a stir bar, sodium hydride (1.50 mmol, 60% dispersion in mineral oil) was added and the atmosphere exchanged for N<sub>2</sub>. The sodium hydride was then washed with hexanes (3 mL) before the addition of THF (3 mL) and cooled to 0 °C. In a separate vial, the phenol (1.0 mmol) was dissolved in DMF (2 mL) and added to the sodium hydride solution mixture slowly. The reaction was allowed to stir for 5 min before the slow addition of the alkyl bromide (1.1 mmol). Once the reaction was deemed complete by TLC, the reaction was quenched with saturated aqueous sodium bicarbonate (5 mL), diluted with EtOAc (50 mL), and washed with water (30 mL) and brine (30 mL × 3). The organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude mixture was then purified on a silica column, eluting with EtOAc–hexanes.</div><div id="sec4_3_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 5-(4-Propoxyphenyl)oxazole</h5><div class="NLM_p last">Brown solid (155 mg, 31% yield). LC–MS <i>m</i>/<i>z</i> 204.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (s, 1H), 7.57 (d, <i>J</i> = 9.2 Hz, 2H), 7.22 (s, 1H), 6.94 (d, <i>J</i> = 9.2 Hz, 2H), 3.96 (t, <i>J</i> = 6.4 Hz, 2H), 1.83 (sxt. <i>J</i> = 6.8 Hz, 2H), 1.05 (t, <i>J</i> = 7.2 Hz, 3H).</div></div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure for Phenol Deprotection</h4><div class="NLM_p">In a dry round-bottom flask equipped with a stir bar, the methoxy phenol (2.0 mmol) is dissolved in DCM (20 mL). The solution was then cooled to −78 °C and the headspace exchanged for N<sub>2</sub>. Boron tribromide (12 mL, 12.0 mmol, 1.0 M in DCM) was then added slowly. The reaction was then allowed to reach RT over 18 h before cooling to −78 °C and slowly quenching with methanol (30 mL). The crude reaction mixture was then warmed to RT and concentrated under reduced pressure. The crude mixture was then dissolved EtOAc (300 mL) and extracted with brine (200 mL x 3). The organic layer was then dried over sodium sulfate, filtered and concentrated under reduced pressure.</div><div id="sec4_3_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 4-(2-Phenyloxazol-5-yl)phenol</h5><div class="NLM_p last">Tan solid (423 mg, 91% yield). LC–MS <i>m</i>/<i>z</i> 328.1 (APCI<sup>+</sup>). <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>6</sub>-DMSO): δ 9.89 (s, 1H), 8.08 (d, <i>J</i> = 6.3 Hz, 2H), 7.69 (d, <i>J</i> = 7.8 Hz, 2H), 7.62 (s, 1H), 7.56–7.54 (m, 3H), 6.93 (d, <i>J</i> = 7.8 Hz, 2H).</div></div><div id="sec4_3_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 4-(Oxazol-5-yl)phenol</h5><div class="NLM_p last">Brown solid (777 mg, 96% yield). LC–MS <i>m</i>/<i>z</i> 162.1 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>6</sub>-DMSO): δ 9.82 (s, 1H), 8.34 (s, 1H), 7.55 (d, <i>J</i> = 7.3 Hz, 2H), 7.46 (s, 1H), 6.88 (d, <i>J</i> = 6.9, 2 H).</div></div><div id="sec4_3_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 4-(2-(Pyrimidin-5-yl)oxazol-5-yl)phenol</h5><div class="NLM_p last">Light yellow solid (42 mg, 95% yield). LC–MS <i>m</i>/<i>z</i> 240.1 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 9.40 (s, 2H), 9.24 (s, 1H), 7.68 (d, <i>J</i> = 9.0 Hz, 2H), 7.54 (s, 1H), 6.90 (d, <i>J</i> = 8.0 Hz, 2H).</div></div><div id="sec4_3_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-phenyloxazole (<b>1</b>)</h5><div class="NLM_p last">White solid (296 mg, 81% yield). LC–MS <i>m</i>/<i>z</i> 306.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.07 (d, <i>J</i> = 7.4 Hz, 2H), 7.60 (d, <i>J</i> = 8.3 Hz, 2H), 7.45–7.38 (m, 3H), 7.29 (s, 1H), 6.95 (d, <i>J</i> = 6.3 Hz, 2H), 5.48 (t, <i>J</i> = 6.4 Hz, 1H), 4.51 (d, <i>J</i> = 6.9 Hz, 2H), 1.78 (s, 3H), 1.73 (s, 3H). <sup>13</sup>C (500 MHz, CDCl<sub>3</sub>): δ 160.53, 159.18, 151.42, 138.46, 130.10, 128.81, 127.68, 126.16, 125.73, 121.97, 120.80, 119.48, 115.16, 64.93, 25.88, 18.28. HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 306.1489, found 306.1502 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (<i>E</i>)-5-(4-[(3,7-Dimethylocta-2,6-dien-1-yl)oxy]phenyl)-2-(pyridin-3-yl)oxazole (<b>2</b>)</h5><div class="NLM_p last">Yellow oil (95 mg, 20%). LC–MS <i>m</i>/<i>z</i> 375.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.31 (s, 1H), 8.66 (d, <i>J</i> = 4.4 Hz, 1H), 8.32 (d, <i>J</i> = 7.8 Hz, 1H), 7.63 (d, <i>J</i> = 8.8 Hz, 2H), 7.40 (dd, <i>J</i> = 6.8 Hz, 4.8 Hz, 1 H), 7.34 (s, 1H), 6.98 (d, <i>J</i> = 8.8 Hz, 2H), 5.49 (t, <i>J</i> = 6.3 Hz, 1 H), 5.09 (t, <i>J</i> = 5.8 Hz, 1H), 4.58 (d, <i>J</i> = 6.3 Hz, 2H), 2.09–2.14 (m, 4H), 1.75 (s, 3H), 1.67 (s, 3H), 1.60 (s, 3H). <sup>13</sup>C (500 MHz, CDCl<sub>3</sub>): δ 159.60, 158.24, 152.34, 150.86, 147.58, 141.79, 133.34, 132.03, 126.02, 123.99, 123.89, 123.73, 122.25, 120.42, 119.28, 115.42, 65.20, 39.70, 26.44, 25.84, 17.87, 16.87. HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 375.2067, found 375.2062 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(pyridin-3-yl)oxazole (<b>3</b>)</h5><div class="NLM_p last">Pale yellow solid (82 mg, 40%). LC–MS <i>m</i>/<i>z</i> 307.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.32 (s, 1H), 8.68 (d, <i>J</i> = 3.9 Hz, 1H), 8.35 (dt, <i>J</i> = 8.2 Hz, 2.0 Hz, 1H), 7.65 (d, <i>J</i> = 9.0 Hz, 2H), 7.42 (dd, <i>J</i> = 7.4 Hz, 4.7 Hz, 1H), 7.36 (s, 1H), 6.99 (d, <i>J</i> = 9.0 Hz, 2H), 5.51 (t, <i>J</i> = 5.1 Hz, 1H), 5.50 (d, <i>J</i> = 1.6 Hz, 2H), 1.82 (s, 3H), 1.77 (s, 3H). <sup>13</sup>C NMR (400 MHz, CDCl<sub>3</sub>): δ 159.60, 158.28, 152.34, 150.90, 147.62, 138.81, 133.35, 126.05, 124.01, 123.73, 122.27, 120.46, 119.45, 65.11, 26.00, 18.41. HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 307.1441, found 307.1442 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (<i>E</i>)-5-(4-[(3,7-Dimethylocta-2,6-dien-1-yl)oxy]phenyl)-2-phenyloxazole (<b>4</b>)</h5><div class="NLM_p last">White solid (152 mg, 45% yield). LC–MS <i>m</i>/<i>z</i> 374.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.09 (d, <i>J</i> = 7.8 Hz, 2H), 7.65 (d, <i>J</i> = 8.3 Hz, 2H), 7.49–7.43 (m, 3H), 7.32 (s, 1h), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 5.50 (t, <i>J</i> = 6.4 Hz, 1H), 5.10 (t, <i>J</i> = 6.1 Hz, 1H), 4.59 (d, <i>J</i> = 6.3 Hz, 2H), 2.17–2.10 (m, 4H), 1.76 (s, 3H), 1.68 (s, 3H), 1.61 (s, 3H). <sup>13</sup>C (500 MHz, CDCl<sub>3</sub>): δ 160.73, 159.35, 151.59, 141.77, 132.07, 130.27, 128. 97, 127.80, 127.80, 126.32, 125.90, 123.93, 122.10, 120.96, 119.38, 115.38, 65.21, 39.74, 26.48, 25.88, 17.90, 16.90. HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 374.2115, found 374.2121 (M + H)<sup>+</sup>.</div></div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> General Procedure for the Van Leusen Oxazole Synthesis</h4><div id="sec4_3_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 5-(4-Methoxyphenyl)oxazole (<b>5</b>)</h5><div class="NLM_p last">In a round-bottom flask equipped with a stir bar, <i>p</i>-toluenesulfonylmethyl isocyanide (10.04 g, 51.41 mmol), anhydrous potassium carbonate (7.00 g, 51.4 mmol), and <i>p</i>-anisaldehyde (6.25 mL, 84.8 mmol) were dissolved in MeOH (257 mL). The solution was then heated to reflux, monitoring by TLC. Once complete, the reaction was cooled to room temperature and concentrated under reduced pressure. The crude mixture was then dissolved in EtOAc (200 mL) and washed with water (100 mL × 3). The organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure to yield 5-(4-methoxyphenyl)oxazole as a light yellow solid (8.7 g, 97% yield). LC–MS 176.1 <i>m</i>/<i>z</i> (APCI) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (s, 1H), 7.59 (d, <i>J</i> = 9.0 Hz, 2H), 7.23 (s, 1H), 6.96 (d, <i>J</i> = 8.6 Hz, 2H), 3.85 (s, 3H).</div></div><div id="sec4_3_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> [Coupling Route] 5-(4-Methoxyphenyl)-2-phenyloxazole (<b>6</b>)</h5><div class="NLM_p last">Yellow solid (580 mg, 41% yield). LC–MS <i>m</i>/<i>z</i> 252.2 (APCI) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.09 (d, <i>J</i> = 7.8 Hz, 2H), 7.64 (d, <i>J</i> = 8.0 Hz, 2H), 7.41–7.50 (m, 3H), 7.31 (s, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 2H), 3.84 (s, 3H).</div></div><div id="sec4_3_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> [Cyclization Route] 5-(4-Methoxyphenyl)-2-phenyloxazole (<b>6</b>)</h5><div class="NLM_p last">In a round-bottom flask equipped with a stir bar, <i>N</i>-(2-(4-methoxyphenyl)-2-oxoethyl)benzamide <b>9</b> was dissolved in acetic anhydride (1 mL) followed by dropwise addition of conc. H<sub>2</sub>SO<sub>4</sub> (10 μL, 0.18 mmol). The reaction was heated to 90 °C and monitored by TLC. Upon completion, the reaction was cooled to RT and diluted with 50 mL of water and 25 mL of DCM. The organic layer was then washed with 25 mL of sat. sodium bicarbonate (×1), brine (×3), and then dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude mixture was purified on a silica gel column, eluting with EtOAc/hexanes to yield 5-(4-methoxyphenyl)-2-phenyloxazole as an off-yellow solid (31.5 mg, 85% yield). LC–MS <i>m</i>/<i>z</i> 252.2 (APCI) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.09 (d, <i>J</i> = 7.8 Hz, 2H), 7.64 (d, <i>J</i> = 8.0 Hz, 2H), 7.41–7.50 (m, 3H), 7.31 (s, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 2H), 3.84 (s, 3H).</div></div><div id="sec4_3_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>N</i>-(2-(4-methoxyphenyl)-2-oxoethyl)benzamide (<b>9</b>)</h5><div class="NLM_p last">In a round-bottom flask equipped with a stir bar, benzoic acid (101.5 mg, 0.83 mmol), and HATU (381.5 mg, 1 mmol) were dissolved in DMF and allowed to stir for 10 min before slow addition of 2-amino-4′-methoxyacetophenone HCl <b>8</b> (177.8 mg, 0.91 mmol). Once homogeneous, DIPEA (0.36 mL, 2 mmol) was added dropwise to the solution. The reaction was monitored by TLC and, upon completion, taken into 20 mL of EtOAc and washed with 50 mL of water (×2) and brine (×3). The organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude mixture was purified on a silica gel column, eluting with EtOAc/hexanes to yield <i>N</i>-(2-(4-methoxyphenyl)-2-oxoethyl)benzamide as a white solid (139.1 mg, 57% yield). LC–MS <i>m</i>/<i>z</i> 270.1 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.05 (dd, 2H), 7.90 (dd, <i>J</i> = 8.3, 1.3 Hz, 2H), 7.59–7.45 (m, 3H), 7.06 (dd, 2H), 3.89 (s, 3H), 3.31 (s, 2H).</div></div><div id="sec4_3_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 5-(4-Propoxyphenyl)-2-(pyridin-3-yl)oxazole (<b>10</b>)</h5><div class="NLM_p last">Yellow solid (69 mg, 30% yield). LC–MS <i>m</i>/<i>z</i> 281.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.32 (s, 1H), 8.67 (d, <i>J</i> = 3.4 Hz, 1H), 8.34 (d, <i>J</i> = 7.8 Hz, 1H), 7.64 (d, <i>J</i> = 8.8 Hz, 2H), 7.41 (dd, <i>J</i> = 7.8 Hz, 5.1 Hz, 1H), 7.35 (s, 1H), 6.97 (d, <i>J</i> = 8.8 Hz, 2H), 3.97 (t, <i>J</i> = 6.8 Hz, 2H), 1.84 (sxt, <i>J</i> = 7.3 Hz, 2H), 1.06 (t, <i>J</i> = 7.8 Hz, 3H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 281.1285, found 281.1293 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 5-(4-Methoxyphenyl)-2-(6-(pyrrolidin-1-yl)pyridin-3-yl)oxazole (<b>11</b>)</h5><div class="NLM_p last">Yellow solid (148 mg, 70% yield). LC–MS <i>m</i>/<i>z</i> 322.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.87 (s, 1H), 8.05 (dd, <i>J</i> = 8.8 Hz, 1.5 Hz, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 2 H), 7.25 (s, 1 H), 6.95 (d, <i>J</i> = 8.3 Hz, 2H), 6.41 (d, <i>J</i> = 8.8 Hz, 2H), 3.84 (s, 3H), 3.53 (broad s, 4H), 2.02 (broad s, 4H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 322.1550, found 322.1551 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (<i>E</i>)-5-(4-[(3,7-Dimethylocta-2,6-dien-1-yl)oxy]phenyl)oxazole (<b>12</b>)</h5><div class="NLM_p last">Yellow solid (259 mg, 28% yield). LC–MS <i>m</i>/<i>z</i> 298.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.78 (s, 1H), 7.77 (d, <i>J</i> = 8.7 Hz, 2H), 7.23 (s, 1H), 6.96 (d, <i>J</i> = 9.0 Hz, 2H), 5.49 (t, <i>J</i> = 5.4 Hz, 1H), 5.09 (t, <i>J</i> = 5.1 Hz, 1H), 4.57 (d, <i>J</i> = 6.3 Hz, 2H), 2.17–2.07 (m, 4H), 1.75 (s, 3H), 1.68 (s, 3H), 1.60 (s, 3H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 282.0873, found 282.0874 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 5-(4-Propoxyphenyl)-2-(pyrimidin-5-yl)oxazole (<b>13</b>)</h5><div class="NLM_p last">Yellow solid (6 mg, 15% yield). LC–MS <i>m</i>/<i>z</i> 282.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.40 (s, 2H), 9.28 (s, 1H), 7.65 (d, <i>J</i> = 9.0 Hz, 2H), 7.39 (s, 1H), 6.99 (d, <i>J</i> = 8.6 Hz, 2H), 3.98 (t, <i>J</i> = 6.7 Hz, 2H), 1.84 (sxt, <i>J</i> = 6.7 Hz, 2H), 1.07 (t, <i>J</i> = 7.4 Hz, 3H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 282.1237, found 282.1243 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_5_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 4-(2-(Pyrimidin-5-yl)oxazol-5-yl)phenyl Acetate (<b>14</b>)</h5><div class="NLM_p last">Pale yellow solid (11 mg, 22% yield). LC–MS <i>m</i>/<i>z</i> 282.1 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.38 (s, 2H), 9.27 (s, 1H), 7.73 (d, <i>J</i> = 9.0 Hz, 2H), 7.48 (s, 1H), 7.20 (d, <i>J</i> = 8.6 Hz, 2H), 2.14 (s, 3H).</div></div><div id="sec4_3_5_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 4-(2-(5-methyl-1<i>H</i>-pyrazol-4-yl)oxazol-5-yl)phenyl Acetate (<b>15</b>)</h5><div class="NLM_p last">Pale yellow solid (9 mg, 51% yield). LC–MS <i>m</i>/<i>z</i> 284.1 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71 (d, <i>J</i> = 9.2 Hz, 2H), 7.68 (s, 1H), 7.31 (s, 1H), 7.17 (d, <i>J</i> = 8.0 Hz, 2H), 6.24 (s, 1H), 3.49 (s, 3H), 2.67 (s, 3H).</div></div><div id="sec4_3_5_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 5-(4-Methoxyphenyl)-2-(5-methyl-1<i>H</i>-pyrazol-4-yl)oxazole (<b>16</b>)</h5><div class="NLM_p last">Pale yellow solid (8 mg, 20% yield). LC–MS <i>m</i>/<i>z</i> 256.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.67 (d, <i>J</i> = 1.6 Hz, 1H), 7.62 (d, <i>J</i> = 8.8 Hz, 2H), 7.21 (s, 1H), 6.95 (d, <i>J</i> = 9.2 Hz, 2H), 6.23 (s, 1H), 3.85 (s, 3H), 2.66 (s, 3H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 256.1081, found 256.1081 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_5_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(5-(pyrrolidin-1-ylmethyl)pyridin-2-yl)oxazole (<b>17</b>)</h5><div class="NLM_p last">Yellow oil (65 mg, 49% yield). LC–MS <i>m</i>/<i>z</i> 390.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.67 (d, <i>J</i> = 1.9 Hz, 1H), 8.10 (d, <i>J</i> = 8.3 Hz, 1H), 7.82 (dd, <i>J</i> = 8.2 Hz, 1.9 Hz, 1H), 7.71 (d, <i>J</i> = 9.0 Hz, 2H), 7.38 (s, 1H), 6.97 (d, <i>J</i> = 8.6 Hz, 2H), 5.50 (tt, <i>J</i> = 6.6 Hz, 1.1 Hz, 1H), 4.56 (d, <i>J</i> = 6.7 Hz, 2H), 3.73 (s, 1H), 3.70 (s, 1H), 2.54 (t, <i>J</i> = 5.1 Hz, 4H), 1.81 (broad s, 6H), 1.76 (broad s, 4H).</div></div><div id="sec4_3_5_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(5-(pyrrolidin-1-ylmethyl)pyridin-2-yl)oxazole Hydrochloride (<b>17-HCl salt</b>)</h5><div class="NLM_p last">Yellow solid (61 mg). LC–MS <i>m</i>/<i>z</i> 390.3 (APCI+) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl3): δ 8.84 (s, 1H), 8.29 (d, <i>J</i> = 8.2 Hz, 1H), 8.16 (dd, 8.2 Hz, 2.3 Hz, 1H), 7.80 (d, <i>J</i> = 9.0 Hz, 2H), 7.61 (s, 1H), 7.04 (d, <i>J</i> = 9.0 Hz, 2H), 5.48 (tt, <i>J</i> = 6.6 Hz, 1.6 Hz, 1H), 4.60 (d, <i>J</i> = 6.7 Hz, 2H), 4.55 (s, 2H), 3.58 (broad s, 2H), 3.26 (broad s, 2H), 2.23 (broad s, 2H), 2.05 (broad s, 2H), 1.80 (d, <i>J</i> = 1.2 Hz, 3H), 1.77 (d, <i>J</i> = 0.8 Hz, 3H). <sup>13</sup>C (400 MHz, CDCl3): δ 159.92, 158.33, 151.05, 146.38, 139.55, 137.66, 125.92, 121.96, 121.74, 199.68, 119.40, 115.01, 64.57, 54.71, 53.77, 24.41, 22.43, 17.83, 16.78. HRMS (ESI) calculated <i>m</i>/<i>z</i> 390.2176, found 390.2193 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_5_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(pyrimidin-5-yl)oxazole (<b>18</b>)</h5><div class="NLM_p last">Yellow solid (6 mg, 13% yield). LC–MS <i>m</i>/<i>z</i> 308.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.38 (s, 2H), 9.28 (s, 1H), 7.65 (d, <i>J</i> = 9.0 Hz, 2H), 7.39 (s, 1H), 7.00 (d, <i>J</i> = 9.0 Hz, 2H), 5.51 (t, <i>J</i> = 6.6 Hz, 1H), 4.57 (d, <i>J</i> = 7.1 Hz, 2H), 1.82 (s, 3H), 1.77 (s, 3H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 308.1394, found 308.1394 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_5_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> <i>N</i>,<i>N</i>-Dimethyl-2-(4-(2-(pyrimidin-5-yl)oxazol-5-yl)phenoxy)ethanamine (<b>19</b>)</h5><div class="NLM_p last">Modification to the general procedures as follows. In this reaction, 3-chloro-<i>N</i>,<i>N</i>-dimethylpropan-1-amine (36 mg, 0.25 mmol) and sodium iodide (4 mg, 0.03 mmol) was used, and the reaction was heated 100 °C. After deemed complete by TLC, the reaction was diluted with DCM (5 mL) and extracted with NaOH (1.0 M, 5 mL × 2). The organic layer was then extracted with HCl (1.0 M, 5 mL × 2). The combined acidic aqueous extracts were extracted with DCM (5 mL × 2). The combined DCM layers were combined, dried over sodium sulfate, filtered, and concentrated under reduced pressure. Amber oil (14 mg, 36% yield), LC–MS <i>m</i>/<i>z</i> 311.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 9.42 (s, 2H), 9.27 (s, 1H), 7.79 (d, <i>J</i> = 9.0 Hz, 2H), 7.61 (s, 1H), 7.09 (d, <i>J</i> = 9.0 Hz, 2H), 3.35 (t, <i>J</i> = 1.6 Hz, 2H), 2.84 (t, <i>J</i> = 5.5 Hz, 2H), 2.40 (s, 6H).</div></div><div id="sec4_3_5_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> <i>N</i>,<i>N</i>-Dimethyl-2-(4-(2-(pyrimidin-5-yl)oxazol-5-yl)phenoxy)ethanamine Hydrochloride (<b>19-HCl salt</b>)</h5><div class="NLM_p last">Yellow solid (6 mg, Quant.). LC–MS <i>m</i>/<i>z</i> 311.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 9.42 (s, 2H), 9.26 (s, 1H), 7.85 (d, <i>J</i> = 9.0 Hz, 2H), 7.64 (s, 1H), 7.18 (d, <i>J</i> = 9.0 Hz, 2H), 4.44 (t, <i>J</i> = 5.1 Hz, 2H), 3.64 (t, <i>J</i> = 5.1 Hz, 2H), 3.01 (s, 6H).</div></div><div id="sec4_3_5_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 4-[(3-methylbut-2-en-1-yl)oxy]benzaldehyde (<b>21</b>)</h5><div class="NLM_p last">Pale yellow oil (475 mg, 61% yield), LC–MS <i>m</i>/<i>z</i> 123.1 (APCI<sup>+</sup>) (M + H – CH<sub>2</sub>CHC(CH<sub>3</sub>)<sub>2</sub>)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.87 (s, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 2H), 6.99 (d, <i>J</i> = 8.3 Hz, 2H), 5.48 (t, <i>J</i> = 6.3 Hz, 1H), 4.58 (d, <i>J</i> = 6.3 Hz, 2H), 1.80 (s, 3H), 1.75 (s, 3H).</div></div><div id="sec4_3_5_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)oxazole (<b>22</b>)</h5><div class="NLM_p last">LC–MS <i>m</i>/<i>z</i> 230.1 <i>m</i>/<i>z</i> (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.86 (s, 1H), 7.56 (d, <i>J</i> = 8.3 Hz, 2H), 7.22 (s, 1H), 6.96 (d, <i>J</i> = 8.3 Hz, 2H), 5.49 (t, <i>J</i> = 5.8 Hz, 1H), 4.54 (d, <i>J</i> = 6.3 Hz, 2H), 1.80 (s, 3H), 1.75 (s, 3H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 230.1176, found 230.1179 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_5_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 6-(5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)nicotinaldehyde (<b>23</b>)</h5><div class="NLM_p last">In a dried flask equipped with a stir bar, <b>22</b> (700 mg, 3.05 mmol), 6-bromonicotinaldehyde (685 mg, 3.66 mmol), anhydrous sodium carbonate (647 mg, 6.11 mmol), copper(I) iodide (581 mg, 5.05 mmol), and triphenylphosphine (800 mg, 3.05 mmol) were dissolved in dry, deoxygenated DMF (3 mL). The reaction was purged with N<sub>2</sub> and heated to reflux for 4.5 h. The reaction was then cooled to RT and poured into a 7% solution of ammonium hydroxide in water (100 mL). The solution was then diluted with DCM (100 mL) and washed with sat. ammonium chloride (70 mL × 1) and sat. sodium bicarbonate (70 mL × 3). The organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude mixture was then purified on a silica column using EtOAc/hexanes. Red solid (484 mg, 47% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.14 (s, 1H), 9.16 (t, <i>J</i> = 1.4 Hz, 1H), 8.28–8.27 (m, 2H), 7.71 (d, <i>J</i> = 9.0 Hz, 2H), 7.45 (s, 1H), 6.97 (d, <i>J</i> = 8.7 Hz, 2H), 5.48 (t, <i>J</i> = 6.6 Hz, 1H), 4.55 (d, <i>J</i> = 6.7 Hz, 2H), 1.79 (s, 3H), 1.75 (s, 3H).</div></div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> General Procedure for Reductive Amination</h4><div class="NLM_p last">In a vial equipped with a stir bar, aldehyde <b>23</b> (30 mg, 0.089 mmol) and amine (0.099 mmol) were dissolved in DCE (1 mL) and allowed to stir for 5 min. Sodium triatoxyborohyride (57 mg, 0.27 mmol) was then added. The reaction was then allowed to stir at r.t. Once complete, as deemed by TLC, the reaction was quenched with saturated aqueous sodium bicarbonate (1 mL). The reaction was then extracted with DCM (1 mL × 2). The combined organic layers were then concentrated under reduced pressure to produce a crude oil. The crude oil was then purified on a silica gel column using a combination of EtOAc and hexanes followed by 1 M NH<sub>3</sub> in MeOH/DCM.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> General Procedure for Salt Formation</h4><div class="NLM_p">In a vial equipped with a stir bar, the amine (1 equiv) is dissolved in ether (1 mL), and HCl (1–2 equiv, 1 M in ether) was added dropwise. The reaction was then allowed to stir for 10 min before concentrating under reduced pressure.</div><div id="sec4_3_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(6-(piperidin-1-ylmethyl)pyridin-3-yl)oxazole (<b>24</b>)</h5><div class="NLM_p last">Red solid (21 mg, 36% yield). LC–MS <i>m</i>/<i>z</i> 404.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 9.16 (s, 1H), 8.42 (d, <i>J</i> = 7.8 Hz, 1H), 7.73 (d, <i>J</i> = 7.1 Hz, 2H), 7.69 (d, <i>J</i> = 7.8 Hz, 1H), 7.51 (d, <i>J</i> = 1.9 Hz, 1H), 7.02 (d, <i>J</i> = 6.7 Hz, 2H), 5.48 (t, <i>J</i> = 6.0 Hz, 1H), 4.59 (d, <i>J</i> = 7.0 Hz, 1H), 3.70 (d, <i>J</i> = 3.1 Hz, 2H) 2.51 (broad s, 4H), 1.80 (s, 3H), 1.77 (s, 3H), 1.63 (t, <i>J</i> = 3.6 Hz, 4H), 1.49 (broad s, 2H).</div></div><div id="sec4_3_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(6-(piperidin-1-ylmethyl)pyridin-3-yl)oxazole Hydrochloride (<b>24-HCl salt</b>)</h5><div class="NLM_p last">Yellow solid (24 mg, quant.). LC–MS <i>m</i>/<i>z</i> 404.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO): δ 10.64 (s, 1H), 9.30 (d, <i>J</i> = 1.5 Hz, 1H), 8.53 (dd, <i>J</i> = 7.8 Hz, 1.9 Hz, 1H), 7.89 (d, <i>J</i> = 8.3 Hz, 1H), 7.83–7.79 (m, 3H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H), 5.45 (t, <i>J</i> = 5.1 Hz, 1H), 4.60 (d, <i>J</i> = 6.7 Hz, 2H), 4.51 (s, 2H), 3.42 (broad s, 2H), 3.00 (broad s, 2H), 1.81 (broad s, 4H), 1.76 (s, 3H), 1.70 (s, 3H), 1.08–1.03 (m, 2H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 404.2333, found 404.2352 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 2-Methyl-<i>N</i>-[(5-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-2-yl)methyl]propan-1-amine (<b>25</b>)</h5><div class="NLM_p last">Yellow oil (28 mg, 80% yield). LC–MS <i>m</i>/<i>z</i> 392.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.67 (s, 1H), 8.15 (d, <i>J</i> = 8.2 Hz, 1H), 7.99 (d, <i>J</i> = 7.9 Hz, 1H), 7.79 (d, <i>J</i> = 8.6 Hz, 2H), 7.54 (s, 1H), 7.02 (d, <i>J</i> = 8.6 Hz, 2H), 5.48 (t, <i>J</i> = 5.6 Hz, 1H), 4.59 (d, <i>J</i> = 6.6 Hz, 2H), 3.87 (s, 2H), 2.43 (d, <i>J</i> = 7.1 Hz, 2H), 2.02–1.92 (m, 1H), 1.80 (s, 3H), 1.77 (s, 3H), 0.94 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec4_3_7_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 2-Methyl-<i>N</i>-[(5-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-2-yl)methyl]propan-1-amine Hydrochloride (<b>25-HCl salt</b>)</h5><div class="NLM_p last">Yellow solid (35 mg, quant.). LC–MS <i>m</i>/<i>z</i> 392.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.85 (broad s, 1H), 8.29 (broad s, 1H), 8.17 (d, <i>J</i> = 8.2 Hz, 1H), 7.80 (d, <i>J</i> = 8.6 Hz, 2H), 7.62 (s, 1H), 7.04 (d, <i>J</i> = 9.0 Hz, 1H), 5.51 (t, <i>J</i> = 5.0 Hz, 1H), 4.60 (d, <i>J</i> = 6.7 Hz, 2H), 4.38 (s, 2H), 2.99 (d, <i>J</i> = 7.1 Hz, 2H), 2.13–2.04 (m, 1H), 1.80 (s, 3H), 1.78 (s, 3H), 1.07 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec4_3_7_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(5-(piperidin-1-ylmethyl)pyridin-2-yl)oxazole (<b>26</b>)</h5><div class="NLM_p last">Yellow oil (7 mg, 19% yield). LC–MS <i>m</i>/<i>z</i> 404.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.64 (s, 1H), 8.16 (d, <i>J</i> = 8.3 Hz, 1H), 7.97 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (d, <i>J</i> = 9.0 Hz, 2H), 7.55 (s, 1H), 7.03 (d, <i>J</i> = 8.2 Hz, 2H), 5.48 (t, <i>J</i> = 6.0 Hz, 1H), 4.60 (d, <i>J</i> = 7.0 Hz, 1H), 3.61 (s, 2H), 3.27 (broad s, 4H), 1.80 (s, 3H), 1.77 (s, 3H), 1.61 (d, <i>J</i> = 5.9 Hz, 4H), 1.51 (t, <i>J</i> = 9.0 Hz, 2H).</div></div><div id="sec4_3_7_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy)phenyl)-2-(5-(piperidin-1-ylmethyl]pyridin-2-yl)oxazole Hydrochloride (<b>26-HCl salt</b>)</h5><div class="NLM_p last">Yellow solid (12 mg, quant.) LC–MS <i>m</i>/<i>z</i> 404.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO): δ 10.38 (s, 1H), 8.87 (s, 1H), 8.25–8.18 (m, 2H), 7.81 (s, 1H), 7.77 (d, <i>J</i> = 8.6 Hz, 2H), 7.19 (d, <i>J</i> = 9.0 Hz, 2H), 5.45 (t, <i>J</i> = 1.6 Hz, 1H), 4.60 (d, <i>J</i> = 6.7 Hz, 2H), 4.40 (d, <i>J</i> = 5.1 Hz, 2H), 2.90 (q, <i>J</i> = 11.3 Hz, 4H), 1.79 (broad s, 4H), 1.76 (s, 3H), 1.73 (s, 3H), 1.38 (bs, 2H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 404.2333, found 404.2346 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> <i>N</i>-Methyl-<i>N</i>-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]cyclohexanamine (<b>27</b>)</h5><div class="NLM_p last">Yellow oil (44%). LCMS: 432.3 <i>m</i>/<i>z</i> (APCI) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.63 (s, 1H), 8.14 (d, <i>J</i> = 7.8 Hz, 1H), 7.95 (d, <i>J</i> = 8.6 Hz, 2H), 7.54 (s, 1H), 7.03 (d, <i>J</i> = 8.6 Hz, 2H), 5.48 (d, <i>J</i> = 6.6 Hz, 1H), 4.59 (d, <i>J</i> = 6.7 Hz, 2H), 3.72 (s, 2H), 2.48 (t, <i>J</i> = 1.3 Hz, 1H), 2.24 (s, 3H), 1.93 (d, <i>J</i> = 10.9 Hz, 2H), 1.84 (d, <i>J</i> = 11.4 Hz, 2H), 1.80 (s, 3H), 1.77 (s, 3H) 1.65 (d, <i>J</i> = 14.0 Hz, 1H), 1.42–1.18 (m, 5H).</div></div><div id="sec4_3_7_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> <i>N</i>-Methyl-<i>N</i>-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]cyclohexanamine Hydrochloride (<b>27-HCl salt</b>)</h5><div class="NLM_p last">Yellow solid (20 mg, quant.). LC–MS <i>m</i>/<i>z</i> 432.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.87 (bs, 1H), 8.34 (bs, 1H), 8.19 (d, <i>J</i> = 8.2 Hz, 1H), 7.80 (d, <i>J</i> = 8.6 Hz, 2H), 7.65 (s, 1H), 7.04 (d, <i>J</i> = 8.6 Hz, 2H), 5.49 (t, <i>J</i> = 4.3 Hz, 1H), 4.60 (d, <i>J</i> = 6.3 Hz, 2H), 4.37 (d, <i>J</i> = 12.9 Hz, 1H), 2.78 (s, 3H), 2.23–2.14 (m, 2H), 2.03–1.97 (m, 2H), 1.80 (s, 3H), 1.78 (s, 3H), 1.64–1.61 (m, 2H), 1.50–1.42 (m, 2H), 1.30 (t, <i>J</i> = 13.7 Hz, 1H), 1.17 (td, <i>J</i> = 7.0 Hz, 1.1 Hz, 1H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 432.2646, found 432.2657 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> (<i>R</i>)-<i>N</i>,<i>N</i>-Dimethyl-1-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]pyrrolidin-3-amine (<b>28</b>)</h5><div class="NLM_p last">Yellow oil (22 mg, 57% yield). LC–MS <i>m</i>/<i>z</i> 433.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.63 (d, <i>J</i> = 1.5 Hz, 1H), 8.14 (d, <i>J</i> = 8.2 Hz, 1H), 7.95 (dd, <i>J</i> = 8.2 Hz, 1.9 Hz, 1H), 7.78 (d, <i>J</i> = 9.0 Hz, 2H), 7.53 (s, 1H), 7.01 (d, <i>J</i> = 9.0 Hz, 2H), 5.46 (t, <i>J</i> = 5.1 Hz, 1H), 4.58 (d, <i>J</i> = 6.2 Hz, 2H), 4.55 (bs, 2H), 3.74 (q, <i>J</i> = 13.7 Hz, 2H), 2.85 (t, <i>J</i> = 7.8 Hz, 1H), 2.64–2.61 (m, 1H), 2.28–2.50 (m, 8H), 2.02 (d, <i>J</i> = 9.0 Hz, 1H), 1.78 (s, 3H), 1.76 (s, 3H).</div></div><div id="sec4_3_7_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> (<i>R</i>)-<i>N</i>,<i>N</i>-Dimethyl-1-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]pyrrolidin-3-amine Dihydrochloride (<b>28-HCl salt</b>)</h5><div class="NLM_p last">Two equivalents of HCl was used. Yellow solid (35 mg, quant.). LC–MS <i>m</i>/<i>z</i> 433.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.93 (s, 1H), 8.45–8.21 (m, 2H), 7.81–7.76 (m, 3H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H), 5.46 (t, <i>J</i> = 6.4 Hz, 1H), 4.56 (bs, 2H) 4.60 (d, <i>J</i> = 6.7 Hz, 2H), 3.34 (s, 1H), 2.99 (s, 1H), 2.80–2.72 (m, 9H), 2.09 (s, 1H), 1.96 (d, <i>J</i> = 10.6 Hz, 1H), 1.76 (s, 3H), 1.74 (s, 3H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 433.2598, found 433.2600 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 6-[((6-(5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl)amino]hexan-1-ol (<b>29</b>)</h5><div class="NLM_p last">Yellow oil (17 mg, 44% yield). LC–MS <i>m</i>/<i>z</i> 436.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.67 (d, <i>J</i> = 1.5 Hz, 1H), 8.16 (d, <i>J</i> = 7.4 Hz, 1H), 7.99 (dd, <i>J</i> = 8.2 Hz, 2.3 Hz, 1H), 7.80 (d, <i>J</i> = 8.6 Hz, 2H), 7.55 (s, 1H), 7.03 (d, <i>J</i> = 9.0 Hz, 2H), 5.48 (t, <i>J</i> = 1.6 Hz, 1H), 4.60 (d, <i>J</i> = 6.6 Hz, 2H), 3.89 (s, 2H), 3.54 (t, <i>J</i> = 6.7 Hz, 2H), 1.92 (t, <i>J</i> = 6.6 Hz, 2H), 1.80 (s, 3H), 1.78 (s, 3H), 1.60–1.49 (m, 4H), 1.42–1.35 (m, 4H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 436.2595, found 436.2598 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 6-[((6-(5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl)amino]hexan-1-ol Hydrochloride (<b>29-HCl salt</b>)</h5><div class="NLM_p last">Yellow solid (29 mg, quant.). LC–MS <i>m</i>/<i>z</i> 436.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.83 (bs, 1H), 8.30 (bs, 1H), 8.17 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (d, <i>J</i> = 9.0 Hz, 2H), 7.63 (bs, 1H), 7.04 (d, <i>J</i> = 8.6 Hz, 2H), 5.48 (t, <i>J</i> = 5.1 Hz, 1H), 4.60 (d, <i>J</i> = 6.3 Hz, 2H), 4.37 (s, 2H), 3.57 (t, <i>J</i> = 6.3 Hz, 4H), 1.80 (s, 4H), 1.78 (s, 4H), 1.61–1.53 (m, 2H), 1.49–1.42 (m, 4H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 436.2595, found 436.2598 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> (<i>S</i>)-Methyl-1-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]pyrrolidine-2-carboxylate (<b>30</b>)</h5><div class="NLM_p last">Yellow oil (16 mg, 40% yield). LC–MS <i>m</i>/<i>z</i> 448.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.65 (d, <i>J</i> = 2.0 Hz, 1H), 8.14 (d, <i>J</i> = 8.2 Hz, 1H), 7.98 (dd, <i>J</i> = 8.2 Hz, 2.0 Hz, 1H), 7.80 (d, <i>J</i> = 2.3 Hz, 2H), 7.79 (s, 1H), 7.03 (d, <i>J</i> = 9.0 Hz, 2H), 5.48 (t, <i>J</i> = 1.6 Hz, 1H), 4.59 (d, <i>J</i> = 6.6 Hz, 2H), 3.99 (d, <i>J</i> = 3.3 Hz, 1H), 3.71 (d, <i>J</i> = 13.7 Hz, 1H), 3.64 (s, 3H), 3.37–3.32 (m, 1H), 3.06–3.01 m, 1H), 2.49 (q, <i>J</i> = 8.2 Hz, 1H), 2.23–2.15 (m, 1H), 1.96–1.83 (m, 3H), 1.80 (s, 3H), 1.77 (s, 3H).</div></div><div id="sec4_3_7_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> (<i>S</i>)-Methyl-1-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]pyrrolidine-2-carboxylate Hydrochloride (<b>30-HCl salt</b>)</h5><div class="NLM_p last">Yellow solid (20 mg, quant.). LC–MS <i>m</i>/<i>z</i> 448.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.85 (s, 1H), 8.23 (t, <i>J</i> = 8.2 Hz, 1H), 8.16 (d, <i>J</i> = 6.6 Hz, 1H), 7.81–7.76 (m, 3H), 7.09 (d, <i>J</i> = 8.7 Hz, 2H), 5.44 (t, <i>J</i> = 6.2 Hz, 1H), 4.60 (d, <i>J</i> = 6.7 Hz, 3H), 4.53 (bs, 1H), 3.68 (s, 3H), 3.57 (bs, 1H), 3.44 (q, <i>J</i> = 7.1 Hz, 2H), 3.34 (s, 2H), 1.76 (s, 3H), 1.74 (s, 3H), 1.08–1.03 (m, 2H). HRMS (ESI) calculated <i>m</i>/<i>z</i> 448.2231, found 448.2236 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> <i>N</i>,<i>N</i>-Dimethyl-1-(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methanamine (<b>31</b>)</h5><div class="NLM_p last">Yellow oil (17 mg, 49% yield). LC–MS <i>m</i>/<i>z</i> 364.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.64 (d, <i>J</i> = 1.9 Hz, 1H), 8.17 (d, <i>J</i> = 7.8 Hz, 1H), 7.96 (dd, <i>J</i> = 8.2 Hz 2.0 Hz, 1H), 7.80 (d, <i>J</i> = 9.0 Hz, 2H), 7.55 (s, 1H), 7.03 (d, <i>J</i> = 9.0 Hz, 2H), 5.47 (t, <i>J</i> = 5.6 Hz, 1H), 4.60 (d, <i>J</i> = 6.6 Hz, 2H), 3.60 (s, 2H), 2.30 (s, 6H), 1.80 (s, 3H), 1.78 (s, 3H).</div></div><div id="sec4_3_7_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> <i>N</i>,<i>N</i>-Dimethyl-1-(5-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-2-yl)methanamine Hydrochloride (<b>31-HCl salt</b>)</h5><div class="NLM_p last">Tan solid (21 mg, quant.). LC–MS <i>m</i>/<i>z</i> 364.2 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.79 (s, 1H), 8.28 (d, <i>J</i> = 8.2 Hz, 1H), 8.11 (dd, <i>J</i> = 8.2 Hz, 2.4 Hz, 1H), 7.80 (d, <i>J</i> = 9.0 Hz, 2H), 7.60 (s, 1H), 7.04 (d, <i>J</i> = 9.0 Hz, 2H), 5.49 (t, <i>J</i> = 7.2 Hz, 1H), 4.60 (d, <i>J</i> = 6.7 Hz, 2H), 4.33 (s, 2H), 2.84 (s, 6H), 1.80 (s, 3H), 1.78 (s, 3H). HRMS (ESI) calculated <i>m</i>/<i>z</i> 364.2020, found 364.2024 (M + H)<sup>+</sup>. HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 448.2231, found 448.2236 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> <i>N</i>-Ethyl-<i>N</i>-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]ethanamine (<b>32</b>)</h5><div class="NLM_p last">Yellow oil (25 mg, 71% yield). LC–MS <i>m</i>/<i>z</i> 392.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.65 (s, 1H), 8.14 (dd, <i>J</i> = 8.3 Hz, 3.6 Hz, 1H), 7.97 (dd, <i>J</i> = 8.2 Hz, 2.0 Hz, 1H), 7.79 (d, <i>J</i> = 9.0 Hz, 2H), 7.54 (s, 1H), 7.03 (d, <i>J</i> = 9.0 Hz, 2H), 5.48 (t, <i>J</i> = 2.3 Hz, 1H), 4.59 (s, <i>J</i> = 6.6 Hz, 2H), 3.72 (s, 2H), 2.59 (q, <i>J</i> = 7.0 Hz, 4H), 1.80 (s, 3H), 1.77 (s, 3H), 1.10 (t, <i>J</i> = 7.0 Hz, 6H).</div></div><div id="sec4_3_7_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> <i>N</i>-Ethyl-<i>N</i>-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]ethanamine Hydrochloride (<b>32-HCl salt</b>)</h5><div class="NLM_p last">Orange oil (29 mg, Quant.). LC–MS <i>m</i>/<i>z</i> 392.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.85 (s, 1H), 8.30 (d, <i>J</i> = 8.2 Hz, 1H), 8.18 (dd, <i>J</i> = 8.2 Hz, 1.9 Hz, 1H), 7.80 (d, <i>J</i> = 8.6 Hz, 2H), 7.62 (s, 1H), 7.04 (d, <i>J</i> = 8.6 Hz, 2H), 5.49 (t, <i>J</i> = 8.4 Hz, 1H), 4.60 (d, <i>J</i> = 6.6 Hz, 2H), 4.52 (s, 2H), 3.31 (quin, <i>J</i> = 1.5 Hz, 4H), 1.80 (s, 3H), 1.78 (s, 3H), 1.40 (t, 7.4 Hz, 6H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 392.2333, found 392.2317 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(5-[(4-methylpiperazin-1-yl)methyl]pyridin-2-yl)oxazole (<b>33</b>)</h5><div class="NLM_p last">Yellow oil (8 mg, 21% yield). LC–MS <i>m</i>/<i>z</i> 419.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.65 (s, 1H), 8.16 (d, <i>J</i> = 8.2 Hz, 1H), 7.97 (d, <i>J</i> = 8.7 Hz, 1H), 7.79 (d, <i>J</i> = 7.8 Hz, 2H), 7.55 (s, 1H), 7.03 (d, <i>J</i> = 7.9 Hz, 2H), 5.48 (t, <i>J</i> = 6.4 Hz, 1H), 4.60 (d, <i>J</i> = 6.2 Hz, 2H), 3.66 (s, 2H), 3.60–3.53 (m, 4H), 2.45 (t, <i>J</i> = 5.1 Hz, 2H), 2.40 (t, <i>J</i> = 5.0 Hz, 2H), 2.30 (d, <i>J</i> = 1.2 Hz, 3H), 2.29 (s, 2H), 1.80 (s, 3H), 1.77 (s, 3H).</div></div><div id="sec4_3_7_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(5-[(4-methylpiperazin-1-yl)methyl]pyridin-2-yl)oxazole Dihydrochloride (<b>33-HCl salt</b>)</h5><div class="NLM_p last">Two equivalents of HCl were used. Tan solid (12 mg, quant.). LC–MS <i>m</i>/<i>z</i> 419.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.64 (s, 1H), 8.12 (d, <i>J</i> = 8.3 Hz, 1H), 8.06 (s, 1H), 8.02 (d, <i>J</i> = 7.8 Hz, 1H), 7.92 (d, <i>J</i> = 8.2 Hz, 2H), 6.94 (d, <i>J</i> = 9.0 Hz, 2H), 5.47 (t, <i>J</i> = 9.0 Hz, 1H), 4.58 (d, <i>J</i> = 6.6 Hz, 2H), 3.87 (s, 2H), 3.46 (t, <i>J</i> = 7.7 Hz, 4H), 2.91–2.89 (m, 6H), 2.13 (s, 1H), 1.77 (s, 3H), 1.74 (s, 3H), 1.23 (s, 1H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 419.2442, found 419.2430 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_7_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> 1-[(6-(5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl]pyridin-3-yl)methyl)pyrrolidin-2-one (<b>34</b>)</h5><div class="NLM_p last">Yellow oil (30 mg, 83% yield). LC–MS <i>m</i>/<i>z</i> 405.3 (APCI<sup>+</sup>) (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>4</sub>-MeOD): δ 8.61 (d, <i>J</i> = 1.9 Hz, 1H), 8.17 (d, <i>J</i> = 8.2 Hz, 1H), 7.89 (dd, <i>J</i> = 8.2 Hz, 2.3 Hz, 1H), 7.79 (d, <i>J</i> = 9.0 Hz, 2H), 7.55 (s, 1H), 7.03 (d, <i>J</i> = 8.6 Hz, 2HL), 5.48 (t, <i>J</i> = 1.6 Hz, 1H), 4.61–4.58 (m, 4H), 3.43 (t, <i>J</i> = 7.1 Hz, 2H), 2.47 (t, <i>J</i> = 7.8 Hz, 2H), 2.08 (quin, <i>J</i> = 7.4 Hz, 2H), 1.80 (s, 3H), 1.77 (s, 3H). HRMS (ESI<sup>+</sup>) calculated <i>m</i>/<i>z</i> 404.1969, found 404.1979 (M + H)<sup>+</sup>.</div></div></div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Biological Experiments</h3><div id="sec4_3_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Cell Culture</h4><div class="NLM_p last">MDA-MB-468, MDA-MB-453, MDA-MB-231, HCC1937, HCC70, and A-10 cell lines were purchased directly from the American Type Culture Collection (Manassas, VA, USA). The BT-549 cell line was obtained from Lombardi Comprehensive Cancer Center of Georgetown University (Washington, DC, USA), and the identity was validated by Promega (Fitchburg, WI, USA). MDA-MB-453 and MDA-MB-231 cells were cultured in IMEM (Gibco) containing 25 μg/mL gentamicin (Gibco) and 10% FBS. MDA-MB-468, HCC70, HCC1937, and BT-549 cells were cultured in RPMI-1640 medium (Sigma-Aldrich) containing 50 μg/mL gentamicin and 10% FBS. A-10 cells were cultured in Basal Medium Eagle (Sigma-Aldrich) containing 50 μg/mL gentamicin and 10% FBS. Cells were maintained in humidified incubators at 37 °C with 5% CO<sub>2</sub>. All cell lines were initially expanded and frozen as stocks in liquid nitrogen. Cells were passaged for no more than 3 months after revival from liquid nitrogen.</div></div><div id="sec4_3_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Sulforhodamine B (SRB) Assay</h4><div class="NLM_p last">The antiproliferative and cytotoxic effects of all compounds were evaluated with the SRB assay as previously described.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Cells were treated with the compounds indicated for 48–96 h, and cell density at the time of treatment (<i>T</i><sub>0</sub>) was measured to determine cytotoxic activity. Concentration–response curves were plotted, and the concentrations causing 50% inhibition of proliferation compared to vehicle control (GI<sub>50</sub>), total growth inhibition (TGI), and 50% cell death compared to <i>T</i><sub>0</sub> (LC<sub>50</sub>) were interpolated from nonlinear regressions of the data using Prism 6 (GraphPad Software).</div></div><div id="sec4_3_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Cell Cycle Analysis by Flow Cytometry</h4><div class="NLM_p last">The effects of selected compounds on cell cycle distribution were evaluated by flow cytometry. MDA-MB-453 cells were treated with vehicle (DMSO) or predetermined concentrations of the test compound for 18 h. Cells were then harvested, stained with Krishan’s reagent,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and their DNA content was measured using a Muse Cell Analyzer (EMD Millipore).</div></div><div id="sec4_3_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Intracellular Signaling Array</h4><div class="NLM_p last">Cells were treated with vehicle or the test compound, harvested by scraping and lysed in Cell Extraction Buffer (Life Technologies, Waltham, MA, USA) containing protease inhibitor cocktail, PMSF, and Na<sub>3</sub>VO<sub>4</sub> (Sigma-Aldrich). Protein concentrations were quantified with a Pierce Coomassie Plus Assay Kit (Life Technologies), and equal amounts of protein were evaluated with a PathScan intracellular signaling array (fluorescent readout; Cell Signaling Technology) according to the manufacturer’s protocol. Near-infrared fluorescent signals were captured with an Odyssey CLx (LI-COR Biosciences, Lincoln, NE, USA) and quantified with ImageStudio (LI-COR Biosciences).</div></div><div id="sec4_3_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Cell Lysis and Immunoblotting</h4><div class="NLM_p last">Cells were treated with vehicle or the test compound, harvested by scraping, and lysed as described for the intracellular signaling array. Protein concentrations were quantified with a Pierce Coomassie Plus Assay Kit (Life Technologies), and equal amounts of protein were separated by SDS-PAGE on NuPAGE Bis-Tris gels (Life Technologies). Proteins were transferred to PVDF membranes (EMD Millipore, Billerica, MA, USA), which were subsequently blocked with Odyssey Blocking Buffer (LI-COR Biosciences) in tris-buffered saline. Membranes were probed with antibodies for P-mTOR, mTOR, P-S6K, S6K, P-RPS6, RPS6, P-S473-Akt, P-T308-Akt, or pan Akt (Cell Signaling Technology, Danvers, MA, USA), diluted in Odyssey Blocking Buffer. Membranes were incubated with appropriate IRDye 680 or IRDye 800 secondary antibodies (LI-COR Biosciences), and near-infrared fluorescence signals were captured on an Odyssey FC (LI-COR Biosciences). Signal intensities were quantified with ImageStudio (LI-COR Biosciences).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01228">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47815" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47815" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01228" class="ext-link">10.1021/acs.jmedchem.7b01228</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C, gCOSY, and NOESY2D NMR spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01228/suppl_file/jm7b01228_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular strings file (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01228/suppl_file/jm7b01228_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01228/suppl_file/jm7b01228_si_001.pdf">jm7b01228_si_001.pdf (1.47 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01228/suppl_file/jm7b01228_si_002.csv">jm7b01228_si_002.csv (1.62 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01228" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanton F. McHardy</span> - <span class="hlFld-Affiliation affiliation">Center
for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0070-4924" title="Orcid link">http://orcid.org/0000-0003-0070-4924</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5e2d2a3f302a313070333d363f2c3a271e2b2a2d3f703b3a2b"><span class="__cf_email__" data-cfemail="eb989f8a859f8485c58688838a998f92ab9e9f988ac58e8f9e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan L. Mooberry</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology and ‡UT Health San Antonio Cancer Center, UT Health San Antonio, 7703 Floyd Curl Drive, San
Antonio, Texas 78229, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Natural Product Discovery
Group, Institute for Natural Products Applications
and Research Technologies, and ⊥Department of Chemistry & Biochemistry, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f39e9c9c919681818ab386879b80908092dd969786"><span class="__cf_email__" data-cfemail="1e7371717c7b6c6c675e6b6a766d7d6d7f307b7a6b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Robles</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology and ‡UT Health San Antonio Cancer Center, UT Health San Antonio, 7703 Floyd Curl Drive, San
Antonio, Texas 78229, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Natural Product Discovery
Group, Institute for Natural Products Applications
and Research Technologies, and ⊥Department of Chemistry & Biochemistry, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3447-0169" title="Orcid link">http://orcid.org/0000-0003-3447-0169</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shelby McCowen</span> - <span class="hlFld-Affiliation affiliation">Center
for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shengxin Cai</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology and ‡UT Health San Antonio Cancer Center, UT Health San Antonio, 7703 Floyd Curl Drive, San
Antonio, Texas 78229, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Natural Product Discovery
Group, Institute for Natural Products Applications
and Research Technologies, and ⊥Department of Chemistry & Biochemistry, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michaels Glassman</span> - <span class="hlFld-Affiliation affiliation">Center
for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Ruiz</span> - <span class="hlFld-Affiliation affiliation">Center
for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert H. Cichewicz</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology and ‡UT Health San Antonio Cancer Center, UT Health San Antonio, 7703 Floyd Curl Drive, San
Antonio, Texas 78229, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Innovative Drug Discovery, Department of Chemistry, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, Texas 78249, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Natural Product Discovery
Group, Institute for Natural Products Applications
and Research Technologies, and ⊥Department of Chemistry & Biochemistry, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0744-4117" title="Orcid link">http://orcid.org/0000-0003-0744-4117</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.J.R. and S.L.M. designed the biological experiments, and A.J.R. conducted them. S.F.M. and S.M. designed all analogs and planned all chemistry experiments and compound synthesis. S.M. synthesized and characterized all compounds and analogs. M.G. developed alternative synthesis routes. S.C. and R.H.C. planned the isolation of the natural products. S.C. isolated the natural products and determined their structures. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This study was funded by grants to S.L.M. and R.H.C. from the National Cancer Institute (UO1CA182740), the UTHSCSA President’s Council Excellence Award (to S.L.M), and the Greehey Distinguished Chair in Targeted Molecular Therapeutics endowment (to S.L.M.). Support of the Flow Cytometry, Macromolecular Structure, and Mass Spectrometry Shared Resources of the CTRC Cancer Center Support Grant (P30 CA054174) are gratefully acknowledged. A.J.R was partially supported by the IMSD program of the NIGMS (1R25GM095480-01). Medicinal chemistry support from the Cancer Prevention Research Institute of Texas (CPRIT) grant RP160844 (to S.F.M) is gratefully acknowledged.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d225e5160-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank the San Antonio Botanical Gardens for allowing us to collect samples of <i>Amyris texana</i> for these studies.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i87" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i87"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i88" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i88"> Abbreviations Used</h2><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progesterone receptor</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">BL1</td><td class="NLM_def"><p class="first last">basal-like 1</p></td></tr><tr><td class="NLM_term">BL2</td><td class="NLM_def"><p class="first last">basal-like 2</p></td></tr><tr><td class="NLM_term">M</td><td class="NLM_def"><p class="first last">mesenchymal-like</p></td></tr><tr><td class="NLM_term">LAR</td><td class="NLM_def"><p class="first last">luminal androgen receptor</p></td></tr><tr><td class="NLM_term">SRB</td><td class="NLM_def"><p class="first last">sulforhodamine B</p></td></tr><tr><td class="NLM_term">SARs</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[Bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">Ac<sub>2</sub>O</td><td class="NLM_def"><p class="first last">acetic anhydride</p></td></tr><tr><td class="NLM_term">HPLC–MS</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Dent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudeau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawka, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lickley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlinson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narod, S. A.</span><span> </span><span class="NLM_article-title">Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">15 Pt 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4434</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-3045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1158%2F1078-0432.CCR-06-3045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=17671126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A280%3ADC%252BD2svltlShtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=4429-4434&issue=15+Pt+1&author=R.+Dentauthor=M.+Trudeauauthor=K.+I.+Pritchardauthor=W.+M.+Hannaauthor=H.+K.+Kahnauthor=C.+A.+Sawkaauthor=L.+A.+Lickleyauthor=E.+Rawlinsonauthor=P.+Sunauthor=S.+A.+Narod&title=Triple-Negative+Breast+Cancer%3A+Clinical+Features+and+Patterns+of+Recurrence&doi=10.1158%2F1078-0432.CCR-06-3045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: clinical features and patterns of recurrence</span></div><div class="casAuthors">Dent Rebecca; Trudeau Maureen; Pritchard Kathleen I; Hanna Wedad M; Kahn Harriet K; Sawka Carol A; Lickley Lavina A; Rawlinson Ellen; Sun Ping; Narod Steven A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15 Pt 1</span>),
    <span class="NLM_cas:pages">4429-34</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">PURPOSE:  To compare the clinical features, natural history, and outcomes for women with "triple-negative" breast cancer with women with other types of breast cancer.  EXPERIMENTAL DESIGN:  We studied a cohort of 1,601 patients with breast cancer, diagnosed between January 1987 and December 1997 at Women's College Hospital in Toronto.  Triple-negative breast cancers were defined as those that were estrogen receptor negative, progesterone receptor negative, and HER2neu negative.  The prognostic significance of triple-negative breast cancer was explored.  RESULTS:  The median follow-up time of the 1,601 women was 8.1 years.  One hundred and eighty of 1,601 patients (11.2%) had triple-negative breast cancer.  Compared with other women with breast cancer, those with triple-negative breast cancer had an increased likelihood of distant recurrence (hazard ratio, 2.6; 95% confidence interval, 2.0-3.5; P < 0.0001) and death (hazard ratio, 3.2; 95% confidence interval, 2.3-4.5; P < 0.001) within 5 years of diagnosis but not thereafter.  The pattern of recurrence was also qualitatively different; among the triple-negative group, the risk of distant recurrence peaked at approximately 3 years and declined rapidly thereafter.  Among the "other" group, the recurrence risk seemed to be constant over the period of follow-up.  CONCLUSIONS:  Triple-negative breast cancers have a more aggressive clinical course than other forms of breast cancer, but the adverse effect is transient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgv_jWdHp-NeIHSmpohpd0fW6udTcc2ebscejdhOsTDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svltlShtQ%253D%253D&md5=7ee3954fe80ef97f1966768b115e6050</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-3045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-3045%26sid%3Dliteratum%253Aachs%26aulast%3DDent%26aufirst%3DR.%26aulast%3DTrudeau%26aufirst%3DM.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DHanna%26aufirst%3DW.%2BM.%26aulast%3DKahn%26aufirst%3DH.%2BK.%26aulast%3DSawka%26aufirst%3DC.%2BA.%26aulast%3DLickley%26aufirst%3DL.%2BA.%26aulast%3DRawlinson%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DNarod%26aufirst%3DS.%2BA.%26atitle%3DTriple-Negative%2520Breast%2520Cancer%253A%2520Clinical%2520Features%2520and%2520Patterns%2520of%2520Recurrence%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D15%2520Pt%25201%26spage%3D4429%26epage%3D4434%26doi%3D10.1158%2F1078-0432.CCR-06-3045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Irvin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, L. A.</span><span> </span><span class="NLM_article-title">What Is Triple-Negative Breast Cancer?</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">2799</span><span class="NLM_x">–</span> <span class="NLM_lpage">2805</span><span class="refDoi"> DOI: 10.1016/j.ejca.2008.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.ejca.2008.09.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2008&pages=2799-2805&issue=18&author=W.+J.+Irvinauthor=L.+A.+Carey&title=What+Is+Triple-Negative+Breast+Cancer%3F&doi=10.1016%2Fj.ejca.2008.09.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2008.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2008.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DIrvin%26aufirst%3DW.%2BJ.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26atitle%3DWhat%2520Is%2520Triple-Negative%2520Breast%2520Cancer%253F%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2008%26volume%3D44%26issue%3D18%26spage%3D2799%26epage%3D2805%26doi%3D10.1016%2Fj.ejca.2008.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Vaz-Luis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottesen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edge, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Angulo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theriault, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N. U.</span><span> </span><span class="NLM_article-title">Outcomes by Tumor Subtype and Treatment Pattern in Women with Small, Node-Negative Breast Cancer: A Multi-Institutional Study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">2142</span><span class="NLM_x">–</span> <span class="NLM_lpage">2150</span><span class="refDoi"> DOI: 10.1200/JCO.2013.53.1608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1200%2FJCO.2013.53.1608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=24888816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A280%3ADC%252BC2cjotlGqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=2142-2150&issue=20&author=I.+Vaz-Luisauthor=R.+A.+Ottesenauthor=M.+E.+Hughesauthor=R.+Mametauthor=H.+J.+Bursteinauthor=S.+B.+Edgeauthor=A.+M.+Gonzalez-Anguloauthor=B.+Moyauthor=H.+S.+Rugoauthor=R.+L.+Theriaultauthor=J.+C.+Weeksauthor=E.+P.+Winerauthor=N.+U.+Lin&title=Outcomes+by+Tumor+Subtype+and+Treatment+Pattern+in+Women+with+Small%2C+Node-Negative+Breast+Cancer%3A+A+Multi-Institutional+Study&doi=10.1200%2FJCO.2013.53.1608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study</span></div><div class="casAuthors">Vaz-Luis Ines; Ottesen Rebecca A; Hughes Melissa E; Mamet Rizvan; Burstein Harold J; Edge Stephen B; Gonzalez-Angulo Ana M; Moy Beverly; Rugo Hope S; Theriault Richard L; Weeks Jane C; Winer Eric P; Lin Nancy U</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2142-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Treatment decisions for patients with T1a,bN0M0 breast cancer are challenging.  We studied the time trends in use of adjuvant chemotherapy and survival outcomes among these patients.  PATIENTS AND METHODS:  This was a prospective cohort study within the National Comprehensive Cancer Network Database that included 4,113 women with T1a,bN0M0 breast cancer treated between 2000 and 2009.  Tumors were grouped by size (T1a, T1b), biologic subtype defined by hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status, and receipt of chemotherapy with or without trastuzumab.  RESULTS:  Median follow-up time was 5.5 years.  Eight percent of patients with HR-positive/HER2-negative tumors were treated with chemotherapy.  Fifty-two percent of those with HER2-positive or HR-negative/HER2-negative breast cancers received chemotherapy, with an increase over the last decade.  Survival outcomes diverged by subtype and size, but the 5-year distant relapse-free survival (DRFS) did not exceed 10% in any subgroup.  The 5-year DRFS for patients with T1a tumors untreated with chemotherapy ranged from 93% to 98% (n = 49 to 972), and for patients with T1b tumors, it ranged from 90% to 96% (n = 17 to 2,005).  Patients with HR-positive/HER2-negative disease had the best DRFS estimates, and patients with HR-negative/HER2-negative tumors had the lowest.  In this observational, nonrandomized cohort study, the 5-year DRFS for treated patients with T1a tumors was 100% for all subgroups (n = 12 to 33), and for patients with T1b tumors, it ranged from 94% to 96% (n = 88 to 241).  CONCLUSION:  Women with T1a,b tumors have an excellent prognosis without chemotherapy.  Size and tumor subtype may identify patients in whom the rate of recurrence justifies consideration of chemotherapy.  These patients represent an optimal group for evaluating less toxic adjuvant regimens to maintain efficacy while minimizing short- and long-term risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQseX2_cqEHUWZyxfu64m4ffW6udTcc2eZQ4kcUWPUlM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjotlGqsw%253D%253D&md5=230f2c91abecaa0bf85b3994b9207e9d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1200%2FJCO.2013.53.1608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2013.53.1608%26sid%3Dliteratum%253Aachs%26aulast%3DVaz-Luis%26aufirst%3DI.%26aulast%3DOttesen%26aufirst%3DR.%2BA.%26aulast%3DHughes%26aufirst%3DM.%2BE.%26aulast%3DMamet%26aufirst%3DR.%26aulast%3DBurstein%26aufirst%3DH.%2BJ.%26aulast%3DEdge%26aufirst%3DS.%2BB.%26aulast%3DGonzalez-Angulo%26aufirst%3DA.%2BM.%26aulast%3DMoy%26aufirst%3DB.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DTheriault%26aufirst%3DR.%2BL.%26aulast%3DWeeks%26aufirst%3DJ.%2BC.%26aulast%3DWiner%26aufirst%3DE.%2BP.%26aulast%3DLin%26aufirst%3DN.%2BU.%26atitle%3DOutcomes%2520by%2520Tumor%2520Subtype%2520and%2520Treatment%2520Pattern%2520in%2520Women%2520with%2520Small%252C%2520Node-Negative%2520Breast%2520Cancer%253A%2520A%2520Multi-Institutional%2520Study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D32%26issue%3D20%26spage%3D2142%26epage%3D2150%26doi%3D10.1200%2FJCO.2013.53.1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Brewster, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-MacGregor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span> </span><span class="NLM_article-title">Epidemiology, Biology, and Treatment of Triple-Negative Breast Cancer in Women of African Ancestry</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">e625</span><span class="NLM_x">–</span> <span class="NLM_lpage">e634</span><span class="refDoi"> DOI: 10.1016/S1470-2045(14)70364-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2FS1470-2045%2814%2970364-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=25456381" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=e625-e634&issue=13&author=A.+M.+Brewsterauthor=M.+Chavez-MacGregorauthor=P.+Brown&title=Epidemiology%2C+Biology%2C+and+Treatment+of+Triple-Negative+Breast+Cancer+in+Women+of+African+Ancestry&doi=10.1016%2FS1470-2045%2814%2970364-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2814%2970364-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252814%252970364-X%26sid%3Dliteratum%253Aachs%26aulast%3DBrewster%26aufirst%3DA.%2BM.%26aulast%3DChavez-MacGregor%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DP.%26atitle%3DEpidemiology%252C%2520Biology%252C%2520and%2520Treatment%2520of%2520Triple-Negative%2520Breast%2520Cancer%2520in%2520Women%2520of%2520African%2520Ancestry%26jtitle%3DLancet%2520Oncol.%26date%3D2014%26volume%3D15%26issue%3D13%26spage%3De625%26epage%3De634%26doi%3D10.1016%2FS1470-2045%2814%2970364-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Abramson, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, I. A.</span><span> </span><span class="NLM_article-title">Molecular Heterogeneity of Triple Negative Breast Cancer</span> <span class="citation_source-journal">Curr. Breast Cancer Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span><span class="refDoi"> DOI: 10.1007/s12609-014-0152-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1007%2Fs12609-014-0152-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=25419441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFelsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=154-158&issue=3&author=V.+G.+Abramsonauthor=I.+A.+Mayer&title=Molecular+Heterogeneity+of+Triple+Negative+Breast+Cancer&doi=10.1007%2Fs12609-014-0152-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Heterogeneity of Triple-Negative Breast Cancer</span></div><div class="casAuthors">Abramson, Vandana G.; Mayer, Ingrid A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Breast Cancer Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">154-158</span>CODEN:
                <span class="NLM_cas:coden">CBCRAO</span>;
        ISSN:<span class="NLM_cas:issn">1943-4588</span>.
    
            (<span class="NLM_cas:orgname">Current Medicine Group LLC</span>)
        </div><div class="casAbstract">A review.  Triple-neg. breast cancers (TNBCs) are a group of aggressive breast cancers with a greater incidence of relapse, stage-for-stage, than ER/PR-pos. and HER2-pos. breast cancers, despite optimum loco-regional and systemic therapy.  To date, no single targeted therapy has been approved for treatment of TNBC, and cytotoxic chemotherapy remains the std. systemic treatment.  Recently, gene expression anal. identified six distinct TNBC subtypes, each with unique biol.  In this review we discuss current and forthcoming therapeutic strategies and novel approaches to targeted treatment of these TNBC subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpO3IivUBIbVg90H21EOLACvtfcHk0ljgRGePlXLJ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFelsro%253D&md5=a3c812dfcd8a150b1c70966d5f0829a4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs12609-014-0152-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12609-014-0152-1%26sid%3Dliteratum%253Aachs%26aulast%3DAbramson%26aufirst%3DV.%2BG.%26aulast%3DMayer%26aufirst%3DI.%2BA.%26atitle%3DMolecular%2520Heterogeneity%2520of%2520Triple%2520Negative%2520Breast%2520Cancer%26jtitle%3DCurr.%2520Breast%2520Cancer%2520Rep.%26date%3D2014%26volume%3D6%26issue%3D3%26spage%3D154%26epage%3D158%26doi%3D10.1007%2Fs12609-014-0152-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mayer, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramson, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. A.</span><span> </span><span class="NLM_article-title">New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-0583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1158%2F1078-0432.CCR-13-0583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=24536073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVejsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=782-790&issue=4&author=I.+A.+Mayerauthor=V.+G.+Abramsonauthor=B.+D.+Lehmannauthor=J.+A.+Pietenpol&title=New+Strategies+for+Triple-Negative+Breast+Cancer-Deciphering+the+Heterogeneity&doi=10.1158%2F1078-0432.CCR-13-0583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity</span></div><div class="casAuthors">Mayer, Ingrid A.; Abramson, Vandana G.; Lehmann, Brian D.; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">782-790</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Triple-neg. breast cancer (TNBC) is a heterogeneous disease; gene expression analyses recently identified six distinct TNBC subtypes, each displaying a unique biol.  Exploring novel approaches to treatment of these subtypes is crit. because less than 30% of women with metastatic breast cancer survive five years and virtually all women with metastatic TNBC will ultimately die of their disease despite systemic therapy.  To date, not a single targeted therapy has been approved for the treatment of TNBC and cytotoxic chemotherapy remains the std. treatment.  We discuss the current and upcoming therapeutic strategies being explored in an attempt to "target" TNBC.  Clin Cancer Res; 20(4); 782-90. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdvsR_JjXMyLVg90H21EOLACvtfcHk0ljgRGePlXLJ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVejsb0%253D&md5=4ce0876cb914096f913a7a637d7b63d5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0583%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DAbramson%26aufirst%3DV.%2BG.%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26atitle%3DNew%2520Strategies%2520for%2520Triple-Negative%2520Breast%2520Cancer-Deciphering%2520the%2520Heterogeneity%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26issue%3D4%26spage%3D782%26epage%3D790%26doi%3D10.1158%2F1078-0432.CCR-13-0583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarthy, a B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyr, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. a.</span><span> </span><span class="NLM_article-title">Identification of Human Triple-Negative Breast Cancer Subtypes and Preclinical Models for Selection of Targeted Therapies</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2750</span><span class="NLM_x">–</span> <span class="NLM_lpage">2767</span><span class="refDoi"> DOI: 10.1172/JCI45014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1172%2FJCI45014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=21633166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=2750-2767&issue=7&author=B.+D.+Lehmannauthor=J.+A.+Bauerauthor=X.+Chenauthor=M.+E.+Sandersauthor=a+B.+Chakravarthyauthor=Y.+Shyrauthor=J.+a.+Pietenpol&title=Identification+of+Human+Triple-Negative+Breast+Cancer+Subtypes+and+Preclinical+Models+for+Selection+of+Targeted+Therapies&doi=10.1172%2FJCI45014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies</span></div><div class="casAuthors">Lehmann, Brian D.; Bauer, Joshua A.; Chen, Xi; Sanders, Melinda E.; Chakravarthy, A. Bapsi; Shyr, Yu; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2750-2767</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a highly diverse group of cancers, and subtyping is necessary to better identify mol.-based therapies.  In this study, we analyzed gene expression (GE) profiles from 21 breast cancer data sets and identified 587 TNBC cases.  Cluster anal. identified 6 TNBC subtypes displaying unique GE and ontologies, including 2 basal-like (BL1 and BL2), an immunomodulatory (IM), a mesenchymal (M), a mesenchymal stem-like (MSL), and a luminal androgen receptor (LAR) subtype.  Further, GE anal. allowed us to identify TNBC cell line models representative of these subtypes.  Predicted "driver" signaling pathways were pharmacol. targeted in these cell line models as proof of concept that anal. of distinct GE signatures can inform therapy selection.  BL1 and BL2 subtypes had higher expression of cell cycle and DNA damage response genes, and representative cell lines preferentially responded to cisplatin.  M and MSL subtypes were enriched in GE for epithelial-mesenchymal transition, and growth factor pathways and cell models responded to NVP-BEZ235 (a PI3K/mTOR inhibitor) and dasatinib (an abl/src inhibitor).  The LAR subtype includes patients with decreased relapse-free survival and was characterized by androgen receptor (AR) signaling.  LAR cell lines were uniquely sensitive to bicalutamide (an AR antagonist).  These data may be useful in biomarker selection, drug discovery, and clin. trial design that will enable alignment of TNBC patients to appropriate targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbhoQQUFogW7Vg90H21EOLACvtfcHk0lguo8REZ9WVBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVKgu78%253D&md5=c3681c79e0b972f16f6d5a5ecdc99fec</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1172%2FJCI45014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI45014%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DBauer%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DChakravarthy%26aufirst%3Da%2BB.%26aulast%3DShyr%26aufirst%3DY.%26aulast%3DPietenpol%26aufirst%3DJ.%2Ba.%26atitle%3DIdentification%2520of%2520Human%2520Triple-Negative%2520Breast%2520Cancer%2520Subtypes%2520and%2520Preclinical%2520Models%2520for%2520Selection%2520of%2520Targeted%2520Therapies%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26issue%3D7%26spage%3D2750%26epage%3D2767%26doi%3D10.1172%2FJCI45014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovanović, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyr, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. A.</span><span> </span><span class="NLM_article-title">Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">e0157368</span><span class="refDoi"> DOI: 10.1371/journal.pone.0157368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1371%2Fjournal.pone.0157368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=27310713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOqtr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0157368&issue=6&author=B.+D.+Lehmannauthor=B.+Jovanovi%C4%87author=X.+Chenauthor=M.+V.+Estradaauthor=K.+N.+Johnsonauthor=Y.+Shyrauthor=H.+L.+Mosesauthor=M.+E.+Sandersauthor=J.+A.+Pietenpol&title=Refinement+of+Triple-Negative+Breast+Cancer+Molecular+Subtypes%3A+Implications+for+Neoadjuvant+Chemotherapy+Selection&doi=10.1371%2Fjournal.pone.0157368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection</span></div><div class="casAuthors">Lehmann, Brian D.; Jovanovic, Bojana; Chen, Xi; Estrada, Monica V.; Johnson, Kimberly N.; Shyr, Yu; Moses, Harold L.; Sanders, Melinda E.; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0157368/1-e0157368/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a heterogeneous disease that can be classified into distinct mol. subtypes by gene expression profiling.  Considered a difficult-to-treat cancer, a fraction of TNBC patients benefit significantly from neoadjuvant chemotherapy and have far better overall survival.  Outside of BRCA1/2 mutation status, biomarkers do not exist to identify patients most likely to respond to current chemotherapy; and, to date, no FDA-approved targeted therapies are available for TNBC patients.  Previously, we developed an approach to identify six mol. subtypes TNBC (TNBCtype), with each subtype displaying unique ontologies and differential response to std.-of-care chemotherapy.  Given the complexity of the varying histol. landscape of tumor specimens, we used histopathol. quantification and laser-capture microdissection to det. that transcripts in the previously described immunomodulatory (IM) and mesenchymal stem-like (MSL) subtypes were contributed from infiltrating lymphocytes and tumor-assocd. stromal cells, resp.  Therefore, we refined TNBC mol. subtypes from six (TNBCtype) into four (TNBCtype-4) tumor-specific subtypes (BL1, BL2, M and LAR) and demonstrate differences in diagnosis age, grade, local and distant disease progression and histopathol.  Using five publicly available, neoadjuvant chemotherapy breast cancer gene expression datasets, we retrospectively evaluated chemotherapy response of over 300 TNBC patients from pretreatment biopsies subtyped using either the intrinsic (PAM50) or TNBCtype approaches.  Combined anal. of TNBC patients demonstrated that TNBC subtypes significantly differ in response to similar neoadjuvant chemotherapy with 41% of BL1 patients achieving a pathol. complete response compared to 18% for BL2 and 29% for LAR with 95% confidence intervals (CIs; [33, 51], [9, 28], [17, 41], resp.).  Collectively, we provide pre-clin. data that could inform clin. trials designed to test the hypothesis that improved outcomes can be achieved for TNBC patients, if selection and combination of existing chemotherapies is directed by knowledge of mol. TNBC subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjbtsOOP5UtLVg90H21EOLACvtfcHk0lguo8REZ9WVBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOqtr3P&md5=62dddc464beb0b81b34c325e787c698d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0157368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0157368%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DJovanovi%25C4%2587%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DEstrada%26aufirst%3DM.%2BV.%26aulast%3DJohnson%26aufirst%3DK.%2BN.%26aulast%3DShyr%26aufirst%3DY.%26aulast%3DMoses%26aufirst%3DH.%2BL.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26atitle%3DRefinement%2520of%2520Triple-Negative%2520Breast%2520Cancer%2520Molecular%2520Subtypes%253A%2520Implications%2520for%2520Neoadjuvant%2520Chemotherapy%2520Selection%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3De0157368%26doi%3D10.1371%2Fjournal.pone.0157368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichewicz, R. H.</span><span> </span><span class="NLM_article-title">Crowdsourcing Natural Products Discovery to Access Uncharted Dimensions of Fungal Metabolite Diversity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span><span class="refDoi"> DOI: 10.1002/anie.201306549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1002%2Fanie.201306549" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=804-809&issue=3&author=L.+Duauthor=A.+J.+Roblesauthor=J.+B.+Kingauthor=D.+R.+Powellauthor=A.+N.+Millerauthor=S.+L.+Mooberryauthor=R.+H.+Cichewicz&title=Crowdsourcing+Natural+Products+Discovery+to+Access+Uncharted+Dimensions+of+Fungal+Metabolite+Diversity&doi=10.1002%2Fanie.201306549"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fanie.201306549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201306549%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DL.%26aulast%3DRobles%26aufirst%3DA.%2BJ.%26aulast%3DKing%26aufirst%3DJ.%2BB.%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DMiller%26aufirst%3DA.%2BN.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26aulast%3DCichewicz%26aufirst%3DR.%2BH.%26atitle%3DCrowdsourcing%2520Natural%2520Products%2520Discovery%2520to%2520Access%2520Uncharted%2520Dimensions%2520of%2520Fungal%2520Metabolite%2520Diversity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D3%26spage%3D804%26epage%3D809%26doi%3D10.1002%2Fanie.201306549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Robles, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichewicz, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span> </span><span class="NLM_article-title">Selective Activity of Deguelin Identifies Therapeutic Targets for Androgen Receptor-Positive Breast Cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1007/s10549-016-3841-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1007%2Fs10549-016-3841-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=27255535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpt1eht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=475-488&issue=3&author=A.+J.+Roblesauthor=S.+Caiauthor=R.+H.+Cichewiczauthor=S.+L.+Mooberry&title=Selective+Activity+of+Deguelin+Identifies+Therapeutic+Targets+for+Androgen+Receptor-Positive+Breast+Cancer&doi=10.1007%2Fs10549-016-3841-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer</span></div><div class="casAuthors">Robles, Andrew J.; Cai, Shengxin; Cichewicz, Robert H.; Mooberry, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-488</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Triple-neg. breast cancers (TNBC) are aggressive malignancies with no effective targeted therapies.  Recent gene expression profiling of these heterogeneous cancers and the classification of cell line models now allows for the identification of compds. with selective activities against mol. subtypes of TNBC.  The natural product deguelin was found to have selective activity against MDA-MB-453 and SUM-185PE cell lines, which both model the luminal androgen receptor (LAR) subtype of TNBC.  Deguelin potently inhibited proliferation of these cells with GI50 values of 30 and 61 nM, in MDA-MB-453 and SUM-185PE cells, resp.  Deguelin had exceptionally high selectivity, 197 to 566-fold, for these cell lines compared to cell lines representing other TNBC subtypes.  Deguelin's mechanisms of action were investigated to det. how it produced these potent and selective effects.  Our results show that deguelin has dual activities, inhibiting PI3K/Akt/mTOR signaling, and decreasing androgen receptor levels and nuclear localization.  Based on these data, we hypothesized that the combination of the mTOR inhibitor rapamycin and the antiandrogen enzalutamide would have efficacy in LAR models.  Rapamycin and enzalutamide showed additive effects in MDA-MB-453 cells, and both drugs had potent antitumor efficacy in a LAR xenograft model.  These results suggest that the combination of antiandrogens and mTOR inhibitors might be an effective strategy for the treatment of androgen receptor-expressing TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZqE2z6HXqK7Vg90H21EOLACvtfcHk0lhDHMEoj4oz_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpt1eht78%253D&md5=68bd5d3b3a17d5ec592a7d00dec8cbaa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10549-016-3841-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-016-3841-9%26sid%3Dliteratum%253Aachs%26aulast%3DRobles%26aufirst%3DA.%2BJ.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DCichewicz%26aufirst%3DR.%2BH.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DSelective%2520Activity%2520of%2520Deguelin%2520Identifies%2520Therapeutic%2520Targets%2520for%2520Androgen%2520Receptor-Positive%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2016%26volume%3D157%26issue%3D3%26spage%3D475%26epage%3D488%26doi%3D10.1007%2Fs10549-016-3841-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Philip, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, H.</span><span> </span><span class="NLM_article-title">Amyris of Jamaica. 2,5-Diaryloxazoles and a Chromane from Amyris Plumieri D.C (Rutaceae)</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="refDoi"> DOI: 10.3987/R-1984-01-0009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.3987%2FR-1984-01-0009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1984&pages=9&issue=1&author=S.+Philipauthor=B.+A.+Burkeauthor=H.+Jacobs&title=Amyris+of+Jamaica.+2%2C5-Diaryloxazoles+and+a+Chromane+from+Amyris+Plumieri+D.C+%28Rutaceae%29&doi=10.3987%2FR-1984-01-0009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3987%2FR-1984-01-0009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FR-1984-01-0009%26sid%3Dliteratum%253Aachs%26aulast%3DPhilip%26aufirst%3DS.%26aulast%3DBurke%26aufirst%3DB.%2BA.%26aulast%3DJacobs%26aufirst%3DH.%26atitle%3DAmyris%2520of%2520Jamaica.%25202%252C5-Diaryloxazoles%2520and%2520a%2520Chromane%2520from%2520Amyris%2520Plumieri%2520D.C%2520%2528Rutaceae%2529%26jtitle%3DHeterocycles%26date%3D1984%26volume%3D22%26issue%3D1%26spage%3D9%26doi%3D10.3987%2FR-1984-01-0009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&issue=1%E2%80%933&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+to+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lhrjAgLVo5N_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520to%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26issue%3D1%25E2%2580%25933%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rastogi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abaul, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devallois, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philogène, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, P.</span><span> </span><span class="NLM_article-title">Antimycobacterial Activity of Chemically Defined Natural Substances from the Caribbean Flora in Guadeloupe</span> <span class="citation_source-journal">FEMS Immunol. Med. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1111/j.1574-695X.1998.tb01136.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1111%2Fj.1574-695X.1998.tb01136.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=9626931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADyaK1cXisFals70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1998&pages=267-273&issue=4&author=N.+Rastogiauthor=J.+Abaulauthor=K.+S.+Gohauthor=A.+Devalloisauthor=E.+Philog%C3%A8neauthor=P.+Bourgeois&title=Antimycobacterial+Activity+of+Chemically+Defined+Natural+Substances+from+the+Caribbean+Flora+in+Guadeloupe&doi=10.1111%2Fj.1574-695X.1998.tb01136.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antimycobacterial activity of chemically defined natural substances from the Caribbean flora in Guadeloupe</span></div><div class="casAuthors">Rastogi, Nalin; Abaul, Jacqueline; Goh, Khye Seng; Devallois, Anne; Philogene, Emile; Bourgeois, Paul</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Immunology and Medical Microbiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">FIMIEV</span>;
        ISSN:<span class="NLM_cas:issn">0928-8244</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Eight chem. defined, naturally occurring compds. were extd. from the tropical flora of the Caribbean island of Guadeloupe: pilocarpine, an alkaloid from Pilocarpus racemosus; heraclenol and isomeranzin, coumarins from Triphasia trifolia; lochnerin, an indole alkaloid from Rauwolfia biauriculata; ibogaine and voacangine, indole alkaloids from Tabernaemontana citrifolia; texalin, an oxazole from Amyris elemifera; and canellal, a sesquiterpene dialdehyde from Canella winterana.  An essential oil fraction from Canella winterana was also tested.  The antimycobacterial activity of these substances was tested against Mycobacterium tuberculosis, M. avium and M. kansasii using the Middlebrook 7H11 agar medium, the Bactec 460-TB radiometric methodol., and detn. of bacterial viable counts.  Three compds., namely ibogaine, voacangine and texalin, showed antimycobacterial activity.  Investigations on the structure-modification and structure-activity relationships of these compds. may help det. new targets for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTowf_fiDubVg90H21EOLACvtfcHk0lgEXgUBg51EhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFals70%253D&md5=8e103d427b1a7cf0fb061c02efd3a18e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-695X.1998.tb01136.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-695X.1998.tb01136.x%26sid%3Dliteratum%253Aachs%26aulast%3DRastogi%26aufirst%3DN.%26aulast%3DAbaul%26aufirst%3DJ.%26aulast%3DGoh%26aufirst%3DK.%2BS.%26aulast%3DDevallois%26aufirst%3DA.%26aulast%3DPhilog%25C3%25A8ne%26aufirst%3DE.%26aulast%3DBourgeois%26aufirst%3DP.%26atitle%3DAntimycobacterial%2520Activity%2520of%2520Chemically%2520Defined%2520Natural%2520Substances%2520from%2520the%2520Caribbean%2520Flora%2520in%2520Guadeloupe%26jtitle%3DFEMS%2520Immunol.%2520Med.%2520Microbiol.%26date%3D1998%26volume%3D20%26issue%3D4%26spage%3D267%26epage%3D273%26doi%3D10.1111%2Fj.1574-695X.1998.tb01136.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Burke, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkins, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie Talbot, A.</span><span> </span><span class="NLM_article-title">An Oxazole and Its Precursor in Amyris Balsamifera</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">349</span><span class="refDoi"> DOI: 10.3987/R-1979-03-0349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.3987%2FR-1979-03-0349" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1979&pages=349&issue=3&author=B.+A.+Burkeauthor=B.+Burkeauthor=H.+Parkinsauthor=A.+Marie+Talbot&title=An+Oxazole+and+Its+Precursor+in+Amyris+Balsamifera&doi=10.3987%2FR-1979-03-0349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3987%2FR-1979-03-0349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FR-1979-03-0349%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DB.%2BA.%26aulast%3DBurke%26aufirst%3DB.%26aulast%3DParkins%26aufirst%3DH.%26aulast%3DMarie%2BTalbot%26aufirst%3DA.%26atitle%3DAn%2520Oxazole%2520and%2520Its%2520Precursor%2520in%2520Amyris%2520Balsamifera%26jtitle%3DHeterocycles%26date%3D1979%26volume%3D12%26issue%3D3%26spage%3D349%26doi%3D10.3987%2FR-1979-03-0349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yoshizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, M.</span><span> </span><span class="NLM_article-title">Synthesis of 2,5-Diaryloxazoles through van Leusen Reaction and Copper-Mediated Direct Arylation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3273</span><span class="NLM_x">–</span> <span class="NLM_lpage">3276</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2009.02.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.tetlet.2009.02.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVenurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3273-3276&author=T.+Yoshizumiauthor=T.+Satohauthor=K.+Hiranoauthor=D.+Matsuoauthor=A.+Oritaauthor=J.+Oteraauthor=M.+Miura&title=Synthesis+of+2%2C5-Diaryloxazoles+through+van+Leusen+Reaction+and+Copper-Mediated+Direct+Arylation&doi=10.1016%2Fj.tetlet.2009.02.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2,5-diaryloxazoles through van Leusen reaction and copper-mediated direct arylation</span></div><div class="casAuthors">Yoshizumi, Tomoki; Satoh, Tetsuya; Hirano, Koji; Matsuo, Daisuke; Orita, Akihiro; Otera, Junzo; Miura, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3273-3276</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The direct arylation of 5-aryloxazoles, prepd. by the van Leusen reaction, with various aryl iodides is effectively promoted by a system of CuI combined with PPh3 and Na2CO3 as a ligand and a base, resp., in DMF to produce the corresponding 2,5-diaryloxazoles in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJit5uWBaIurVg90H21EOLACvtfcHk0lgEXgUBg51EhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVenurk%253D&md5=415ec2dcf7313ca792a266ffe52d85ca</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.02.039%26sid%3Dliteratum%253Aachs%26aulast%3DYoshizumi%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DD.%26aulast%3DOrita%26aufirst%3DA.%26aulast%3DOtera%26aufirst%3DJ.%26aulast%3DMiura%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25202%252C5-Diaryloxazoles%2520through%2520van%2520Leusen%2520Reaction%2520and%2520Copper-Mediated%2520Direct%2520Arylation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3273%26epage%3D3276%26doi%3D10.1016%2Fj.tetlet.2009.02.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cheplogoi, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulholland, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randrianarivelojosia, M.</span><span> </span><span class="NLM_article-title">An Azole, an Amide and a Limonoid from Vepris Uguenensis (Rutaceae)</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1384</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1016/j.phytochem.2007.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.phytochem.2007.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=1384-1388&issue=6&author=P.+K.+Cheplogoiauthor=D.+A.+Mulhollandauthor=P.+H.+Coombesauthor=M.+Randrianarivelojosia&title=An+Azole%2C+an+Amide+and+a+Limonoid+from+Vepris+Uguenensis+%28Rutaceae%29&doi=10.1016%2Fj.phytochem.2007.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2007.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2007.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DCheplogoi%26aufirst%3DP.%2BK.%26aulast%3DMulholland%26aufirst%3DD.%2BA.%26aulast%3DCoombes%26aufirst%3DP.%2BH.%26aulast%3DRandrianarivelojosia%26aufirst%3DM.%26atitle%3DAn%2520Azole%252C%2520an%2520Amide%2520and%2520a%2520Limonoid%2520from%2520Vepris%2520Uguenensis%2520%2528Rutaceae%2529%26jtitle%3DPhytochemistry%26date%3D2008%26volume%3D69%26issue%3D6%26spage%3D1384%26epage%3D1388%26doi%3D10.1016%2Fj.phytochem.2007.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Meepagala, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burandt, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, S. O.</span><span> </span><span class="NLM_article-title">New Class of Algicidal Compounds and Fungicidal Activities Derived from a Chromene Amide of Amyris Texana</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">9476</span><span class="NLM_x">–</span> <span class="NLM_lpage">9482</span><span class="refDoi"> DOI: 10.1021/jf101626g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf101626g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVaqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=9476-9482&author=K.+M.+Meepagalaauthor=K.+K.+Schraderauthor=C.+L.+Burandtauthor=D.+E.+Wedgeauthor=S.+O.+Duke&title=New+Class+of+Algicidal+Compounds+and+Fungicidal+Activities+Derived+from+a+Chromene+Amide+of+Amyris+Texana&doi=10.1021%2Fjf101626g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">New Class of Algicidal Compounds and Fungicidal Activities Derived from a Chromene Amide of Amyris texana</span></div><div class="casAuthors">Meepagala, Kumudini M.; Schrader, Kevin K.; Burandt, Charles L.; Wedge, David E.; Duke, Stephen O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9476-9482</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A chromene amide, N-[2-(2,2-dimethyl-2H-1-benzopyran-6-yl)ethyl]-N,3-dimethylbutanamide, was isolated from the EtOAc ext. of the leaves of Amyris texana and found to have moderate antifungal activity against Colletotrichum spp. and selective algicidal activity against Planktothrix perornata, a cyanobacterium (blue-green alga) that causes musty off-flavor in farm-raised channel catfish (Ictalurus punctatus).  To improve the selective algicidal activity and provide water soly., a series of chromene analogs were synthesized and evaluated for algicidal activity using a 96-well microplate rapid bioassay.  In addn., the chromene analogs were evaluated for antifungal and phytotoxic activities.  Hydrochloride salts of a chromene amine analog showed improved water soly. and selectivity toward P. perornata with activity comparable to that of the naturally occurring chromene amide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEV7xk1lBajrVg90H21EOLACvtfcHk0lhWocQPC13iJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVaqtrw%253D&md5=185041db8093c62cf56bad32a7560885</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjf101626g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf101626g%26sid%3Dliteratum%253Aachs%26aulast%3DMeepagala%26aufirst%3DK.%2BM.%26aulast%3DSchrader%26aufirst%3DK.%2BK.%26aulast%3DBurandt%26aufirst%3DC.%2BL.%26aulast%3DWedge%26aufirst%3DD.%2BE.%26aulast%3DDuke%26aufirst%3DS.%2BO.%26atitle%3DNew%2520Class%2520of%2520Algicidal%2520Compounds%2520and%2520Fungicidal%2520Activities%2520Derived%2520from%2520a%2520Chromene%2520Amide%2520of%2520Amyris%2520Texana%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2010%26volume%3D58%26spage%3D9476%26epage%3D9482%26doi%3D10.1021%2Fjf101626g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span><span class="refDoi"> DOI: 10.1093/jnci/82.13.1107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&issue=13&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+Colorimetric+Cytotoxicity+Assay+for+Anticancer-Drug+Screening&doi=10.1093%2Fjnci%2F82.13.1107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0lieyunT5dz_rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520Colorimetric%2520Cytotoxicity%2520Assay%2520for%2520Anticancer-Drug%2520Screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26issue%3D13%26spage%3D1107%26epage%3D1112%26doi%3D10.1093%2Fjnci%2F82.13.1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Boyd, M. R.; Paull, K. D.; Rubinstein, L. R.</span><span> </span><span class="NLM_article-title">Data Display and Analysis Strategies for the NCI Disease-Oriented in Vitro Antitumor Drug Screen</span>. In  <span class="citation_source-book">Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development: Proceedings of the Twenty-Second Annual Cancer Symposium</span>, Detroit, Michigan, USA, April 26–28, 1990; <span class="NLM_contrib-group">Valeriote, F. A.; Corbett, T. H.; Baker, L. H.</span>, Eds.; <span class="NLM_publisher-name">Springer US</span>: <span class="NLM_publisher-loc">Boston, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1007%2F978-1-4615-3492-1_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=11-34&author=M.+R.+Boyd&author=K.+D.+Paull&author=L.+R.+Rubinsteinauthor=F.+A.+Valeriote&author=T.+H.+Corbett&author=L.+H.+Baker&title=Cytotoxic+Anticancer+Drugs%3A+Models+and+Concepts+for+Drug+Discovery+and+Development%3A+Proceedings+of+the+Twenty-Second+Annual+Cancer+Symposium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2F978-1-4615-3492-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4615-3492-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DData%2520Display%2520and%2520Analysis%2520Strategies%2520for%2520the%2520NCI%2520Disease-Oriented%2520in%2520Vitro%2520Antitumor%2520Drug%2520Screen%26btitle%3DCytotoxic%2520Anticancer%2520Drugs%253A%2520Models%2520and%2520Concepts%2520for%2520Drug%2520Discovery%2520and%2520Development%253A%2520Proceedings%2520of%2520the%2520Twenty-Second%2520Annual%2520Cancer%2520Symposium%26aulast%3DValeriote%26aufirst%3DF.%2BA.%26pub%3DSpringer%2520US%26date%3D1992%26spage%3D11%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Besselièvre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piguel, S.</span><span> </span><span class="NLM_article-title">Ligandless Microwave-Assisted Pd/Cu-Catalyzed Direct Arylation of Oxazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3278</span><span class="NLM_x">–</span> <span class="NLM_lpage">3280</span><span class="refDoi"> DOI: 10.1021/jo7027135</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo7027135" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=3278-3280&issue=8&author=F.+Besseli%C3%A8vreauthor=F.+Mahuteau-Betzerauthor=D.+S.+Griersonauthor=S.+Piguel&title=Ligandless+Microwave-Assisted+Pd%2FCu-Catalyzed+Direct+Arylation+of+Oxazoles&doi=10.1021%2Fjo7027135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo7027135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo7027135%26sid%3Dliteratum%253Aachs%26aulast%3DBesseli%25C3%25A8vre%26aufirst%3DF.%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26aulast%3DPiguel%26aufirst%3DS.%26atitle%3DLigandless%2520Microwave-Assisted%2520Pd%252FCu-Catalyzed%2520Direct%2520Arylation%2520of%2520Oxazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26issue%3D8%26spage%3D3278%26epage%3D3280%26doi%3D10.1021%2Fjo7027135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Giddens, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copp, B. R.</span><span> </span><span class="NLM_article-title">Antimycobacterial Natural Products: Synthesis and Preliminary Biological Evaluation of the Oxazole-Containing Alkaloid Texaline</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">7355</span><span class="NLM_x">–</span> <span class="NLM_lpage">7357</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2005.08.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.tetlet.2005.08.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVanur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=7355-7357&author=A.+C.+Giddensauthor=H.+I.+M.+Boshoffauthor=S.+G.+Franzblauauthor=C.+E.+Barryauthor=B.+R.+Copp&title=Antimycobacterial+Natural+Products%3A+Synthesis+and+Preliminary+Biological+Evaluation+of+the+Oxazole-Containing+Alkaloid+Texaline&doi=10.1016%2Fj.tetlet.2005.08.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antimycobacterial natural products: synthesis and preliminary biological evaluation of the oxazole-containing alkaloid texaline</span></div><div class="casAuthors">Giddens, Anna C.; Boshoff, Helena I. M.; Franzblau, Scott G.; Barry, Clifton E.; Copp, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">7355-7357</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Texaline (I), an antimycobacterial oxazole-contg. alkaloid previously isolated from Amyris texana and A. elemifera, and related compds. have been synthesized in order to explore aspects of the structure-antituberculosis activity relationship.  While texaline was found to be inactive in these assays, simpler diaryloxazoles were more active while also exhibiting modest toxic selectivity, leading to their identification as potential lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCBDtB-8tPzbVg90H21EOLACvtfcHk0lg8vMTCRA2kFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVanur7P&md5=dbe63c061eb460f5159135320fe8be72</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.08.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.08.119%26sid%3Dliteratum%253Aachs%26aulast%3DGiddens%26aufirst%3DA.%2BC.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26atitle%3DAntimycobacterial%2520Natural%2520Products%253A%2520Synthesis%2520and%2520Preliminary%2520Biological%2520Evaluation%2520of%2520the%2520Oxazole-Containing%2520Alkaloid%2520Texaline%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D7355%26epage%3D7357%26doi%3D10.1016%2Fj.tetlet.2005.08.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span><span class="refDoi"> DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+Amination+of+Aldehydes+and+Ketones+with+Sodium+Triacetoxyborohydride.+Studies+on+Direct+and+Indirect+Reductive+Amination+Procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0lg8vMTCRA2kFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520Amination%2520of%2520Aldehydes%2520and%2520Ketones%2520with%2520Sodium%2520Triacetoxyborohydride.%2520Studies%2520on%2520Direct%2520and%2520Indirect%2520Reductive%2520Amination%2520Procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendleton, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balko, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. A.</span><span> </span><span class="NLM_article-title">PIK3CA Mutations in Androgen Receptor-Positive Triple Negative Breast Cancer Confer Sensitivity to the Combination of PI3K and Androgen Receptor Inhibitors</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">406</span><span class="refDoi"> DOI: 10.1186/s13058-014-0406-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1186%2Fs13058-014-0406-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=25103565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2ltr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=406&issue=4&author=B.+D.+Lehmannauthor=J.+A.+Bauerauthor=J.+M.+Schaferauthor=C.+S.+Pendletonauthor=L.+Tangauthor=K.+C.+Johnsonauthor=X.+Chenauthor=J.+M.+Balkoauthor=H.+G%C3%B3mezauthor=C.+L.+Arteagaauthor=G.+B.+Millsauthor=M.+E.+Sandersauthor=J.+A.+Pietenpol&title=PIK3CA+Mutations+in+Androgen+Receptor-Positive+Triple+Negative+Breast+Cancer+Confer+Sensitivity+to+the+Combination+of+PI3K+and+Androgen+Receptor+Inhibitors&doi=10.1186%2Fs13058-014-0406-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors</span></div><div class="casAuthors">Lehmann, Brian D.; Bauer, Joshua A.; Schafer, Johanna M.; Pendleton, Christopher S.; Tang, Luojia; Johnson, Kimberly C.; Chen, Xi; Balko, Justin M.; Gomez, Henry; Arteaga, Carlos L.; Mills, Gordon B.; Sanders, Melinda E.; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">406/1-406/26</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Triple neg. breast cancer (TNBC) is a heterogeneous collection of biol. diverse cancers, which contributes to variable clin. outcomes.  Previously, we identified a TNBC subtype that has a luminal phenotype and expresses the androgen receptor (AR+).  TNBC cells derived from these luminal AR + tumors have high frequency phosphatidylinositol-4,5- bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations.  The purpose of this study was to det. if targeting phosphoinositide 3-kinase (PI3K) alone or in combination with an AR antagonist is effective in AR + TNBC.  We detd. the frequency of activating PIK3CA mutations in AR + and AR- TNBC clin. cases.  Using AR + TNBC cell line and xenograft models we evaluated the effectiveness of PI3K inhibitors, used alone or in combination with an AR antagonist, on tumor cell growth and viability.  PIK3CA kinase mutations were highly clonal, more frequent in AR + vs.  AR- TNBC (40% vs. 4%), and often assocd. with concurrent amplification of the PIK3CA locus.  PI3K/mTOR inhibitors had an additive growth inhibitory effect when combined with genetic or pharmacol. AR targeting in AR + TNBC cells.  We also analyzed the combination of bicalutamide +/- the pan-PI3K inhibitor GDC-0941 or the dual PI3K/mTOR inhibitor GDC-0980 in xenograft tumor studies and obsd. additive effects.  While approx. one third of TNBC patients respond to neoadjuvant/adjuvant chemotherapy, recent studies have shown that patients with androgen receptor pos. (AR+) TNBC are far less likely to benefit from the current std. of care chemotherapy regimens and novel targeted approaches need to be investigated.  In this study, we show that activating PIK3CA mutations are enriched in AR + TNBC; and, we show that the growth and viability of AR + TNBC cell line models is significantly reduced after treatment with PI3K inhibitors used in combination with an AR antagonist.  These results provide rationale for pre-selection of TNBC patients with a biomarker (AR expression) to investigate the use of AR antagonists in combination with PI3K/mTOR inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmleFMAS1kQbVg90H21EOLACvtfcHk0lj4IXRgiFy_UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2ltr%252FN&md5=d9521bd84e970b86dd7d9355b3b73b5a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2Fs13058-014-0406-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13058-014-0406-x%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DBauer%26aufirst%3DJ.%2BA.%26aulast%3DSchafer%26aufirst%3DJ.%2BM.%26aulast%3DPendleton%26aufirst%3DC.%2BS.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DK.%2BC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBalko%26aufirst%3DJ.%2BM.%26aulast%3DG%25C3%25B3mez%26aufirst%3DH.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26atitle%3DPIK3CA%2520Mutations%2520in%2520Androgen%2520Receptor-Positive%2520Triple%2520Negative%2520Breast%2520Cancer%2520Confer%2520Sensitivity%2520to%2520the%2520Combination%2520of%2520PI3K%2520and%2520Androgen%2520Receptor%2520Inhibitors%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2014%26volume%3D16%26issue%3D4%26spage%3D406%26doi%3D10.1186%2Fs13058-014-0406-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">O’Reilly, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Q.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1500</span><span class="NLM_x">–</span> <span class="NLM_lpage">1508</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1158%2F0008-5472.CAN-05-2925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=16452206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVegtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1500-1508&issue=3&author=K.+E.+O%E2%80%99Reillyauthor=F.+Rojoauthor=Q.-B.+Sheauthor=D.+Solitauthor=G.+B.+Millsauthor=D.+Smithauthor=H.+Laneauthor=F.+Hofmannauthor=D.+J.+Hicklinauthor=D.+L.+Ludwigauthor=J.+Baselgaauthor=N.+Rosen&title=mTOR+Inhibition+Induces+Upstream+Receptor+Tyrosine+Kinase+Signaling+and+Activates+Akt&doi=10.1158%2F0008-5472.CAN-05-2925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt</span></div><div class="casAuthors">O'Reilly, Kathryn E.; Rojo, Fredi; She, Qing-Bai; Solit, David; Mills, Gordon B.; Smith, Debra; Lane, Heidi; Hofmann, Francesco; Hicklin, Daniel J.; Ludwig, Dale L.; Baselga, Jose; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1500-1508</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Stimulation of the insulin and insulin-like growth factor I (IGF-I) receptor activates the phosphoinositide-3-kinase/Akt/mTOR pathway causing pleiotropic cellular effects including an mTOR-dependent loss in insulin receptor substrate-1 expression leading to feedback down-regulation of signaling through the pathway.  In model systems, tumors exhibiting mutational activation of phosphoinositide-3-kinase/Akt kinase, a common event in cancers, are hypersensitive to mTOR inhibitors, including rapamycin.  Despite the activity in model systems, in patients, mTOR inhibitors exhibit more modest antitumor activity.  We now show that mTOR inhibition induces insulin receptor substrate-1 expression and abrogates feedback inhibition of the pathway, resulting in Akt activation both in cancer cell lines and in patient tumors treated with the rapamycin deriv., RAD001.  IGF-I receptor inhibition prevents rapamycin-induced Akt activation and sensitizes tumor cells to inhibition of mTOR.  In contrast, IGF-I reverses the antiproliferative effects of rapamycin in serum-free medium.  The data suggest that feedback down-regulation of receptor tyrosine kinase signaling is a frequent event in tumor cells with constitutive mTOR activation.  Reversal of this feedback loop by rapamycin may attenuate its therapeutic effects, whereas combination therapy that ablates mTOR function and prevents Akt activation may have improved antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIDQUdQ-jbi7Vg90H21EOLACvtfcHk0lhfGZ3nccTu3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVegtg%253D%253D&md5=758cd9999dc156bf498edf32174fc2e7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2925%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DK.%2BE.%26aulast%3DRojo%26aufirst%3DF.%26aulast%3DShe%26aufirst%3DQ.-B.%26aulast%3DSolit%26aufirst%3DD.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DLane%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DF.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DLudwig%26aufirst%3DD.%2BL.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DmTOR%2520Inhibition%2520Induces%2520Upstream%2520Receptor%2520Tyrosine%2520Kinase%2520Signaling%2520and%2520Activates%2520Akt%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D3%26spage%3D1500%26epage%3D1508%26doi%3D10.1158%2F0008-5472.CAN-05-2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Masuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baggerly, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Angulo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meric-Bernstam, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symmans, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, N. T.</span><span> </span><span class="NLM_article-title">Differential Response to Neoadjuvant Chemotherapy among 7 Triple-Negative Breast Cancer Molecular Subtypes</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5533</span><span class="NLM_x">–</span> <span class="NLM_lpage">5540</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-0799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1158%2F1078-0432.CCR-13-0799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=23948975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFynsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=5533-5540&issue=19&author=H.+Masudaauthor=K.+A.+Baggerlyauthor=Y.+Wangauthor=Y.+Zhangauthor=A.+M.+Gonzalez-Anguloauthor=F.+Meric-Bernstamauthor=V.+Valeroauthor=B.+D.+Lehmannauthor=J.+A.+Pietenpolauthor=G.+N.+Hortobagyiauthor=W.+F.+Symmansauthor=N.+T.+Ueno&title=Differential+Response+to+Neoadjuvant+Chemotherapy+among+7+Triple-Negative+Breast+Cancer+Molecular+Subtypes&doi=10.1158%2F1078-0432.CCR-13-0799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes</span></div><div class="casAuthors">Masuda, Hiroko; Baggerly, Keith A.; Wang, Ying; Zhang, Ya; Gonzalez-Angulo, Ana Maria; Meric-Bernstam, Funda; Valero, Vicente; Lehmann, Brian D.; Pietenpol, Jennifer A.; Hortobagyi, Gabriel N.; Symmans, W. Fraser; Ueno, Naoto T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5533-5540</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The clin. relevancy of the 7-subtype classification of triple-neg. breast cancer (TNBC) reported by Lehmann and colleagues is unknown.  We investigated the clin. relevancy of TNBC heterogeneity by detg. pathol. complete response (pCR) rates after neoadjuvant chemotherapy, based on TNBC subtypes.  Exptl. Design: We revalidated the Lehmann and colleagues expts. using Affymetrix CEL files from public datasets.  We applied these methods to 146 patients with TNBC with gene expression microarrays obtained from June 2000 to March 2010 at our institution.  Of those, 130 had received std. neoadjuvant chemotherapy and had evaluable pathol. response data.  We classified the TNBC samples by subtype and then correlated subtype and pCR status using Fisher exact test and a logistic regression model.  We also assessed survival and compared the subtypes with PAM50 intrinsic subtypes and residual cancer burden (RCB) index.  Results: TNBC subtype and pCR status were significantly assocd. (P = 0.04379).  The basal-like 1 (BL1) subtype had the highest pCR rate (52%); basal-like 2 (BL2) and luminal androgen receptor had the lowest (0% and 10%, resp.).  TNBC subtype was an independent predictor of pCR status (P = 0.022) by a likelihood ratio test.  The subtypes better predicted pCR status than did the PAM50 intrinsic subtypes (basal-like vs. non basal-like).  Conclusions: Classifying TNBC by 7 subtypes predicts high vs. low pCR rate.  We confirm the clin. relevancy of the 7 subtypes of TNBC.  We need to prospectively validate whether the pCR rate differences translate into long-term outcome differences.  The 7-subtype classification may spur innovative personalized medicine strategies for patients with TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqWCdcnpnUTrVg90H21EOLACvtfcHk0lhfGZ3nccTu3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFynsL7P&md5=a98409bc9f49e7948b21cde4c39df3ea</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0799%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DH.%26aulast%3DBaggerly%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGonzalez-Angulo%26aufirst%3DA.%2BM.%26aulast%3DMeric-Bernstam%26aufirst%3DF.%26aulast%3DValero%26aufirst%3DV.%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26aulast%3DSymmans%26aufirst%3DW.%2BF.%26aulast%3DUeno%26aufirst%3DN.%2BT.%26atitle%3DDifferential%2520Response%2520to%2520Neoadjuvant%2520Chemotherapy%2520among%25207%2520Triple-Negative%2520Breast%2520Cancer%2520Molecular%2520Subtypes%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26issue%3D19%26spage%3D5533%26epage%3D5540%26doi%3D10.1158%2F1078-0432.CCR-13-0799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risinger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, T. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichewicz, R. H.</span><span> </span><span class="NLM_article-title">Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00874</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00874" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=490-498&author=S.+Caiauthor=A.+L.+Risingerauthor=S.+Nairauthor=J.+Pengauthor=T.+J.+C.+Andersonauthor=L.+Duauthor=D.+R.+Powellauthor=S.+L.+Mooberryauthor=R.+H.+Cichewicz&title=Identification+of+Compounds+with+Efficacy+against+Malaria+Parasites+from+Common+North+American+Plants&doi=10.1021%2Facs.jnatprod.5b00874"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00874%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DNair%26aufirst%3DS.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26aulast%3DCichewicz%26aufirst%3DR.%2BH.%26atitle%3DIdentification%2520of%2520Compounds%2520with%2520Efficacy%2520against%2520Malaria%2520Parasites%2520from%2520Common%2520North%2520American%2520Plants%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D490%26epage%3D498%26doi%3D10.1021%2Facs.jnatprod.5b00874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hasbum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, O.</span><span> </span><span class="NLM_article-title">A New Benzamide from Bark of Amyris Brenesii</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span><span class="refDoi"> DOI: 10.1021/np50058a035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50058a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1988&pages=817-818&issue=4&author=C.+Hasbumauthor=O.+Castro&title=A+New+Benzamide+from+Bark+of+Amyris+Brenesii&doi=10.1021%2Fnp50058a035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fnp50058a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50058a035%26sid%3Dliteratum%253Aachs%26aulast%3DHasbum%26aufirst%3DC.%26aulast%3DCastro%26aufirst%3DO.%26atitle%3DA%2520New%2520Benzamide%2520from%2520Bark%2520of%2520Amyris%2520Brenesii%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1988%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D818%26doi%3D10.1021%2Fnp50058a035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. H.</span><span> </span><span class="NLM_article-title">Indium-Mediated One-Pot Synthesis of Benzoxazoles or Oxazoles from 2-Nitrophenols or 1-Aryl-2-Nitroethanones</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">43</span><span class="NLM_x">) </span> <span class="NLM_fpage">8821</span><span class="NLM_x">–</span> <span class="NLM_lpage">8831</span><span class="refDoi"> DOI: 10.1016/j.tet.2009.08.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.tet.2009.08.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=8821-8831&issue=43&author=J.+J.+Leeauthor=J.+Kimauthor=Y.+M.+Junauthor=B.+M.+Leeauthor=B.+H.+Kim&title=Indium-Mediated+One-Pot+Synthesis+of+Benzoxazoles+or+Oxazoles+from+2-Nitrophenols+or+1-Aryl-2-Nitroethanones&doi=10.1016%2Fj.tet.2009.08.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2009.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2009.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DY.%2BM.%26aulast%3DLee%26aufirst%3DB.%2BM.%26aulast%3DKim%26aufirst%3DB.%2BH.%26atitle%3DIndium-Mediated%2520One-Pot%2520Synthesis%2520of%2520Benzoxazoles%2520or%2520Oxazoles%2520from%25202-Nitrophenols%2520or%25201-Aryl-2-Nitroethanones%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26issue%3D43%26spage%3D8821%26epage%3D8831%26doi%3D10.1016%2Fj.tet.2009.08.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piguel, S.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Photophysical Properties of Series of π-Conjugated Oxazole Dyes</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">3188</span><span class="NLM_x">–</span> <span class="NLM_lpage">3193</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2013.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.tetlet.2013.04.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=3188-3193&issue=24&author=F.+Mahuteau-Betzerauthor=S.+Piguel&title=Synthesis+and+Evaluation+of+Photophysical+Properties+of+Series+of+%CF%80-Conjugated+Oxazole+Dyes&doi=10.1016%2Fj.tetlet.2013.04.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2013.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2013.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DPiguel%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Photophysical%2520Properties%2520of%2520Series%2520of%2520%25CF%2580-Conjugated%2520Oxazole%2520Dyes%26jtitle%3DTetrahedron%2520Lett.%26date%3D2013%26volume%3D54%26issue%3D24%26spage%3D3188%26epage%3D3193%26doi%3D10.1016%2Fj.tetlet.2013.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Krishan, A.</span><span> </span><span class="NLM_article-title">Rapid Flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span><span class="refDoi"> DOI: 10.1083/jcb.66.1.188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1083%2Fjcb.66.1.188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1975&pages=188-193&author=A.+Krishan&title=Rapid+Flow+cytofluorometric+analysis+of+mammalian+cell+cycle+by+propidium+iodide+staining&doi=10.1083%2Fjcb.66.1.188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1083%2Fjcb.66.1.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.66.1.188%26sid%3Dliteratum%253Aachs%26aulast%3DKrishan%26aufirst%3DA.%26atitle%3DRapid%2520Flow%2520cytofluorometric%2520analysis%2520of%2520mammalian%2520cell%2520cycle%2520by%2520propidium%2520iodide%2520staining%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1975%26volume%3D66%26spage%3D188%26epage%3D193%26doi%3D10.1083%2Fjcb.66.1.188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Cai Gao, Qianting Zhou, Li Yang, Xinying Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xuesen Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-Amidoketones through the Cascade Reaction of Carboxylic Acids with Vinyl Azides under Catalyst-Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (21)
                                     , 13710-13720. <a href="https://doi.org/10.1021/acs.joc.0c01871" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01871%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-Amidoketones%252Bthrough%252Bthe%252BCascade%252BReaction%252Bof%252BCarboxylic%252BAcids%252Bwith%252BVinyl%252BAzides%252Bunder%252BCatalyst-Free%252BConditions%26aulast%3DGao%26aufirst%3DCai%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03082020%26date%3D28102020%26volume%3D85%26issue%3D21%26spage%3D13710%26epage%3D13720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Narasimharao Mukku, Prabhakara Madivalappa Davanagere, Kaushik Chanda, <span class="NLM_string-name hlFld-ContribAuthor">Barnali Maiti</span>. </span><span class="cited-content_cbyCitation_article-title">A Facile Microwave-Assisted Synthesis of Oxazoles and Diastereoselective Oxazolines Using Aryl-Aldehydes, p-Toluenesulfonylmethyl Isocyanide under Controlled Basic Conditions. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (43)
                                     , 28239-28248. <a href="https://doi.org/10.1021/acsomega.0c04130" title="DOI URL">https://doi.org/10.1021/acsomega.0c04130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c04130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c04130%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DA%252BFacile%252BMicrowave-Assisted%252BSynthesis%252Bof%252BOxazoles%252Band%252BDiastereoselective%252BOxazolines%252BUsing%252BAryl-Aldehydes%25252C%252Bp-Toluenesulfonylmethyl%252BIsocyanide%252Bunder%252BControlled%252BBasic%252BConditions%26aulast%3DMukku%26aufirst%3DNarasimharao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26082020%26date%3D06102020%26date%3D20102020%26volume%3D5%26issue%3D43%26spage%3D28239%26epage%3D28248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Corena V. Grant, Shengxin Cai, April L. Risinger, Huiyun Liang, Barry R. O’Keefe, John G. Doench, Robert H. Cichewicz, <span class="NLM_string-name hlFld-ContribAuthor">Susan L. Mooberry</span>. </span><span class="cited-content_cbyCitation_article-title">CRISPR-Cas9 Genome-Wide Knockout Screen Identifies Mechanism of Selective Activity of Dehydrofalcarinol in Mesenchymal Stem-like Triple-Negative Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (10)
                                     , 3080-3092. <a href="https://doi.org/10.1021/acs.jnatprod.0c00642" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c00642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c00642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c00642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DCRISPR-Cas9%252BGenome-Wide%252BKnockout%252BScreen%252BIdentifies%252BMechanism%252Bof%252BSelective%252BActivity%252Bof%252BDehydrofalcarinol%252Bin%252BMesenchymal%252BStem-like%252BTriple-Negative%252BBreast%252BCancer%252BCells%26aulast%3DGrant%26aufirst%3DCorena%2BV.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09062020%26date%3D06102020%26volume%3D83%26issue%3D10%26spage%3D3080%26epage%3D3092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Petra J. Pederson, Shengxin Cai, Chase Carver, Douglas R. Powell, April L. Risinger, Tanja Grkovic, Barry R. O’Keefe, Susan L. Mooberry, <span class="NLM_string-name hlFld-ContribAuthor">Robert H. Cichewicz</span>. </span><span class="cited-content_cbyCitation_article-title">Triple-Negative Breast Cancer Cells Exhibit Differential Sensitivity to Cardenolides from Calotropis gigantea. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (7)
                                     , 2269-2280. <a href="https://doi.org/10.1021/acs.jnatprod.0c00423" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c00423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c00423%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DTriple-Negative%252BBreast%252BCancer%252BCells%252BExhibit%252BDifferential%252BSensitivity%252Bto%252BCardenolides%252Bfrom%252BCalotropis%252Bgigantea%26aulast%3DPederson%26aufirst%3DPetra%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16042020%26date%3D10072020%26volume%3D83%26issue%3D7%26spage%3D2269%26epage%3D2280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Diksha Singh, Gangam Srikanth Kumar, <span class="NLM_string-name hlFld-ContribAuthor">Manmohan Kapur</span>. </span><span class="cited-content_cbyCitation_article-title">Oxazolinyl-Assisted Ru(II)-Catalyzed C–H Allylation with Allyl Alcohols and Synthesis of 4-Methyleneisochroman-1-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (20)
                                     , 12881-12892. <a href="https://doi.org/10.1021/acs.joc.9b01536" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01536%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOxazolinyl-Assisted%252BRu%252528II%252529-Catalyzed%252BC%2525E2%252580%252593H%252BAllylation%252Bwith%252BAllyl%252BAlcohols%252Band%252BSynthesis%252Bof%252B4-Methyleneisochroman-1-ones%26aulast%3DSingh%26aufirst%3DDiksha%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10062019%26date%3D28082019%26date%3D16082019%26volume%3D84%26issue%3D20%26spage%3D12881%26epage%3D12892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Narita</span>, <span class="hlFld-ContribAuthor ">Keisuke  Suganuma</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Murata</span>, <span class="hlFld-ContribAuthor ">Ryutaro  Kondo</span>, <span class="hlFld-ContribAuthor ">Hiroka  Satoh</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kenroh  Sasaki</span>, <span class="hlFld-ContribAuthor ">Noboru  Inoue</span>, <span class="hlFld-ContribAuthor ">Yuichi  Yoshimura</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of trypanocidal activity of derivatives of naturally occurring 2,5-diphenyloxazoles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>42 </em>, 116253. <a href="https://doi.org/10.1016/j.bmc.2021.116253" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116253%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Btrypanocidal%252Bactivity%252Bof%252Bderivatives%252Bof%252Bnaturally%252Boccurring%252B2%25252C5-diphenyloxazoles%26aulast%3DNarita%26aufirst%3DKoichi%26date%3D2021%26volume%3D42%26spage%3D116253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. Keith  Chenault</span>. </span><span class="cited-content_cbyCitation_article-title">Introduction to Pyrrolidone and Caprolactam Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-69. <a href="https://doi.org/10.1002/9781119468769.hpcbm001" title="DOI URL">https://doi.org/10.1002/9781119468769.hpcbm001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119468769.hpcbm001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119468769.hpcbm001%26sid%3Dliteratum%253Aachs%26atitle%3DIntroduction%252Bto%252BPyrrolidone%252Band%252BCaprolactam%252BChemistry%26aulast%3DChenault%26aufirst%3DH.%2BKeith%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D69%26pub%3DWiley%26atitle%3DHandbook%252Bof%252BPyrrolidone%252Band%252BCaprolactam%252BBased%252BMaterials%26aulast%3DMusa%26aufirst%3DOsama%26date%3D2022%26date%3D2022%26volume%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles S.  Fermaintt</span>, <span class="hlFld-ContribAuthor ">Thilini  Peramuna</span>, <span class="hlFld-ContribAuthor ">Shengxin  Cai</span>, <span class="hlFld-ContribAuthor ">Leila  Takahashi-Ruiz</span>, <span class="hlFld-ContribAuthor ">Jacob Nathaniel  Essif</span>, <span class="hlFld-ContribAuthor ">Corena V.  Grant</span>, <span class="hlFld-ContribAuthor ">Barry R.  O’Keefe</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, <span class="hlFld-ContribAuthor ">Robert H.  Cichewicz</span>, <span class="hlFld-ContribAuthor ">April L.  Risinger</span>. </span><span class="cited-content_cbyCitation_article-title">Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (11)
                                     , 2834. <a href="https://doi.org/10.3390/cancers13112834" title="DOI URL">https://doi.org/10.3390/cancers13112834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13112834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13112834%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DYuanhuacine%252BIs%252Ba%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252Bthe%252BBasal-Like%252B2%252BSubtype%252Bof%252BTriple%252BNegative%252BBreast%252BCancer%252Bwith%252BImmunogenic%252BPotential%26aulast%3DFermaintt%26aufirst%3DCharles%2BS.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D11%26spage%3D2834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Thamer</span>, <span class="hlFld-ContribAuthor ">Salim Wisam  Taher</span>, <span class="hlFld-ContribAuthor ">Muslim Farah  Aqeel Rashid</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of dithiolene compounds from xanthydrole. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physics: Conference Series</span><span> <strong>2020,</strong> <em>1660 </em>, 012033. <a href="https://doi.org/10.1088/1742-6596/1660/1/012033" title="DOI URL">https://doi.org/10.1088/1742-6596/1660/1/012033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1088/1742-6596/1660/1/012033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1088%2F1742-6596%2F1660%2F1%2F012033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physics%253A%2520Conference%2520Series%26atitle%3DSynthesis%252Bof%252Bdithiolene%252Bcompounds%252Bfrom%252Bxanthydrole%26aulast%3DThamer%26aufirst%3DAhmed%26date%3D2020%26date%3D2020%26volume%3D1660%26spage%3D012033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinjia  Yan</span>, <span class="hlFld-ContribAuthor ">Jing  Wen</span>, <span class="hlFld-ContribAuthor ">Lin  Zhou</span>, <span class="hlFld-ContribAuthor ">Lei  Fan</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Current Scenario of 1,3-oxazole Derivatives for Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (21)
                                     , 1916-1937. <a href="https://doi.org/10.2174/1568026620666200624161151" title="DOI URL">https://doi.org/10.2174/1568026620666200624161151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200624161151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200624161151%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252BScenario%252Bof%252B1%25252C3-oxazole%252BDerivatives%252Bfor%252BAnticancer%252BActivity%26aulast%3DYan%26aufirst%3DXinjia%26date%3D2020%26volume%3D20%26issue%3D21%26spage%3D1916%26epage%3D1937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyong  Ke</span>, <span class="hlFld-ContribAuthor ">Wei  Fang</span>, <span class="hlFld-ContribAuthor ">Wenbo  Huang</span>, <span class="hlFld-ContribAuthor ">Zhigang  Zhang</span>, <span class="hlFld-ContribAuthor ">Liqiao  Shi</span>, <span class="hlFld-ContribAuthor ">Zhongyi  Wan</span>, <span class="hlFld-ContribAuthor ">Kaimei  Wang</span>, <span class="hlFld-ContribAuthor ">Chunxia  Cao</span>, <span class="hlFld-ContribAuthor ">Daye  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing natural hinduchelins derivatives as potential antifungal agents against Rhizoctonia solani. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (13)
                                     , 127245. <a href="https://doi.org/10.1016/j.bmcl.2020.127245" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127245%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSulfur-containing%252Bnatural%252Bhinduchelins%252Bderivatives%252Bas%252Bpotential%252Bantifungal%252Bagents%252Bagainst%252BRhizoctonia%252Bsolani%26aulast%3DKe%26aufirst%3DShaoyong%26date%3D2020%26volume%3D30%26issue%3D13%26spage%3D127245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  El-Mekabaty</span>, <span class="hlFld-ContribAuthor ">Mona  E. Ibrahim</span>. </span><span class="cited-content_cbyCitation_article-title">Facile and Convenient Synthesis of New Isoxazolo[5,4-b]pyridine, Pyrrolo[3,2-d]isoxazole, Isoxazolo[5,4-b]azepine-4,7-dione and Isoxazole Derivatives with Potential Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2020,</strong> <em>100 </em>
                                    (6)
                                     , 901. <a href="https://doi.org/10.3987/COM-20-14245" title="DOI URL">https://doi.org/10.3987/COM-20-14245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-20-14245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-20-14245%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DFacile%252Band%252BConvenient%252BSynthesis%252Bof%252BNew%252BIsoxazolo%25255B5%25252C4-b%25255Dpyridine%25252C%252BPyrrolo%25255B3%25252C2-d%25255Disoxazole%25252C%252BIsoxazolo%25255B5%25252C4-b%25255Dazepine-4%25252C7-dione%252Band%252BIsoxazole%252BDerivatives%252Bwith%252BPotential%252BAnticancer%252BActivity%26aulast%3DEl-Mekabaty%26aufirst%3DAhmed%26date%3D2020%26volume%3D100%26issue%3D6%26spage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bandaru T.  Ramanjaneyulu</span>, <span class="hlFld-ContribAuthor ">Shinde  Vidyacharan</span>, <span class="hlFld-ContribAuthor ">Se Jun  Yim</span>, <span class="hlFld-ContribAuthor ">Dong-Pyo  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Fast-Synthesis of α-Phosphonyloxy Ketones as Drug Scaffolds in a Capillary Microreactor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (47)
                                     , 7730-7734. <a href="https://doi.org/10.1002/ejoc.201901655" title="DOI URL">https://doi.org/10.1002/ejoc.201901655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901655%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFast-Synthesis%252Bof%252B%2525CE%2525B1-Phosphonyloxy%252BKetones%252Bas%252BDrug%252BScaffolds%252Bin%252Ba%252BCapillary%252BMicroreactor%26aulast%3DRamanjaneyulu%26aufirst%3DBandaru%2BT.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D47%26spage%3D7730%26epage%3D7734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corena V.  Grant</span>, <span class="hlFld-ContribAuthor ">Chase M.  Carver</span>, <span class="hlFld-ContribAuthor ">Shayne D.  Hastings</span>, <span class="hlFld-ContribAuthor ">Karthik  Ramachandran</span>, <span class="hlFld-ContribAuthor ">Madesh  Muniswamy</span>, <span class="hlFld-ContribAuthor ">April L.  Risinger</span>, <span class="hlFld-ContribAuthor ">John A.  Beutler</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>. </span><span class="cited-content_cbyCitation_article-title">Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2019,</strong> <em>177 </em>
                                    (2)
                                     , 345-355. <a href="https://doi.org/10.1007/s10549-019-05324-7" title="DOI URL">https://doi.org/10.1007/s10549-019-05324-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-019-05324-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-019-05324-7%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DTriple-negative%252Bbreast%252Bcancer%252Bcell%252Bline%252Bsensitivity%252Bto%252Benglerin%252BA%252Bidentifies%252Ba%252Bnew%25252C%252Btargetable%252Bsubtype%26aulast%3DGrant%26aufirst%3DCorena%2BV.%26date%3D2019%26date%3D2019%26volume%3D177%26issue%3D2%26spage%3D345%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyong  Ke</span>, <span class="hlFld-ContribAuthor ">Zhigang  Zhang</span>, <span class="hlFld-ContribAuthor ">Liqiao  Shi</span>, <span class="hlFld-ContribAuthor ">Manli  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Fang</span>, <span class="hlFld-ContribAuthor ">Yani  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhaoyuan  Wu</span>, <span class="hlFld-ContribAuthor ">Zhongyi  Wan</span>, <span class="hlFld-ContribAuthor ">Tong  Long</span>, <span class="hlFld-ContribAuthor ">Kaimei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis and bioactivity evaluation of oxazole-containing natural hinduchelins A–D and their derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (14)
                                     , 3635-3639. <a href="https://doi.org/10.1039/C9OB00352E" title="DOI URL">https://doi.org/10.1039/C9OB00352E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00352E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00352E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAn%252Befficient%252Bsynthesis%252Band%252Bbioactivity%252Bevaluation%252Bof%252Boxazole-containing%252Bnatural%252Bhinduchelins%252BA%2525E2%252580%252593D%252Band%252Btheir%252Bderivatives%26aulast%3DKe%26aufirst%3DShaoyong%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D14%26spage%3D3635%26epage%3D3639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiwei  Jie</span>, <span class="hlFld-ContribAuthor ">Ziang  Xie</span>, <span class="hlFld-ContribAuthor ">Xiangde  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuewu  Sun</span>, <span class="hlFld-ContribAuthor ">Hejun  Yu</span>, <span class="hlFld-ContribAuthor ">Xin  Pan</span>, <span class="hlFld-ContribAuthor ">Shuying  Shen</span>, <span class="hlFld-ContribAuthor ">An  Qin</span>, <span class="hlFld-ContribAuthor ">Xiangqian  Fang</span>, <span class="hlFld-ContribAuthor ">Shunwu  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Glabridin inhibits osteosarcoma migration and invasion via blocking the p38‐ and JNK‐mediated CREB–AP1 complexes formation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2019,</strong> <em>234 </em>
                                    (4)
                                     , 4167-4178. <a href="https://doi.org/10.1002/jcp.27171" title="DOI URL">https://doi.org/10.1002/jcp.27171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.27171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.27171%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DGlabridin%252Binhibits%252Bosteosarcoma%252Bmigration%252Band%252Binvasion%252Bvia%252Bblocking%252Bthe%252Bp38%2525E2%252580%252590%252Band%252BJNK%2525E2%252580%252590mediated%252BCREB%2525E2%252580%252593AP1%252Bcomplexes%252Bformation%26aulast%3DJie%26aufirst%3DZhiwei%26date%3D2019%26date%3D2018%26volume%3D234%26issue%3D4%26spage%3D4167%26epage%3D4178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danielle  Cicka</span>, <span class="hlFld-ContribAuthor ">Cassandra  Quave</span>. </span><span class="cited-content_cbyCitation_article-title">Bioprospecting for Pharmaceuticals: An Overview and Vision for Future Access and Benefit Sharing. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 17-34. <a href="https://doi.org/10.1007/978-3-030-31269-5_2" title="DOI URL">https://doi.org/10.1007/978-3-030-31269-5_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-31269-5_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-31269-5_2%26sid%3Dliteratum%253Aachs%26atitle%3DBioprospecting%252Bfor%252BPharmaceuticals%25253A%252BAn%252BOverview%252Band%252BVision%252Bfor%252BFuture%252BAccess%252Band%252BBenefit%252BSharing%26aulast%3DCicka%26aufirst%3DDanielle%26date%3D2019%26date%3D2019%26spage%3D17%26epage%3D34%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMedicinal%252BPlants%26aulast%3DJoshee%26aufirst%3DNirmal%26date%3D2019%26volume%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Burcu  Çalışkan</span>, <span class="hlFld-ContribAuthor ">Esra  Sinoplu</span>, <span class="hlFld-ContribAuthor ">Kübra  İbiş</span>, <span class="hlFld-ContribAuthor ">Ece  Akhan Güzelcan</span>, <span class="hlFld-ContribAuthor ">Rengül  Çetin Atalay</span>, <span class="hlFld-ContribAuthor ">Erden  Banoglu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 1352-1361. <a href="https://doi.org/10.1080/14756366.2018.1504041" title="DOI URL">https://doi.org/10.1080/14756366.2018.1504041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1504041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1504041%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bcellular%252Bbioactivities%252Bof%252Bnovel%252Bisoxazole%252Bderivatives%252Bincorporating%252Ban%252Barylpiperazine%252Bmoiety%252Bas%252Banticancer%252Bagents%26aulast%3D%25C3%2587al%25C4%25B1%25C5%259Fkan%26aufirst%3DBurcu%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D1352%26epage%3D1361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <i>Amyris texana</i> extract and isolated compounds selectively inhibit growth of LAR cells. SRB assay concentration–response curves for a crude supercritical CO<sub>2</sub> extract of <i>Amyris texana</i> (A); fractions F2 (B) and F3 (C); and isolated pure compounds <b>1</b> (D) and <b>2</b> (E) against TNBC cell lines representing different molecular subtypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of isolated natural products <b>1</b> and <b>2</b> and similar diaryloxazoles reported from other plant species.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of First Generation Analogues <b>10</b>–<b>20</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Natural Products <b>1</b> and <b>2</b> and Analogs <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) <i>p</i>-toluenesulfonylmethylisocyanide (1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.7 equiv), MeOH (0.2 M), reflux, 97%; (b) Pd(OAc)<sub>2</sub> (0.2 equiv), CuI (1 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), Ar–Br (1.2 equiv), DMF (0.85M), mW, 150 °C, 41–55%; (c) Ar–Br (1.2 equiv), CuI (1 equiv, PPh<sub>3</sub> (1 equiv), Na<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF (1.0 M), 30–65% yield; (d) BBr<sub>3</sub> (6 equiv), DCM (0.2 M), −78 °C to r.t., 96% yield; (e) NaH (1.1 equiv), R-Br (1.1 equiv), THF/DMF (0.1M), 0 °C to r.t., 28–63%; (f) benzoic acid, HATU, DIPEA, DMF, 57% yield; (g) conc. H<sub>2</sub>SO<sub>4</sub>, Ac<sub>2</sub>O, 90 °C, 85% yield.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis and structures of analogs <b>24–34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) NaH (1.1 equiv), prenylbromide (1 equiv), ACN (1.0M), 0 °C, 61% yield; (b) <i>p</i>-toluenesulfonylmethylisocyanide (1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.7 equiv), MeOH (0.2M), reflux, 98%; (c) 2-bromonicotinaldehyde or 3- bromonicotinaldehyde, CuI (1 equiv), PPh<sub>3</sub> (1 equiv), Na<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF (1.0 M), 160 °C, 47% yield; (d) HNR<sub>1</sub>R<sub>2</sub> (1.1 equiv), NaHB(OAc)<sub>3</sub>, DCE, r.t., 21–71% yield; (e) HCl (1.0 equiv), ether (1.0 M), r.t.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>17</b> more potently inhibits growth of MDA-MB-453 cells than natural product hits. SRB assay concentration–response curves for <b>17</b> (A) and potency measurements (B) in five TNBC cell lines representing different molecular subtypes. Results represent mean ± SE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Second generation analogs selectively inhibit growth of LAR cell lines MDA-MB-453 and SUM-185PE. SRB assay concentration–response curves for <b>24</b> (A), <b>26</b> (B), <b>27</b> (C), <b>28</b> (D), <b>30</b> (E), and <b>31</b> (F) in six TNBC cell lines representing five different molecular subtypes. Results represent mean ± SE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/medium/jm-2017-01228d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>30</b> rapidly decreases abundance of activated mTORC1 signaling proteins in LAR cells. Immunoblotting of compound <b>30</b>-treated MDA-MB-453 whole-cell lysates for phosphorylated and total PI3K/Akt/mTORC1 signaling proteins. Cells were treated with vehicle (DMSO) or 1 μM <b>30</b> for 1–6 h, as indicated. Quantification of phosphorylated protein relative to total protein is indicated below each band.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01228&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Dent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudeau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawka, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lickley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlinson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narod, S. A.</span><span> </span><span class="NLM_article-title">Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">15 Pt 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4434</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-3045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1158%2F1078-0432.CCR-06-3045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=17671126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A280%3ADC%252BD2svltlShtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=4429-4434&issue=15+Pt+1&author=R.+Dentauthor=M.+Trudeauauthor=K.+I.+Pritchardauthor=W.+M.+Hannaauthor=H.+K.+Kahnauthor=C.+A.+Sawkaauthor=L.+A.+Lickleyauthor=E.+Rawlinsonauthor=P.+Sunauthor=S.+A.+Narod&title=Triple-Negative+Breast+Cancer%3A+Clinical+Features+and+Patterns+of+Recurrence&doi=10.1158%2F1078-0432.CCR-06-3045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: clinical features and patterns of recurrence</span></div><div class="casAuthors">Dent Rebecca; Trudeau Maureen; Pritchard Kathleen I; Hanna Wedad M; Kahn Harriet K; Sawka Carol A; Lickley Lavina A; Rawlinson Ellen; Sun Ping; Narod Steven A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15 Pt 1</span>),
    <span class="NLM_cas:pages">4429-34</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">PURPOSE:  To compare the clinical features, natural history, and outcomes for women with "triple-negative" breast cancer with women with other types of breast cancer.  EXPERIMENTAL DESIGN:  We studied a cohort of 1,601 patients with breast cancer, diagnosed between January 1987 and December 1997 at Women's College Hospital in Toronto.  Triple-negative breast cancers were defined as those that were estrogen receptor negative, progesterone receptor negative, and HER2neu negative.  The prognostic significance of triple-negative breast cancer was explored.  RESULTS:  The median follow-up time of the 1,601 women was 8.1 years.  One hundred and eighty of 1,601 patients (11.2%) had triple-negative breast cancer.  Compared with other women with breast cancer, those with triple-negative breast cancer had an increased likelihood of distant recurrence (hazard ratio, 2.6; 95% confidence interval, 2.0-3.5; P < 0.0001) and death (hazard ratio, 3.2; 95% confidence interval, 2.3-4.5; P < 0.001) within 5 years of diagnosis but not thereafter.  The pattern of recurrence was also qualitatively different; among the triple-negative group, the risk of distant recurrence peaked at approximately 3 years and declined rapidly thereafter.  Among the "other" group, the recurrence risk seemed to be constant over the period of follow-up.  CONCLUSIONS:  Triple-negative breast cancers have a more aggressive clinical course than other forms of breast cancer, but the adverse effect is transient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgv_jWdHp-NeIHSmpohpd0fW6udTcc2eaXqv_iYiwj6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svltlShtQ%253D%253D&md5=7ee3954fe80ef97f1966768b115e6050</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-3045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-3045%26sid%3Dliteratum%253Aachs%26aulast%3DDent%26aufirst%3DR.%26aulast%3DTrudeau%26aufirst%3DM.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DHanna%26aufirst%3DW.%2BM.%26aulast%3DKahn%26aufirst%3DH.%2BK.%26aulast%3DSawka%26aufirst%3DC.%2BA.%26aulast%3DLickley%26aufirst%3DL.%2BA.%26aulast%3DRawlinson%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DNarod%26aufirst%3DS.%2BA.%26atitle%3DTriple-Negative%2520Breast%2520Cancer%253A%2520Clinical%2520Features%2520and%2520Patterns%2520of%2520Recurrence%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D15%2520Pt%25201%26spage%3D4429%26epage%3D4434%26doi%3D10.1158%2F1078-0432.CCR-06-3045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Irvin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, L. A.</span><span> </span><span class="NLM_article-title">What Is Triple-Negative Breast Cancer?</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">2799</span><span class="NLM_x">–</span> <span class="NLM_lpage">2805</span><span class="refDoi"> DOI: 10.1016/j.ejca.2008.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.ejca.2008.09.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2008&pages=2799-2805&issue=18&author=W.+J.+Irvinauthor=L.+A.+Carey&title=What+Is+Triple-Negative+Breast+Cancer%3F&doi=10.1016%2Fj.ejca.2008.09.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2008.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2008.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DIrvin%26aufirst%3DW.%2BJ.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26atitle%3DWhat%2520Is%2520Triple-Negative%2520Breast%2520Cancer%253F%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2008%26volume%3D44%26issue%3D18%26spage%3D2799%26epage%3D2805%26doi%3D10.1016%2Fj.ejca.2008.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Vaz-Luis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottesen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edge, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Angulo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theriault, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N. U.</span><span> </span><span class="NLM_article-title">Outcomes by Tumor Subtype and Treatment Pattern in Women with Small, Node-Negative Breast Cancer: A Multi-Institutional Study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">2142</span><span class="NLM_x">–</span> <span class="NLM_lpage">2150</span><span class="refDoi"> DOI: 10.1200/JCO.2013.53.1608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1200%2FJCO.2013.53.1608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=24888816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A280%3ADC%252BC2cjotlGqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=2142-2150&issue=20&author=I.+Vaz-Luisauthor=R.+A.+Ottesenauthor=M.+E.+Hughesauthor=R.+Mametauthor=H.+J.+Bursteinauthor=S.+B.+Edgeauthor=A.+M.+Gonzalez-Anguloauthor=B.+Moyauthor=H.+S.+Rugoauthor=R.+L.+Theriaultauthor=J.+C.+Weeksauthor=E.+P.+Winerauthor=N.+U.+Lin&title=Outcomes+by+Tumor+Subtype+and+Treatment+Pattern+in+Women+with+Small%2C+Node-Negative+Breast+Cancer%3A+A+Multi-Institutional+Study&doi=10.1200%2FJCO.2013.53.1608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study</span></div><div class="casAuthors">Vaz-Luis Ines; Ottesen Rebecca A; Hughes Melissa E; Mamet Rizvan; Burstein Harold J; Edge Stephen B; Gonzalez-Angulo Ana M; Moy Beverly; Rugo Hope S; Theriault Richard L; Weeks Jane C; Winer Eric P; Lin Nancy U</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2142-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Treatment decisions for patients with T1a,bN0M0 breast cancer are challenging.  We studied the time trends in use of adjuvant chemotherapy and survival outcomes among these patients.  PATIENTS AND METHODS:  This was a prospective cohort study within the National Comprehensive Cancer Network Database that included 4,113 women with T1a,bN0M0 breast cancer treated between 2000 and 2009.  Tumors were grouped by size (T1a, T1b), biologic subtype defined by hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status, and receipt of chemotherapy with or without trastuzumab.  RESULTS:  Median follow-up time was 5.5 years.  Eight percent of patients with HR-positive/HER2-negative tumors were treated with chemotherapy.  Fifty-two percent of those with HER2-positive or HR-negative/HER2-negative breast cancers received chemotherapy, with an increase over the last decade.  Survival outcomes diverged by subtype and size, but the 5-year distant relapse-free survival (DRFS) did not exceed 10% in any subgroup.  The 5-year DRFS for patients with T1a tumors untreated with chemotherapy ranged from 93% to 98% (n = 49 to 972), and for patients with T1b tumors, it ranged from 90% to 96% (n = 17 to 2,005).  Patients with HR-positive/HER2-negative disease had the best DRFS estimates, and patients with HR-negative/HER2-negative tumors had the lowest.  In this observational, nonrandomized cohort study, the 5-year DRFS for treated patients with T1a tumors was 100% for all subgroups (n = 12 to 33), and for patients with T1b tumors, it ranged from 94% to 96% (n = 88 to 241).  CONCLUSION:  Women with T1a,b tumors have an excellent prognosis without chemotherapy.  Size and tumor subtype may identify patients in whom the rate of recurrence justifies consideration of chemotherapy.  These patients represent an optimal group for evaluating less toxic adjuvant regimens to maintain efficacy while minimizing short- and long-term risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQseX2_cqEHUWZyxfu64m4ffW6udTcc2eY8GpDtB3vRCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjotlGqsw%253D%253D&md5=230f2c91abecaa0bf85b3994b9207e9d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1200%2FJCO.2013.53.1608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2013.53.1608%26sid%3Dliteratum%253Aachs%26aulast%3DVaz-Luis%26aufirst%3DI.%26aulast%3DOttesen%26aufirst%3DR.%2BA.%26aulast%3DHughes%26aufirst%3DM.%2BE.%26aulast%3DMamet%26aufirst%3DR.%26aulast%3DBurstein%26aufirst%3DH.%2BJ.%26aulast%3DEdge%26aufirst%3DS.%2BB.%26aulast%3DGonzalez-Angulo%26aufirst%3DA.%2BM.%26aulast%3DMoy%26aufirst%3DB.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DTheriault%26aufirst%3DR.%2BL.%26aulast%3DWeeks%26aufirst%3DJ.%2BC.%26aulast%3DWiner%26aufirst%3DE.%2BP.%26aulast%3DLin%26aufirst%3DN.%2BU.%26atitle%3DOutcomes%2520by%2520Tumor%2520Subtype%2520and%2520Treatment%2520Pattern%2520in%2520Women%2520with%2520Small%252C%2520Node-Negative%2520Breast%2520Cancer%253A%2520A%2520Multi-Institutional%2520Study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D32%26issue%3D20%26spage%3D2142%26epage%3D2150%26doi%3D10.1200%2FJCO.2013.53.1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Brewster, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-MacGregor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span> </span><span class="NLM_article-title">Epidemiology, Biology, and Treatment of Triple-Negative Breast Cancer in Women of African Ancestry</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">e625</span><span class="NLM_x">–</span> <span class="NLM_lpage">e634</span><span class="refDoi"> DOI: 10.1016/S1470-2045(14)70364-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2FS1470-2045%2814%2970364-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=25456381" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=e625-e634&issue=13&author=A.+M.+Brewsterauthor=M.+Chavez-MacGregorauthor=P.+Brown&title=Epidemiology%2C+Biology%2C+and+Treatment+of+Triple-Negative+Breast+Cancer+in+Women+of+African+Ancestry&doi=10.1016%2FS1470-2045%2814%2970364-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2814%2970364-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252814%252970364-X%26sid%3Dliteratum%253Aachs%26aulast%3DBrewster%26aufirst%3DA.%2BM.%26aulast%3DChavez-MacGregor%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DP.%26atitle%3DEpidemiology%252C%2520Biology%252C%2520and%2520Treatment%2520of%2520Triple-Negative%2520Breast%2520Cancer%2520in%2520Women%2520of%2520African%2520Ancestry%26jtitle%3DLancet%2520Oncol.%26date%3D2014%26volume%3D15%26issue%3D13%26spage%3De625%26epage%3De634%26doi%3D10.1016%2FS1470-2045%2814%2970364-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Abramson, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, I. A.</span><span> </span><span class="NLM_article-title">Molecular Heterogeneity of Triple Negative Breast Cancer</span> <span class="citation_source-journal">Curr. Breast Cancer Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span><span class="refDoi"> DOI: 10.1007/s12609-014-0152-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1007%2Fs12609-014-0152-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=25419441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFelsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=154-158&issue=3&author=V.+G.+Abramsonauthor=I.+A.+Mayer&title=Molecular+Heterogeneity+of+Triple+Negative+Breast+Cancer&doi=10.1007%2Fs12609-014-0152-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Heterogeneity of Triple-Negative Breast Cancer</span></div><div class="casAuthors">Abramson, Vandana G.; Mayer, Ingrid A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Breast Cancer Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">154-158</span>CODEN:
                <span class="NLM_cas:coden">CBCRAO</span>;
        ISSN:<span class="NLM_cas:issn">1943-4588</span>.
    
            (<span class="NLM_cas:orgname">Current Medicine Group LLC</span>)
        </div><div class="casAbstract">A review.  Triple-neg. breast cancers (TNBCs) are a group of aggressive breast cancers with a greater incidence of relapse, stage-for-stage, than ER/PR-pos. and HER2-pos. breast cancers, despite optimum loco-regional and systemic therapy.  To date, no single targeted therapy has been approved for treatment of TNBC, and cytotoxic chemotherapy remains the std. systemic treatment.  Recently, gene expression anal. identified six distinct TNBC subtypes, each with unique biol.  In this review we discuss current and forthcoming therapeutic strategies and novel approaches to targeted treatment of these TNBC subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpO3IivUBIbVg90H21EOLACvtfcHk0liVh_YZ84laPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFelsro%253D&md5=a3c812dfcd8a150b1c70966d5f0829a4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs12609-014-0152-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12609-014-0152-1%26sid%3Dliteratum%253Aachs%26aulast%3DAbramson%26aufirst%3DV.%2BG.%26aulast%3DMayer%26aufirst%3DI.%2BA.%26atitle%3DMolecular%2520Heterogeneity%2520of%2520Triple%2520Negative%2520Breast%2520Cancer%26jtitle%3DCurr.%2520Breast%2520Cancer%2520Rep.%26date%3D2014%26volume%3D6%26issue%3D3%26spage%3D154%26epage%3D158%26doi%3D10.1007%2Fs12609-014-0152-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mayer, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramson, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. A.</span><span> </span><span class="NLM_article-title">New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-0583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1158%2F1078-0432.CCR-13-0583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=24536073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVejsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=782-790&issue=4&author=I.+A.+Mayerauthor=V.+G.+Abramsonauthor=B.+D.+Lehmannauthor=J.+A.+Pietenpol&title=New+Strategies+for+Triple-Negative+Breast+Cancer-Deciphering+the+Heterogeneity&doi=10.1158%2F1078-0432.CCR-13-0583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity</span></div><div class="casAuthors">Mayer, Ingrid A.; Abramson, Vandana G.; Lehmann, Brian D.; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">782-790</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Triple-neg. breast cancer (TNBC) is a heterogeneous disease; gene expression analyses recently identified six distinct TNBC subtypes, each displaying a unique biol.  Exploring novel approaches to treatment of these subtypes is crit. because less than 30% of women with metastatic breast cancer survive five years and virtually all women with metastatic TNBC will ultimately die of their disease despite systemic therapy.  To date, not a single targeted therapy has been approved for the treatment of TNBC and cytotoxic chemotherapy remains the std. treatment.  We discuss the current and upcoming therapeutic strategies being explored in an attempt to "target" TNBC.  Clin Cancer Res; 20(4); 782-90. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdvsR_JjXMyLVg90H21EOLACvtfcHk0liVh_YZ84laPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVejsb0%253D&md5=4ce0876cb914096f913a7a637d7b63d5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0583%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DAbramson%26aufirst%3DV.%2BG.%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26atitle%3DNew%2520Strategies%2520for%2520Triple-Negative%2520Breast%2520Cancer-Deciphering%2520the%2520Heterogeneity%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26issue%3D4%26spage%3D782%26epage%3D790%26doi%3D10.1158%2F1078-0432.CCR-13-0583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarthy, a B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyr, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. a.</span><span> </span><span class="NLM_article-title">Identification of Human Triple-Negative Breast Cancer Subtypes and Preclinical Models for Selection of Targeted Therapies</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2750</span><span class="NLM_x">–</span> <span class="NLM_lpage">2767</span><span class="refDoi"> DOI: 10.1172/JCI45014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1172%2FJCI45014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=21633166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=2750-2767&issue=7&author=B.+D.+Lehmannauthor=J.+A.+Bauerauthor=X.+Chenauthor=M.+E.+Sandersauthor=a+B.+Chakravarthyauthor=Y.+Shyrauthor=J.+a.+Pietenpol&title=Identification+of+Human+Triple-Negative+Breast+Cancer+Subtypes+and+Preclinical+Models+for+Selection+of+Targeted+Therapies&doi=10.1172%2FJCI45014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies</span></div><div class="casAuthors">Lehmann, Brian D.; Bauer, Joshua A.; Chen, Xi; Sanders, Melinda E.; Chakravarthy, A. Bapsi; Shyr, Yu; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2750-2767</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a highly diverse group of cancers, and subtyping is necessary to better identify mol.-based therapies.  In this study, we analyzed gene expression (GE) profiles from 21 breast cancer data sets and identified 587 TNBC cases.  Cluster anal. identified 6 TNBC subtypes displaying unique GE and ontologies, including 2 basal-like (BL1 and BL2), an immunomodulatory (IM), a mesenchymal (M), a mesenchymal stem-like (MSL), and a luminal androgen receptor (LAR) subtype.  Further, GE anal. allowed us to identify TNBC cell line models representative of these subtypes.  Predicted "driver" signaling pathways were pharmacol. targeted in these cell line models as proof of concept that anal. of distinct GE signatures can inform therapy selection.  BL1 and BL2 subtypes had higher expression of cell cycle and DNA damage response genes, and representative cell lines preferentially responded to cisplatin.  M and MSL subtypes were enriched in GE for epithelial-mesenchymal transition, and growth factor pathways and cell models responded to NVP-BEZ235 (a PI3K/mTOR inhibitor) and dasatinib (an abl/src inhibitor).  The LAR subtype includes patients with decreased relapse-free survival and was characterized by androgen receptor (AR) signaling.  LAR cell lines were uniquely sensitive to bicalutamide (an AR antagonist).  These data may be useful in biomarker selection, drug discovery, and clin. trial design that will enable alignment of TNBC patients to appropriate targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbhoQQUFogW7Vg90H21EOLACvtfcHk0lgkW97YRaKkbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVKgu78%253D&md5=c3681c79e0b972f16f6d5a5ecdc99fec</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1172%2FJCI45014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI45014%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DBauer%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DChakravarthy%26aufirst%3Da%2BB.%26aulast%3DShyr%26aufirst%3DY.%26aulast%3DPietenpol%26aufirst%3DJ.%2Ba.%26atitle%3DIdentification%2520of%2520Human%2520Triple-Negative%2520Breast%2520Cancer%2520Subtypes%2520and%2520Preclinical%2520Models%2520for%2520Selection%2520of%2520Targeted%2520Therapies%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26issue%3D7%26spage%3D2750%26epage%3D2767%26doi%3D10.1172%2FJCI45014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovanović, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyr, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. A.</span><span> </span><span class="NLM_article-title">Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">e0157368</span><span class="refDoi"> DOI: 10.1371/journal.pone.0157368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1371%2Fjournal.pone.0157368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=27310713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOqtr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0157368&issue=6&author=B.+D.+Lehmannauthor=B.+Jovanovi%C4%87author=X.+Chenauthor=M.+V.+Estradaauthor=K.+N.+Johnsonauthor=Y.+Shyrauthor=H.+L.+Mosesauthor=M.+E.+Sandersauthor=J.+A.+Pietenpol&title=Refinement+of+Triple-Negative+Breast+Cancer+Molecular+Subtypes%3A+Implications+for+Neoadjuvant+Chemotherapy+Selection&doi=10.1371%2Fjournal.pone.0157368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection</span></div><div class="casAuthors">Lehmann, Brian D.; Jovanovic, Bojana; Chen, Xi; Estrada, Monica V.; Johnson, Kimberly N.; Shyr, Yu; Moses, Harold L.; Sanders, Melinda E.; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0157368/1-e0157368/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a heterogeneous disease that can be classified into distinct mol. subtypes by gene expression profiling.  Considered a difficult-to-treat cancer, a fraction of TNBC patients benefit significantly from neoadjuvant chemotherapy and have far better overall survival.  Outside of BRCA1/2 mutation status, biomarkers do not exist to identify patients most likely to respond to current chemotherapy; and, to date, no FDA-approved targeted therapies are available for TNBC patients.  Previously, we developed an approach to identify six mol. subtypes TNBC (TNBCtype), with each subtype displaying unique ontologies and differential response to std.-of-care chemotherapy.  Given the complexity of the varying histol. landscape of tumor specimens, we used histopathol. quantification and laser-capture microdissection to det. that transcripts in the previously described immunomodulatory (IM) and mesenchymal stem-like (MSL) subtypes were contributed from infiltrating lymphocytes and tumor-assocd. stromal cells, resp.  Therefore, we refined TNBC mol. subtypes from six (TNBCtype) into four (TNBCtype-4) tumor-specific subtypes (BL1, BL2, M and LAR) and demonstrate differences in diagnosis age, grade, local and distant disease progression and histopathol.  Using five publicly available, neoadjuvant chemotherapy breast cancer gene expression datasets, we retrospectively evaluated chemotherapy response of over 300 TNBC patients from pretreatment biopsies subtyped using either the intrinsic (PAM50) or TNBCtype approaches.  Combined anal. of TNBC patients demonstrated that TNBC subtypes significantly differ in response to similar neoadjuvant chemotherapy with 41% of BL1 patients achieving a pathol. complete response compared to 18% for BL2 and 29% for LAR with 95% confidence intervals (CIs; [33, 51], [9, 28], [17, 41], resp.).  Collectively, we provide pre-clin. data that could inform clin. trials designed to test the hypothesis that improved outcomes can be achieved for TNBC patients, if selection and combination of existing chemotherapies is directed by knowledge of mol. TNBC subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjbtsOOP5UtLVg90H21EOLACvtfcHk0lgkW97YRaKkbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOqtr3P&md5=62dddc464beb0b81b34c325e787c698d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0157368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0157368%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DJovanovi%25C4%2587%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DEstrada%26aufirst%3DM.%2BV.%26aulast%3DJohnson%26aufirst%3DK.%2BN.%26aulast%3DShyr%26aufirst%3DY.%26aulast%3DMoses%26aufirst%3DH.%2BL.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26atitle%3DRefinement%2520of%2520Triple-Negative%2520Breast%2520Cancer%2520Molecular%2520Subtypes%253A%2520Implications%2520for%2520Neoadjuvant%2520Chemotherapy%2520Selection%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3De0157368%26doi%3D10.1371%2Fjournal.pone.0157368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichewicz, R. H.</span><span> </span><span class="NLM_article-title">Crowdsourcing Natural Products Discovery to Access Uncharted Dimensions of Fungal Metabolite Diversity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span><span class="refDoi"> DOI: 10.1002/anie.201306549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1002%2Fanie.201306549" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=804-809&issue=3&author=L.+Duauthor=A.+J.+Roblesauthor=J.+B.+Kingauthor=D.+R.+Powellauthor=A.+N.+Millerauthor=S.+L.+Mooberryauthor=R.+H.+Cichewicz&title=Crowdsourcing+Natural+Products+Discovery+to+Access+Uncharted+Dimensions+of+Fungal+Metabolite+Diversity&doi=10.1002%2Fanie.201306549"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fanie.201306549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201306549%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DL.%26aulast%3DRobles%26aufirst%3DA.%2BJ.%26aulast%3DKing%26aufirst%3DJ.%2BB.%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DMiller%26aufirst%3DA.%2BN.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26aulast%3DCichewicz%26aufirst%3DR.%2BH.%26atitle%3DCrowdsourcing%2520Natural%2520Products%2520Discovery%2520to%2520Access%2520Uncharted%2520Dimensions%2520of%2520Fungal%2520Metabolite%2520Diversity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D3%26spage%3D804%26epage%3D809%26doi%3D10.1002%2Fanie.201306549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Robles, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichewicz, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span> </span><span class="NLM_article-title">Selective Activity of Deguelin Identifies Therapeutic Targets for Androgen Receptor-Positive Breast Cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1007/s10549-016-3841-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1007%2Fs10549-016-3841-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=27255535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpt1eht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=475-488&issue=3&author=A.+J.+Roblesauthor=S.+Caiauthor=R.+H.+Cichewiczauthor=S.+L.+Mooberry&title=Selective+Activity+of+Deguelin+Identifies+Therapeutic+Targets+for+Androgen+Receptor-Positive+Breast+Cancer&doi=10.1007%2Fs10549-016-3841-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer</span></div><div class="casAuthors">Robles, Andrew J.; Cai, Shengxin; Cichewicz, Robert H.; Mooberry, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-488</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Triple-neg. breast cancers (TNBC) are aggressive malignancies with no effective targeted therapies.  Recent gene expression profiling of these heterogeneous cancers and the classification of cell line models now allows for the identification of compds. with selective activities against mol. subtypes of TNBC.  The natural product deguelin was found to have selective activity against MDA-MB-453 and SUM-185PE cell lines, which both model the luminal androgen receptor (LAR) subtype of TNBC.  Deguelin potently inhibited proliferation of these cells with GI50 values of 30 and 61 nM, in MDA-MB-453 and SUM-185PE cells, resp.  Deguelin had exceptionally high selectivity, 197 to 566-fold, for these cell lines compared to cell lines representing other TNBC subtypes.  Deguelin's mechanisms of action were investigated to det. how it produced these potent and selective effects.  Our results show that deguelin has dual activities, inhibiting PI3K/Akt/mTOR signaling, and decreasing androgen receptor levels and nuclear localization.  Based on these data, we hypothesized that the combination of the mTOR inhibitor rapamycin and the antiandrogen enzalutamide would have efficacy in LAR models.  Rapamycin and enzalutamide showed additive effects in MDA-MB-453 cells, and both drugs had potent antitumor efficacy in a LAR xenograft model.  These results suggest that the combination of antiandrogens and mTOR inhibitors might be an effective strategy for the treatment of androgen receptor-expressing TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZqE2z6HXqK7Vg90H21EOLACvtfcHk0lj0MAntropuGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpt1eht78%253D&md5=68bd5d3b3a17d5ec592a7d00dec8cbaa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10549-016-3841-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-016-3841-9%26sid%3Dliteratum%253Aachs%26aulast%3DRobles%26aufirst%3DA.%2BJ.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DCichewicz%26aufirst%3DR.%2BH.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DSelective%2520Activity%2520of%2520Deguelin%2520Identifies%2520Therapeutic%2520Targets%2520for%2520Androgen%2520Receptor-Positive%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2016%26volume%3D157%26issue%3D3%26spage%3D475%26epage%3D488%26doi%3D10.1007%2Fs10549-016-3841-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Philip, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, H.</span><span> </span><span class="NLM_article-title">Amyris of Jamaica. 2,5-Diaryloxazoles and a Chromane from Amyris Plumieri D.C (Rutaceae)</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="refDoi"> DOI: 10.3987/R-1984-01-0009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.3987%2FR-1984-01-0009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1984&pages=9&issue=1&author=S.+Philipauthor=B.+A.+Burkeauthor=H.+Jacobs&title=Amyris+of+Jamaica.+2%2C5-Diaryloxazoles+and+a+Chromane+from+Amyris+Plumieri+D.C+%28Rutaceae%29&doi=10.3987%2FR-1984-01-0009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3987%2FR-1984-01-0009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FR-1984-01-0009%26sid%3Dliteratum%253Aachs%26aulast%3DPhilip%26aufirst%3DS.%26aulast%3DBurke%26aufirst%3DB.%2BA.%26aulast%3DJacobs%26aufirst%3DH.%26atitle%3DAmyris%2520of%2520Jamaica.%25202%252C5-Diaryloxazoles%2520and%2520a%2520Chromane%2520from%2520Amyris%2520Plumieri%2520D.C%2520%2528Rutaceae%2529%26jtitle%3DHeterocycles%26date%3D1984%26volume%3D22%26issue%3D1%26spage%3D9%26doi%3D10.3987%2FR-1984-01-0009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&issue=1%E2%80%933&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+to+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lj0MAntropuGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520to%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26issue%3D1%25E2%2580%25933%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rastogi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abaul, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devallois, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philogène, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, P.</span><span> </span><span class="NLM_article-title">Antimycobacterial Activity of Chemically Defined Natural Substances from the Caribbean Flora in Guadeloupe</span> <span class="citation_source-journal">FEMS Immunol. Med. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1111/j.1574-695X.1998.tb01136.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1111%2Fj.1574-695X.1998.tb01136.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=9626931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADyaK1cXisFals70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1998&pages=267-273&issue=4&author=N.+Rastogiauthor=J.+Abaulauthor=K.+S.+Gohauthor=A.+Devalloisauthor=E.+Philog%C3%A8neauthor=P.+Bourgeois&title=Antimycobacterial+Activity+of+Chemically+Defined+Natural+Substances+from+the+Caribbean+Flora+in+Guadeloupe&doi=10.1111%2Fj.1574-695X.1998.tb01136.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antimycobacterial activity of chemically defined natural substances from the Caribbean flora in Guadeloupe</span></div><div class="casAuthors">Rastogi, Nalin; Abaul, Jacqueline; Goh, Khye Seng; Devallois, Anne; Philogene, Emile; Bourgeois, Paul</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Immunology and Medical Microbiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">FIMIEV</span>;
        ISSN:<span class="NLM_cas:issn">0928-8244</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Eight chem. defined, naturally occurring compds. were extd. from the tropical flora of the Caribbean island of Guadeloupe: pilocarpine, an alkaloid from Pilocarpus racemosus; heraclenol and isomeranzin, coumarins from Triphasia trifolia; lochnerin, an indole alkaloid from Rauwolfia biauriculata; ibogaine and voacangine, indole alkaloids from Tabernaemontana citrifolia; texalin, an oxazole from Amyris elemifera; and canellal, a sesquiterpene dialdehyde from Canella winterana.  An essential oil fraction from Canella winterana was also tested.  The antimycobacterial activity of these substances was tested against Mycobacterium tuberculosis, M. avium and M. kansasii using the Middlebrook 7H11 agar medium, the Bactec 460-TB radiometric methodol., and detn. of bacterial viable counts.  Three compds., namely ibogaine, voacangine and texalin, showed antimycobacterial activity.  Investigations on the structure-modification and structure-activity relationships of these compds. may help det. new targets for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTowf_fiDubVg90H21EOLACvtfcHk0lj0MAntropuGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFals70%253D&md5=8e103d427b1a7cf0fb061c02efd3a18e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-695X.1998.tb01136.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-695X.1998.tb01136.x%26sid%3Dliteratum%253Aachs%26aulast%3DRastogi%26aufirst%3DN.%26aulast%3DAbaul%26aufirst%3DJ.%26aulast%3DGoh%26aufirst%3DK.%2BS.%26aulast%3DDevallois%26aufirst%3DA.%26aulast%3DPhilog%25C3%25A8ne%26aufirst%3DE.%26aulast%3DBourgeois%26aufirst%3DP.%26atitle%3DAntimycobacterial%2520Activity%2520of%2520Chemically%2520Defined%2520Natural%2520Substances%2520from%2520the%2520Caribbean%2520Flora%2520in%2520Guadeloupe%26jtitle%3DFEMS%2520Immunol.%2520Med.%2520Microbiol.%26date%3D1998%26volume%3D20%26issue%3D4%26spage%3D267%26epage%3D273%26doi%3D10.1111%2Fj.1574-695X.1998.tb01136.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Burke, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkins, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie Talbot, A.</span><span> </span><span class="NLM_article-title">An Oxazole and Its Precursor in Amyris Balsamifera</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">349</span><span class="refDoi"> DOI: 10.3987/R-1979-03-0349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.3987%2FR-1979-03-0349" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1979&pages=349&issue=3&author=B.+A.+Burkeauthor=B.+Burkeauthor=H.+Parkinsauthor=A.+Marie+Talbot&title=An+Oxazole+and+Its+Precursor+in+Amyris+Balsamifera&doi=10.3987%2FR-1979-03-0349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3987%2FR-1979-03-0349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FR-1979-03-0349%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DB.%2BA.%26aulast%3DBurke%26aufirst%3DB.%26aulast%3DParkins%26aufirst%3DH.%26aulast%3DMarie%2BTalbot%26aufirst%3DA.%26atitle%3DAn%2520Oxazole%2520and%2520Its%2520Precursor%2520in%2520Amyris%2520Balsamifera%26jtitle%3DHeterocycles%26date%3D1979%26volume%3D12%26issue%3D3%26spage%3D349%26doi%3D10.3987%2FR-1979-03-0349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yoshizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, M.</span><span> </span><span class="NLM_article-title">Synthesis of 2,5-Diaryloxazoles through van Leusen Reaction and Copper-Mediated Direct Arylation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3273</span><span class="NLM_x">–</span> <span class="NLM_lpage">3276</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2009.02.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.tetlet.2009.02.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVenurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3273-3276&author=T.+Yoshizumiauthor=T.+Satohauthor=K.+Hiranoauthor=D.+Matsuoauthor=A.+Oritaauthor=J.+Oteraauthor=M.+Miura&title=Synthesis+of+2%2C5-Diaryloxazoles+through+van+Leusen+Reaction+and+Copper-Mediated+Direct+Arylation&doi=10.1016%2Fj.tetlet.2009.02.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2,5-diaryloxazoles through van Leusen reaction and copper-mediated direct arylation</span></div><div class="casAuthors">Yoshizumi, Tomoki; Satoh, Tetsuya; Hirano, Koji; Matsuo, Daisuke; Orita, Akihiro; Otera, Junzo; Miura, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3273-3276</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The direct arylation of 5-aryloxazoles, prepd. by the van Leusen reaction, with various aryl iodides is effectively promoted by a system of CuI combined with PPh3 and Na2CO3 as a ligand and a base, resp., in DMF to produce the corresponding 2,5-diaryloxazoles in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJit5uWBaIurVg90H21EOLACvtfcHk0lhuNh-wEqzfKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVenurk%253D&md5=415ec2dcf7313ca792a266ffe52d85ca</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.02.039%26sid%3Dliteratum%253Aachs%26aulast%3DYoshizumi%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DD.%26aulast%3DOrita%26aufirst%3DA.%26aulast%3DOtera%26aufirst%3DJ.%26aulast%3DMiura%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25202%252C5-Diaryloxazoles%2520through%2520van%2520Leusen%2520Reaction%2520and%2520Copper-Mediated%2520Direct%2520Arylation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3273%26epage%3D3276%26doi%3D10.1016%2Fj.tetlet.2009.02.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cheplogoi, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulholland, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randrianarivelojosia, M.</span><span> </span><span class="NLM_article-title">An Azole, an Amide and a Limonoid from Vepris Uguenensis (Rutaceae)</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1384</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1016/j.phytochem.2007.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.phytochem.2007.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=1384-1388&issue=6&author=P.+K.+Cheplogoiauthor=D.+A.+Mulhollandauthor=P.+H.+Coombesauthor=M.+Randrianarivelojosia&title=An+Azole%2C+an+Amide+and+a+Limonoid+from+Vepris+Uguenensis+%28Rutaceae%29&doi=10.1016%2Fj.phytochem.2007.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2007.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2007.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DCheplogoi%26aufirst%3DP.%2BK.%26aulast%3DMulholland%26aufirst%3DD.%2BA.%26aulast%3DCoombes%26aufirst%3DP.%2BH.%26aulast%3DRandrianarivelojosia%26aufirst%3DM.%26atitle%3DAn%2520Azole%252C%2520an%2520Amide%2520and%2520a%2520Limonoid%2520from%2520Vepris%2520Uguenensis%2520%2528Rutaceae%2529%26jtitle%3DPhytochemistry%26date%3D2008%26volume%3D69%26issue%3D6%26spage%3D1384%26epage%3D1388%26doi%3D10.1016%2Fj.phytochem.2007.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Meepagala, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burandt, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, S. O.</span><span> </span><span class="NLM_article-title">New Class of Algicidal Compounds and Fungicidal Activities Derived from a Chromene Amide of Amyris Texana</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">9476</span><span class="NLM_x">–</span> <span class="NLM_lpage">9482</span><span class="refDoi"> DOI: 10.1021/jf101626g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf101626g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVaqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=9476-9482&author=K.+M.+Meepagalaauthor=K.+K.+Schraderauthor=C.+L.+Burandtauthor=D.+E.+Wedgeauthor=S.+O.+Duke&title=New+Class+of+Algicidal+Compounds+and+Fungicidal+Activities+Derived+from+a+Chromene+Amide+of+Amyris+Texana&doi=10.1021%2Fjf101626g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">New Class of Algicidal Compounds and Fungicidal Activities Derived from a Chromene Amide of Amyris texana</span></div><div class="casAuthors">Meepagala, Kumudini M.; Schrader, Kevin K.; Burandt, Charles L.; Wedge, David E.; Duke, Stephen O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9476-9482</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A chromene amide, N-[2-(2,2-dimethyl-2H-1-benzopyran-6-yl)ethyl]-N,3-dimethylbutanamide, was isolated from the EtOAc ext. of the leaves of Amyris texana and found to have moderate antifungal activity against Colletotrichum spp. and selective algicidal activity against Planktothrix perornata, a cyanobacterium (blue-green alga) that causes musty off-flavor in farm-raised channel catfish (Ictalurus punctatus).  To improve the selective algicidal activity and provide water soly., a series of chromene analogs were synthesized and evaluated for algicidal activity using a 96-well microplate rapid bioassay.  In addn., the chromene analogs were evaluated for antifungal and phytotoxic activities.  Hydrochloride salts of a chromene amine analog showed improved water soly. and selectivity toward P. perornata with activity comparable to that of the naturally occurring chromene amide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEV7xk1lBajrVg90H21EOLACvtfcHk0lhuNh-wEqzfKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVaqtrw%253D&md5=185041db8093c62cf56bad32a7560885</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjf101626g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf101626g%26sid%3Dliteratum%253Aachs%26aulast%3DMeepagala%26aufirst%3DK.%2BM.%26aulast%3DSchrader%26aufirst%3DK.%2BK.%26aulast%3DBurandt%26aufirst%3DC.%2BL.%26aulast%3DWedge%26aufirst%3DD.%2BE.%26aulast%3DDuke%26aufirst%3DS.%2BO.%26atitle%3DNew%2520Class%2520of%2520Algicidal%2520Compounds%2520and%2520Fungicidal%2520Activities%2520Derived%2520from%2520a%2520Chromene%2520Amide%2520of%2520Amyris%2520Texana%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2010%26volume%3D58%26spage%3D9476%26epage%3D9482%26doi%3D10.1021%2Fjf101626g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span><span class="refDoi"> DOI: 10.1093/jnci/82.13.1107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&issue=13&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+Colorimetric+Cytotoxicity+Assay+for+Anticancer-Drug+Screening&doi=10.1093%2Fjnci%2F82.13.1107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0limQuA8eyWxaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520Colorimetric%2520Cytotoxicity%2520Assay%2520for%2520Anticancer-Drug%2520Screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26issue%3D13%26spage%3D1107%26epage%3D1112%26doi%3D10.1093%2Fjnci%2F82.13.1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Boyd, M. R.; Paull, K. D.; Rubinstein, L. R.</span><span> </span><span class="NLM_article-title">Data Display and Analysis Strategies for the NCI Disease-Oriented in Vitro Antitumor Drug Screen</span>. In  <span class="citation_source-book">Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development: Proceedings of the Twenty-Second Annual Cancer Symposium</span>, Detroit, Michigan, USA, April 26–28, 1990; <span class="NLM_contrib-group">Valeriote, F. A.; Corbett, T. H.; Baker, L. H.</span>, Eds.; <span class="NLM_publisher-name">Springer US</span>: <span class="NLM_publisher-loc">Boston, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1007%2F978-1-4615-3492-1_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=11-34&author=M.+R.+Boyd&author=K.+D.+Paull&author=L.+R.+Rubinsteinauthor=F.+A.+Valeriote&author=T.+H.+Corbett&author=L.+H.+Baker&title=Cytotoxic+Anticancer+Drugs%3A+Models+and+Concepts+for+Drug+Discovery+and+Development%3A+Proceedings+of+the+Twenty-Second+Annual+Cancer+Symposium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2F978-1-4615-3492-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4615-3492-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DData%2520Display%2520and%2520Analysis%2520Strategies%2520for%2520the%2520NCI%2520Disease-Oriented%2520in%2520Vitro%2520Antitumor%2520Drug%2520Screen%26btitle%3DCytotoxic%2520Anticancer%2520Drugs%253A%2520Models%2520and%2520Concepts%2520for%2520Drug%2520Discovery%2520and%2520Development%253A%2520Proceedings%2520of%2520the%2520Twenty-Second%2520Annual%2520Cancer%2520Symposium%26aulast%3DValeriote%26aufirst%3DF.%2BA.%26pub%3DSpringer%2520US%26date%3D1992%26spage%3D11%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Besselièvre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piguel, S.</span><span> </span><span class="NLM_article-title">Ligandless Microwave-Assisted Pd/Cu-Catalyzed Direct Arylation of Oxazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3278</span><span class="NLM_x">–</span> <span class="NLM_lpage">3280</span><span class="refDoi"> DOI: 10.1021/jo7027135</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo7027135" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=3278-3280&issue=8&author=F.+Besseli%C3%A8vreauthor=F.+Mahuteau-Betzerauthor=D.+S.+Griersonauthor=S.+Piguel&title=Ligandless+Microwave-Assisted+Pd%2FCu-Catalyzed+Direct+Arylation+of+Oxazoles&doi=10.1021%2Fjo7027135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo7027135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo7027135%26sid%3Dliteratum%253Aachs%26aulast%3DBesseli%25C3%25A8vre%26aufirst%3DF.%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26aulast%3DPiguel%26aufirst%3DS.%26atitle%3DLigandless%2520Microwave-Assisted%2520Pd%252FCu-Catalyzed%2520Direct%2520Arylation%2520of%2520Oxazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26issue%3D8%26spage%3D3278%26epage%3D3280%26doi%3D10.1021%2Fjo7027135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Giddens, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copp, B. R.</span><span> </span><span class="NLM_article-title">Antimycobacterial Natural Products: Synthesis and Preliminary Biological Evaluation of the Oxazole-Containing Alkaloid Texaline</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">7355</span><span class="NLM_x">–</span> <span class="NLM_lpage">7357</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2005.08.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.tetlet.2005.08.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVanur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=7355-7357&author=A.+C.+Giddensauthor=H.+I.+M.+Boshoffauthor=S.+G.+Franzblauauthor=C.+E.+Barryauthor=B.+R.+Copp&title=Antimycobacterial+Natural+Products%3A+Synthesis+and+Preliminary+Biological+Evaluation+of+the+Oxazole-Containing+Alkaloid+Texaline&doi=10.1016%2Fj.tetlet.2005.08.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antimycobacterial natural products: synthesis and preliminary biological evaluation of the oxazole-containing alkaloid texaline</span></div><div class="casAuthors">Giddens, Anna C.; Boshoff, Helena I. M.; Franzblau, Scott G.; Barry, Clifton E.; Copp, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">7355-7357</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Texaline (I), an antimycobacterial oxazole-contg. alkaloid previously isolated from Amyris texana and A. elemifera, and related compds. have been synthesized in order to explore aspects of the structure-antituberculosis activity relationship.  While texaline was found to be inactive in these assays, simpler diaryloxazoles were more active while also exhibiting modest toxic selectivity, leading to their identification as potential lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCBDtB-8tPzbVg90H21EOLACvtfcHk0limQuA8eyWxaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVanur7P&md5=dbe63c061eb460f5159135320fe8be72</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.08.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.08.119%26sid%3Dliteratum%253Aachs%26aulast%3DGiddens%26aufirst%3DA.%2BC.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26atitle%3DAntimycobacterial%2520Natural%2520Products%253A%2520Synthesis%2520and%2520Preliminary%2520Biological%2520Evaluation%2520of%2520the%2520Oxazole-Containing%2520Alkaloid%2520Texaline%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D7355%26epage%3D7357%26doi%3D10.1016%2Fj.tetlet.2005.08.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span><span class="refDoi"> DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+Amination+of+Aldehydes+and+Ketones+with+Sodium+Triacetoxyborohydride.+Studies+on+Direct+and+Indirect+Reductive+Amination+Procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0limQuA8eyWxaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520Amination%2520of%2520Aldehydes%2520and%2520Ketones%2520with%2520Sodium%2520Triacetoxyborohydride.%2520Studies%2520on%2520Direct%2520and%2520Indirect%2520Reductive%2520Amination%2520Procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendleton, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balko, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. A.</span><span> </span><span class="NLM_article-title">PIK3CA Mutations in Androgen Receptor-Positive Triple Negative Breast Cancer Confer Sensitivity to the Combination of PI3K and Androgen Receptor Inhibitors</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">406</span><span class="refDoi"> DOI: 10.1186/s13058-014-0406-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1186%2Fs13058-014-0406-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=25103565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2ltr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=406&issue=4&author=B.+D.+Lehmannauthor=J.+A.+Bauerauthor=J.+M.+Schaferauthor=C.+S.+Pendletonauthor=L.+Tangauthor=K.+C.+Johnsonauthor=X.+Chenauthor=J.+M.+Balkoauthor=H.+G%C3%B3mezauthor=C.+L.+Arteagaauthor=G.+B.+Millsauthor=M.+E.+Sandersauthor=J.+A.+Pietenpol&title=PIK3CA+Mutations+in+Androgen+Receptor-Positive+Triple+Negative+Breast+Cancer+Confer+Sensitivity+to+the+Combination+of+PI3K+and+Androgen+Receptor+Inhibitors&doi=10.1186%2Fs13058-014-0406-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors</span></div><div class="casAuthors">Lehmann, Brian D.; Bauer, Joshua A.; Schafer, Johanna M.; Pendleton, Christopher S.; Tang, Luojia; Johnson, Kimberly C.; Chen, Xi; Balko, Justin M.; Gomez, Henry; Arteaga, Carlos L.; Mills, Gordon B.; Sanders, Melinda E.; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">406/1-406/26</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Triple neg. breast cancer (TNBC) is a heterogeneous collection of biol. diverse cancers, which contributes to variable clin. outcomes.  Previously, we identified a TNBC subtype that has a luminal phenotype and expresses the androgen receptor (AR+).  TNBC cells derived from these luminal AR + tumors have high frequency phosphatidylinositol-4,5- bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations.  The purpose of this study was to det. if targeting phosphoinositide 3-kinase (PI3K) alone or in combination with an AR antagonist is effective in AR + TNBC.  We detd. the frequency of activating PIK3CA mutations in AR + and AR- TNBC clin. cases.  Using AR + TNBC cell line and xenograft models we evaluated the effectiveness of PI3K inhibitors, used alone or in combination with an AR antagonist, on tumor cell growth and viability.  PIK3CA kinase mutations were highly clonal, more frequent in AR + vs.  AR- TNBC (40% vs. 4%), and often assocd. with concurrent amplification of the PIK3CA locus.  PI3K/mTOR inhibitors had an additive growth inhibitory effect when combined with genetic or pharmacol. AR targeting in AR + TNBC cells.  We also analyzed the combination of bicalutamide +/- the pan-PI3K inhibitor GDC-0941 or the dual PI3K/mTOR inhibitor GDC-0980 in xenograft tumor studies and obsd. additive effects.  While approx. one third of TNBC patients respond to neoadjuvant/adjuvant chemotherapy, recent studies have shown that patients with androgen receptor pos. (AR+) TNBC are far less likely to benefit from the current std. of care chemotherapy regimens and novel targeted approaches need to be investigated.  In this study, we show that activating PIK3CA mutations are enriched in AR + TNBC; and, we show that the growth and viability of AR + TNBC cell line models is significantly reduced after treatment with PI3K inhibitors used in combination with an AR antagonist.  These results provide rationale for pre-selection of TNBC patients with a biomarker (AR expression) to investigate the use of AR antagonists in combination with PI3K/mTOR inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmleFMAS1kQbVg90H21EOLACvtfcHk0ljhEpge4I8cQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2ltr%252FN&md5=d9521bd84e970b86dd7d9355b3b73b5a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2Fs13058-014-0406-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13058-014-0406-x%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DBauer%26aufirst%3DJ.%2BA.%26aulast%3DSchafer%26aufirst%3DJ.%2BM.%26aulast%3DPendleton%26aufirst%3DC.%2BS.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DK.%2BC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBalko%26aufirst%3DJ.%2BM.%26aulast%3DG%25C3%25B3mez%26aufirst%3DH.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26atitle%3DPIK3CA%2520Mutations%2520in%2520Androgen%2520Receptor-Positive%2520Triple%2520Negative%2520Breast%2520Cancer%2520Confer%2520Sensitivity%2520to%2520the%2520Combination%2520of%2520PI3K%2520and%2520Androgen%2520Receptor%2520Inhibitors%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2014%26volume%3D16%26issue%3D4%26spage%3D406%26doi%3D10.1186%2Fs13058-014-0406-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">O’Reilly, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Q.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1500</span><span class="NLM_x">–</span> <span class="NLM_lpage">1508</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1158%2F0008-5472.CAN-05-2925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=16452206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVegtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1500-1508&issue=3&author=K.+E.+O%E2%80%99Reillyauthor=F.+Rojoauthor=Q.-B.+Sheauthor=D.+Solitauthor=G.+B.+Millsauthor=D.+Smithauthor=H.+Laneauthor=F.+Hofmannauthor=D.+J.+Hicklinauthor=D.+L.+Ludwigauthor=J.+Baselgaauthor=N.+Rosen&title=mTOR+Inhibition+Induces+Upstream+Receptor+Tyrosine+Kinase+Signaling+and+Activates+Akt&doi=10.1158%2F0008-5472.CAN-05-2925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt</span></div><div class="casAuthors">O'Reilly, Kathryn E.; Rojo, Fredi; She, Qing-Bai; Solit, David; Mills, Gordon B.; Smith, Debra; Lane, Heidi; Hofmann, Francesco; Hicklin, Daniel J.; Ludwig, Dale L.; Baselga, Jose; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1500-1508</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Stimulation of the insulin and insulin-like growth factor I (IGF-I) receptor activates the phosphoinositide-3-kinase/Akt/mTOR pathway causing pleiotropic cellular effects including an mTOR-dependent loss in insulin receptor substrate-1 expression leading to feedback down-regulation of signaling through the pathway.  In model systems, tumors exhibiting mutational activation of phosphoinositide-3-kinase/Akt kinase, a common event in cancers, are hypersensitive to mTOR inhibitors, including rapamycin.  Despite the activity in model systems, in patients, mTOR inhibitors exhibit more modest antitumor activity.  We now show that mTOR inhibition induces insulin receptor substrate-1 expression and abrogates feedback inhibition of the pathway, resulting in Akt activation both in cancer cell lines and in patient tumors treated with the rapamycin deriv., RAD001.  IGF-I receptor inhibition prevents rapamycin-induced Akt activation and sensitizes tumor cells to inhibition of mTOR.  In contrast, IGF-I reverses the antiproliferative effects of rapamycin in serum-free medium.  The data suggest that feedback down-regulation of receptor tyrosine kinase signaling is a frequent event in tumor cells with constitutive mTOR activation.  Reversal of this feedback loop by rapamycin may attenuate its therapeutic effects, whereas combination therapy that ablates mTOR function and prevents Akt activation may have improved antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIDQUdQ-jbi7Vg90H21EOLACvtfcHk0ljhEpge4I8cQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVegtg%253D%253D&md5=758cd9999dc156bf498edf32174fc2e7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2925%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DK.%2BE.%26aulast%3DRojo%26aufirst%3DF.%26aulast%3DShe%26aufirst%3DQ.-B.%26aulast%3DSolit%26aufirst%3DD.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DLane%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DF.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DLudwig%26aufirst%3DD.%2BL.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DmTOR%2520Inhibition%2520Induces%2520Upstream%2520Receptor%2520Tyrosine%2520Kinase%2520Signaling%2520and%2520Activates%2520Akt%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D3%26spage%3D1500%26epage%3D1508%26doi%3D10.1158%2F0008-5472.CAN-05-2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Masuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baggerly, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Angulo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meric-Bernstam, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietenpol, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symmans, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, N. T.</span><span> </span><span class="NLM_article-title">Differential Response to Neoadjuvant Chemotherapy among 7 Triple-Negative Breast Cancer Molecular Subtypes</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5533</span><span class="NLM_x">–</span> <span class="NLM_lpage">5540</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-0799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1158%2F1078-0432.CCR-13-0799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=23948975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFynsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=5533-5540&issue=19&author=H.+Masudaauthor=K.+A.+Baggerlyauthor=Y.+Wangauthor=Y.+Zhangauthor=A.+M.+Gonzalez-Anguloauthor=F.+Meric-Bernstamauthor=V.+Valeroauthor=B.+D.+Lehmannauthor=J.+A.+Pietenpolauthor=G.+N.+Hortobagyiauthor=W.+F.+Symmansauthor=N.+T.+Ueno&title=Differential+Response+to+Neoadjuvant+Chemotherapy+among+7+Triple-Negative+Breast+Cancer+Molecular+Subtypes&doi=10.1158%2F1078-0432.CCR-13-0799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes</span></div><div class="casAuthors">Masuda, Hiroko; Baggerly, Keith A.; Wang, Ying; Zhang, Ya; Gonzalez-Angulo, Ana Maria; Meric-Bernstam, Funda; Valero, Vicente; Lehmann, Brian D.; Pietenpol, Jennifer A.; Hortobagyi, Gabriel N.; Symmans, W. Fraser; Ueno, Naoto T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5533-5540</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The clin. relevancy of the 7-subtype classification of triple-neg. breast cancer (TNBC) reported by Lehmann and colleagues is unknown.  We investigated the clin. relevancy of TNBC heterogeneity by detg. pathol. complete response (pCR) rates after neoadjuvant chemotherapy, based on TNBC subtypes.  Exptl. Design: We revalidated the Lehmann and colleagues expts. using Affymetrix CEL files from public datasets.  We applied these methods to 146 patients with TNBC with gene expression microarrays obtained from June 2000 to March 2010 at our institution.  Of those, 130 had received std. neoadjuvant chemotherapy and had evaluable pathol. response data.  We classified the TNBC samples by subtype and then correlated subtype and pCR status using Fisher exact test and a logistic regression model.  We also assessed survival and compared the subtypes with PAM50 intrinsic subtypes and residual cancer burden (RCB) index.  Results: TNBC subtype and pCR status were significantly assocd. (P = 0.04379).  The basal-like 1 (BL1) subtype had the highest pCR rate (52%); basal-like 2 (BL2) and luminal androgen receptor had the lowest (0% and 10%, resp.).  TNBC subtype was an independent predictor of pCR status (P = 0.022) by a likelihood ratio test.  The subtypes better predicted pCR status than did the PAM50 intrinsic subtypes (basal-like vs. non basal-like).  Conclusions: Classifying TNBC by 7 subtypes predicts high vs. low pCR rate.  We confirm the clin. relevancy of the 7 subtypes of TNBC.  We need to prospectively validate whether the pCR rate differences translate into long-term outcome differences.  The 7-subtype classification may spur innovative personalized medicine strategies for patients with TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqWCdcnpnUTrVg90H21EOLACvtfcHk0ljLiws2gE5C3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFynsL7P&md5=a98409bc9f49e7948b21cde4c39df3ea</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0799%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DH.%26aulast%3DBaggerly%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGonzalez-Angulo%26aufirst%3DA.%2BM.%26aulast%3DMeric-Bernstam%26aufirst%3DF.%26aulast%3DValero%26aufirst%3DV.%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26aulast%3DSymmans%26aufirst%3DW.%2BF.%26aulast%3DUeno%26aufirst%3DN.%2BT.%26atitle%3DDifferential%2520Response%2520to%2520Neoadjuvant%2520Chemotherapy%2520among%25207%2520Triple-Negative%2520Breast%2520Cancer%2520Molecular%2520Subtypes%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26issue%3D19%26spage%3D5533%26epage%3D5540%26doi%3D10.1158%2F1078-0432.CCR-13-0799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risinger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, T. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichewicz, R. H.</span><span> </span><span class="NLM_article-title">Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00874</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00874" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=490-498&author=S.+Caiauthor=A.+L.+Risingerauthor=S.+Nairauthor=J.+Pengauthor=T.+J.+C.+Andersonauthor=L.+Duauthor=D.+R.+Powellauthor=S.+L.+Mooberryauthor=R.+H.+Cichewicz&title=Identification+of+Compounds+with+Efficacy+against+Malaria+Parasites+from+Common+North+American+Plants&doi=10.1021%2Facs.jnatprod.5b00874"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00874%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DNair%26aufirst%3DS.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26aulast%3DCichewicz%26aufirst%3DR.%2BH.%26atitle%3DIdentification%2520of%2520Compounds%2520with%2520Efficacy%2520against%2520Malaria%2520Parasites%2520from%2520Common%2520North%2520American%2520Plants%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D490%26epage%3D498%26doi%3D10.1021%2Facs.jnatprod.5b00874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hasbum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, O.</span><span> </span><span class="NLM_article-title">A New Benzamide from Bark of Amyris Brenesii</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span><span class="refDoi"> DOI: 10.1021/np50058a035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50058a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1988&pages=817-818&issue=4&author=C.+Hasbumauthor=O.+Castro&title=A+New+Benzamide+from+Bark+of+Amyris+Brenesii&doi=10.1021%2Fnp50058a035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fnp50058a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50058a035%26sid%3Dliteratum%253Aachs%26aulast%3DHasbum%26aufirst%3DC.%26aulast%3DCastro%26aufirst%3DO.%26atitle%3DA%2520New%2520Benzamide%2520from%2520Bark%2520of%2520Amyris%2520Brenesii%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1988%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D818%26doi%3D10.1021%2Fnp50058a035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. H.</span><span> </span><span class="NLM_article-title">Indium-Mediated One-Pot Synthesis of Benzoxazoles or Oxazoles from 2-Nitrophenols or 1-Aryl-2-Nitroethanones</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">43</span><span class="NLM_x">) </span> <span class="NLM_fpage">8821</span><span class="NLM_x">–</span> <span class="NLM_lpage">8831</span><span class="refDoi"> DOI: 10.1016/j.tet.2009.08.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.tet.2009.08.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=8821-8831&issue=43&author=J.+J.+Leeauthor=J.+Kimauthor=Y.+M.+Junauthor=B.+M.+Leeauthor=B.+H.+Kim&title=Indium-Mediated+One-Pot+Synthesis+of+Benzoxazoles+or+Oxazoles+from+2-Nitrophenols+or+1-Aryl-2-Nitroethanones&doi=10.1016%2Fj.tet.2009.08.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2009.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2009.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DY.%2BM.%26aulast%3DLee%26aufirst%3DB.%2BM.%26aulast%3DKim%26aufirst%3DB.%2BH.%26atitle%3DIndium-Mediated%2520One-Pot%2520Synthesis%2520of%2520Benzoxazoles%2520or%2520Oxazoles%2520from%25202-Nitrophenols%2520or%25201-Aryl-2-Nitroethanones%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26issue%3D43%26spage%3D8821%26epage%3D8831%26doi%3D10.1016%2Fj.tet.2009.08.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piguel, S.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Photophysical Properties of Series of π-Conjugated Oxazole Dyes</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">3188</span><span class="NLM_x">–</span> <span class="NLM_lpage">3193</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2013.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1016%2Fj.tetlet.2013.04.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=3188-3193&issue=24&author=F.+Mahuteau-Betzerauthor=S.+Piguel&title=Synthesis+and+Evaluation+of+Photophysical+Properties+of+Series+of+%CF%80-Conjugated+Oxazole+Dyes&doi=10.1016%2Fj.tetlet.2013.04.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2013.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2013.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DPiguel%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Photophysical%2520Properties%2520of%2520Series%2520of%2520%25CF%2580-Conjugated%2520Oxazole%2520Dyes%26jtitle%3DTetrahedron%2520Lett.%26date%3D2013%26volume%3D54%26issue%3D24%26spage%3D3188%26epage%3D3193%26doi%3D10.1016%2Fj.tetlet.2013.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Krishan, A.</span><span> </span><span class="NLM_article-title">Rapid Flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span><span class="refDoi"> DOI: 10.1083/jcb.66.1.188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;key=10.1083%2Fjcb.66.1.188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1975&pages=188-193&author=A.+Krishan&title=Rapid+Flow+cytofluorometric+analysis+of+mammalian+cell+cycle+by+propidium+iodide+staining&doi=10.1083%2Fjcb.66.1.188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1083%2Fjcb.66.1.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.66.1.188%26sid%3Dliteratum%253Aachs%26aulast%3DKrishan%26aufirst%3DA.%26atitle%3DRapid%2520Flow%2520cytofluorometric%2520analysis%2520of%2520mammalian%2520cell%2520cycle%2520by%2520propidium%2520iodide%2520staining%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1975%26volume%3D66%26spage%3D188%26epage%3D193%26doi%3D10.1083%2Fjcb.66.1.188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01228">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_70157"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01228">10.1021/acs.jmedchem.7b01228</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C, gCOSY, and NOESY2D NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01228/suppl_file/jm7b01228_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular strings file (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01228/suppl_file/jm7b01228_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01228/suppl_file/jm7b01228_si_001.pdf">jm7b01228_si_001.pdf (1.47 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01228/suppl_file/jm7b01228_si_002.csv">jm7b01228_si_002.csv (1.62 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01228&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-22%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01228" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01228" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6798ff1d88bd23c8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
